Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\\n\\n
We wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
IntechOpen is proud to announce that 191 of our authors have made the Clarivate™ Highly Cited Researchers List for 2020, ranking them among the top 1% most-cited.
\n\n
Throughout the years, the list has named a total of 261 IntechOpen authors as Highly Cited. Of those researchers, 69 have been featured on the list multiple times.
\n\n\n\n
Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\n\n
We wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\n'}],latestNews:[{slug:"intechopen-supports-asapbio-s-new-initiative-publish-your-reviews-20220729",title:"IntechOpen Supports ASAPbio’s New Initiative Publish Your Reviews"},{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"}]},book:{item:{type:"book",id:"551",leadTitle:null,fullTitle:"Antiviral Drugs - Aspects of Clinical Use and Recent Advances",title:"Antiviral Drugs",subtitle:"Aspects of Clinical Use and Recent Advances",reviewType:"peer-reviewed",abstract:"The articles that appear in Antiviral Drugs - Aspects of Clinical Use and Recent Advances cover several topics that reflect the varied mechanisms of viral disease pathogenesis and treatment. Clinical management and new developments in the treatment of virus-related diseases are the two main sections of the book. The first part reviews the treatment of hepatitis C virus infection, the management of virus-related acute retinal necrosis, the use of leflunomide therapy in renal transplant patients, and mathematical modeling of HIV-1 treatment responses. Basic research topics are dealt with in the second half of the book. New developments in the treatment of the influenza virus, the use of animal models for HIV-1 drug development, the use of single chain camelid antibodies against negative strand RNA viruses, countering norovirus infection, and the use of plant extracts to treat herpes simplex virus infection are described. The content of the book is not intended to be comprehensive, but aims to provide the reader with insights into selected aspects of established and new viral therapies.",isbn:null,printIsbn:"978-953-51-0256-4",pdfIsbn:"978-953-51-6885-0",doi:"10.5772/1061",price:119,priceEur:129,priceUsd:155,slug:"antiviral-drugs-aspects-of-clinical-use-and-recent-advances",numberOfPages:208,isOpenForSubmission:!1,isInWos:null,isInBkci:!1,hash:"4a607111d1bca42ff287b1cfac2468c0",bookSignature:"Patrick Arbuthnot",publishedDate:"March 14th 2012",coverURL:"https://cdn.intechopen.com/books/images_new/551.jpg",numberOfDownloads:27670,numberOfWosCitations:16,numberOfCrossrefCitations:7,numberOfCrossrefCitationsByBook:2,numberOfDimensionsCitations:15,numberOfDimensionsCitationsByBook:3,hasAltmetrics:0,numberOfTotalCitations:38,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"April 5th 2011",dateEndSecondStepPublish:"May 3rd 2011",dateEndThirdStepPublish:"September 7th 2011",dateEndFourthStepPublish:"October 7th 2011",dateEndFifthStepPublish:"February 6th 2012",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"88695",title:"Dr.",name:"Patrick",middleName:null,surname:"Arbuthnot",slug:"patrick-arbuthnot",fullName:"Patrick Arbuthnot",profilePictureURL:"https://mts.intechopen.com/storage/users/88695/images/2355_n.jpg",biography:"Patrick Arbuthnot is Personal Professor and Director of the Antiviral Gene Therapy Research Unit of the University of the Witwatersrand (Wits) in South Africa. After graduating with a medical degree from Wits, Patrick Arbuthnot completed a PhD in 1992. From 1993 to 1994, he worked as a post-doctoral researcher at Necker Hospital in Paris, and investigated the development of gene therapy for treating liver cancer and hepatitis B virus (HBV) infection. On returning to South Africa, Patrick Arbuthnot established the Antiviral Gene Therapy Research Unit. This unit is now a Centre of Excellence of the African Network for Drug and Diagnostic Innovation (ANDI). The unit has a research interest in HBV infection, liver cancer, HIV-1 infection and developing new methods of treating these diseases.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"University of the Witwatersrand",institutionURL:null,country:{name:"South Africa"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1189",title:"Pharmacotherapy",slug:"drug-discovery-pharmacotherapy"}],chapters:[{id:"31797",title:"Antiviral Therapy in HCV-Infected Decompensated Cirrhotics",doi:"10.5772/28294",slug:"antiviral-therapy-in-hcv-infected-decompensated-cirrhotics",totalDownloads:1702,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Fazal-I-Akbar Danish",downloadPdfUrl:"/chapter/pdf-download/31797",previewPdfUrl:"/chapter/pdf-preview/31797",authors:[{id:"73403",title:"Dr.",name:"Fazal-I-Akbar",surname:"Danish",slug:"fazal-i-akbar-danish",fullName:"Fazal-I-Akbar Danish"}],corrections:null},{id:"31798",title:"Virus Diagnostics and Antiviral Therapy in Acute Retinal Necrosis (ARN)",doi:"10.5772/34141",slug:"virus-diagnostics-and-antiviral-therapy-in-acute-retinal-necrosis-",totalDownloads:2973,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Peter Rautenberg, Jost Hillenkamp, Livia Grančičova, Bernhard Nölle, Johann Roider and Helmut Fickenscher",downloadPdfUrl:"/chapter/pdf-download/31798",previewPdfUrl:"/chapter/pdf-preview/31798",authors:[{id:"31956",title:"Prof.",name:"Helmut",surname:"Fickenscher",slug:"helmut-fickenscher",fullName:"Helmut Fickenscher"},{id:"98884",title:"Prof.",name:"Peter",surname:"Rautenberg",slug:"peter-rautenberg",fullName:"Peter Rautenberg"},{id:"100689",title:"Dr.",name:"Jost",surname:"Hillenkamp",slug:"jost-hillenkamp",fullName:"Jost Hillenkamp"},{id:"100691",title:"Dr.",name:"Livia",surname:"Grančičova",slug:"livia-grancicova",fullName:"Livia Grančičova"},{id:"100697",title:"Dr.",name:"Bernhard",surname:"Nölle",slug:"bernhard-nolle",fullName:"Bernhard Nölle"},{id:"100698",title:"Prof.",name:"Johann",surname:"Roider",slug:"johann-roider",fullName:"Johann Roider"}],corrections:null},{id:"31799",title:"Leflunomide an Immunosuppressive Drug for Antiviral Purpose in Treatment for BK Virus-Associated Nephropathy After Kidney Transplantation",doi:"10.5772/32657",slug:"leflunomide-an-immunosuppressive-drug-for-antiviral-purpose-in-treatment-for-bk-virus-nephropathy-af",totalDownloads:3795,totalCrossrefCites:3,totalDimensionsCites:3,hasAltmetrics:0,abstract:null,signatures:"Christophe Bazin",downloadPdfUrl:"/chapter/pdf-download/31799",previewPdfUrl:"/chapter/pdf-preview/31799",authors:[{id:"92266",title:"Dr.",name:"Christophe",surname:"Bazin",slug:"christophe-bazin",fullName:"Christophe Bazin"}],corrections:null},{id:"31800",title:"Modeling Virologic Response in HIV-1 Infected Patients to Assess Medication Adherence",doi:"10.5772/33471",slug:"modeling-virologic-response-in-hiv-1-infected-patients-to-assess-medication-adherence",totalDownloads:2028,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Yangxin Huang",downloadPdfUrl:"/chapter/pdf-download/31800",previewPdfUrl:"/chapter/pdf-preview/31800",authors:[{id:"95708",title:"Prof.",name:"Yangxin",surname:"Huang",slug:"yangxin-huang",fullName:"Yangxin Huang"}],corrections:null},{id:"31801",title:"Use of Animal Models for Anti-HIV Drug Development",doi:"10.5772/33484",slug:"use-of-animal-models-for-anti-hiv-drug-development",totalDownloads:3836,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Zandrea Ambrose",downloadPdfUrl:"/chapter/pdf-download/31801",previewPdfUrl:"/chapter/pdf-preview/31801",authors:[{id:"95788",title:"Dr.",name:"Zandrea",surname:"Ambrose",slug:"zandrea-ambrose",fullName:"Zandrea Ambrose"}],corrections:null},{id:"31802",title:"Discovery of Novel Antiviral Agents Directed Against the Influenza A Virus Nucleoprotein",doi:"10.5772/33573",slug:"discovery-of-novel-antiviral-agents-directed-against-the-influenza-a-virus-nucleoprotein",totalDownloads:2742,totalCrossrefCites:1,totalDimensionsCites:5,hasAltmetrics:0,abstract:null,signatures:"Yoko Aida, Yutaka Sasaki and Kyoji Hagiwara",downloadPdfUrl:"/chapter/pdf-download/31802",previewPdfUrl:"/chapter/pdf-preview/31802",authors:[{id:"96209",title:"Dr.",name:"Yoko",surname:"Aida",slug:"yoko-aida",fullName:"Yoko Aida"},{id:"100602",title:"Dr.",name:"Kyoji",surname:"Hagiwara",slug:"kyoji-hagiwara",fullName:"Kyoji Hagiwara"},{id:"100606",title:"Dr.",name:"Yutaka",surname:"Sasaki",slug:"yutaka-sasaki",fullName:"Yutaka Sasaki"}],corrections:null},{id:"31803",title:"Targeting Norovirus: Strategies for the Discovery of New Antiviral Drugs",doi:"10.5772/32677",slug:"targeting-norovirus-strategies-for-the-discovery-of-new-antiviral-drugs",totalDownloads:4263,totalCrossrefCites:2,totalDimensionsCites:3,hasAltmetrics:0,abstract:null,signatures:"Joana Rocha-Pereira and Maria São José Nascimento",downloadPdfUrl:"/chapter/pdf-download/31803",previewPdfUrl:"/chapter/pdf-preview/31803",authors:[{id:"92307",title:"Prof.",name:"Maria São José",surname:"Nascimento",slug:"maria-sao-jose-nascimento",fullName:"Maria São José Nascimento"},{id:"98474",title:"MSc.",name:"Joana",surname:"Rocha-Pereira",slug:"joana-rocha-pereira",fullName:"Joana Rocha-Pereira"}],corrections:null},{id:"31804",title:"Single Domain Camelid Antibodies that Neutralize Negative Strand Viruses",doi:"10.5772/34009",slug:"single-domain-camelid-antibodies-that-neutralize-negative-strand-viruses",totalDownloads:3112,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Francisco Miguel Lopez Cardoso, Lorena Itatí Ibañez, Bert Schepens and Xavier Saelens",downloadPdfUrl:"/chapter/pdf-download/31804",previewPdfUrl:"/chapter/pdf-preview/31804",authors:[{id:"98266",title:"Prof.",name:"Xavier",surname:"Saelens",slug:"xavier-saelens",fullName:"Xavier Saelens"},{id:"98285",title:"Mr.",name:"Miguel",surname:"Cardoso",slug:"miguel-cardoso",fullName:"Miguel Cardoso"},{id:"98287",title:"Dr.",name:"Lorena Itatí",surname:"Ibañez",slug:"lorena-itati-ibanez",fullName:"Lorena Itatí Ibañez"},{id:"98290",title:"Dr.",name:"Bert",surname:"Schepens",slug:"bert-schepens",fullName:"Bert Schepens"}],corrections:null},{id:"31805",title:"Treatment of Herpes Simplex Virus with Lignin-Carbohydrate Complex Tablet, an Alternative Therapeutic Formula",doi:"10.5772/32975",slug:"treatment-of-herpes-simplex-virus-with-lignin-carbohydrate-complex-tablet-an-alternative-therapeutic",totalDownloads:3222,totalCrossrefCites:1,totalDimensionsCites:2,hasAltmetrics:0,abstract:null,signatures:"Blanca Silvia González López, Masaji Yamamoto and Hiroshi Sakagami",downloadPdfUrl:"/chapter/pdf-download/31805",previewPdfUrl:"/chapter/pdf-preview/31805",authors:[{id:"82603",title:"Prof.",name:"Hiroshi",surname:"Sakagami",slug:"hiroshi-sakagami",fullName:"Hiroshi Sakagami"},{id:"93425",title:"Dr.",name:"Blanca",surname:"González-López",slug:"blanca-gonzalez-lopez",fullName:"Blanca González-López"},{id:"97471",title:"Mr.",name:"Masaji",surname:"Yamamoto",slug:"masaji-yamamoto",fullName:"Masaji Yamamoto"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"3853",title:"Pharmacology and Therapeutics",subtitle:null,isOpenForSubmission:!1,hash:"09f9295bff8acbce8a68f3c329d51cd7",slug:"pharmacology-and-therapeutics",bookSignature:"Sivakumar Joghi Thatha Gowder",coverURL:"https://cdn.intechopen.com/books/images_new/3853.jpg",editedByType:"Edited by",editors:[{id:"118572",title:"Dr.",name:"Sivakumar Joghi",surname:"Thatha Gowder",slug:"sivakumar-joghi-thatha-gowder",fullName:"Sivakumar Joghi Thatha Gowder"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1516",title:"Pharmacotherapy",subtitle:null,isOpenForSubmission:!1,hash:"5913f56353d16d5484d5a0955843db96",slug:"pharmacotherapy",bookSignature:"Farid Badria",coverURL:"https://cdn.intechopen.com/books/images_new/1516.jpg",editedByType:"Edited by",editors:[{id:"41865",title:"Prof.",name:"Farid A.",surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2270",title:"Fourier Transform",subtitle:"Materials Analysis",isOpenForSubmission:!1,hash:"5e094b066da527193e878e160b4772af",slug:"fourier-transform-materials-analysis",bookSignature:"Salih Mohammed Salih",coverURL:"https://cdn.intechopen.com/books/images_new/2270.jpg",editedByType:"Edited by",editors:[{id:"111691",title:"Dr.Ing.",name:"Salih",surname:"Salih",slug:"salih-salih",fullName:"Salih Salih"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"117",title:"Artificial Neural Networks",subtitle:"Methodological Advances and Biomedical Applications",isOpenForSubmission:!1,hash:null,slug:"artificial-neural-networks-methodological-advances-and-biomedical-applications",bookSignature:"Kenji Suzuki",coverURL:"https://cdn.intechopen.com/books/images_new/117.jpg",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3828",title:"Application of Nanotechnology in Drug Delivery",subtitle:null,isOpenForSubmission:!1,hash:"51a27e7adbfafcfedb6e9683f209cba4",slug:"application-of-nanotechnology-in-drug-delivery",bookSignature:"Ali Demir Sezer",coverURL:"https://cdn.intechopen.com/books/images_new/3828.jpg",editedByType:"Edited by",editors:[{id:"62389",title:"PhD.",name:"Ali Demir",surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"79356",slug:"corrigendum-to-dermatoscopic-features-of-basal-cell-carcinoma",title:"Corrigendum to: Dermatoscopic Features of Basal Cell Carcinoma",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/81445.pdf",downloadPdfUrl:"/chapter/pdf-download/81445",previewPdfUrl:"/chapter/pdf-preview/81445",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/81445",risUrl:"/chapter/ris/81445",chapter:{id:"78974",slug:"dermatoscopic-features-of-basal-cell-carcinoma",signatures:"Tina Zagar, Nika Hlaca and Larisa Prpic-Massari",dateSubmitted:"July 9th 2021",dateReviewed:"September 10th 2021",datePrePublished:"October 15th 2021",datePublished:"March 23rd 2022",book:{id:"11014",title:"Dermatoscopy",subtitle:null,fullTitle:"Dermatoscopy",slug:"dermatoscopy",publishedDate:"March 23rd 2022",bookSignature:"Paweł Pietkiewicz",coverURL:"https://cdn.intechopen.com/books/images_new/11014.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"164394",title:"Ph.D.",name:"Paweł",middleName:"Piotr",surname:"Pietkiewicz",slug:"pawel-pietkiewicz",fullName:"Paweł Pietkiewicz"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"355350",title:"Prof.",name:"Larisa",middleName:null,surname:"Prpic-Massari",fullName:"Larisa Prpic-Massari",slug:"larisa-prpic-massari",email:"larisa.prpic@medri.uniri.hr",position:null,institution:null},{id:"355372",title:"Dr.",name:"Nika",middleName:null,surname:"Hlaca",fullName:"Nika Hlaca",slug:"nika-hlaca",email:"nika.hlaca@uniri.hr",position:null,institution:{name:"Klinički bolnički centar Rijeka",institutionURL:null,country:{name:"Croatia"}}},{id:"355373",title:"Dr.",name:"Tina",middleName:null,surname:"Zagar",fullName:"Tina Zagar",slug:"tina-zagar",email:"tinazagar89@gmail.com",position:null,institution:{name:"Klinički bolnički centar Rijeka",institutionURL:null,country:{name:"Croatia"}}}]}},chapter:{id:"78974",slug:"dermatoscopic-features-of-basal-cell-carcinoma",signatures:"Tina Zagar, Nika Hlaca and Larisa Prpic-Massari",dateSubmitted:"July 9th 2021",dateReviewed:"September 10th 2021",datePrePublished:"October 15th 2021",datePublished:"March 23rd 2022",book:{id:"11014",title:"Dermatoscopy",subtitle:null,fullTitle:"Dermatoscopy",slug:"dermatoscopy",publishedDate:"March 23rd 2022",bookSignature:"Paweł Pietkiewicz",coverURL:"https://cdn.intechopen.com/books/images_new/11014.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"164394",title:"Ph.D.",name:"Paweł",middleName:"Piotr",surname:"Pietkiewicz",slug:"pawel-pietkiewicz",fullName:"Paweł Pietkiewicz"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"355350",title:"Prof.",name:"Larisa",middleName:null,surname:"Prpic-Massari",fullName:"Larisa Prpic-Massari",slug:"larisa-prpic-massari",email:"larisa.prpic@medri.uniri.hr",position:null,institution:null},{id:"355372",title:"Dr.",name:"Nika",middleName:null,surname:"Hlaca",fullName:"Nika Hlaca",slug:"nika-hlaca",email:"nika.hlaca@uniri.hr",position:null,institution:{name:"Klinički bolnički centar Rijeka",institutionURL:null,country:{name:"Croatia"}}},{id:"355373",title:"Dr.",name:"Tina",middleName:null,surname:"Zagar",fullName:"Tina Zagar",slug:"tina-zagar",email:"tinazagar89@gmail.com",position:null,institution:{name:"Klinički bolnički centar Rijeka",institutionURL:null,country:{name:"Croatia"}}}]},book:{id:"11014",title:"Dermatoscopy",subtitle:null,fullTitle:"Dermatoscopy",slug:"dermatoscopy",publishedDate:"March 23rd 2022",bookSignature:"Paweł Pietkiewicz",coverURL:"https://cdn.intechopen.com/books/images_new/11014.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"164394",title:"Ph.D.",name:"Paweł",middleName:"Piotr",surname:"Pietkiewicz",slug:"pawel-pietkiewicz",fullName:"Paweł Pietkiewicz"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"11438",leadTitle:null,title:"Fake News in the Era of Global Crises",subtitle:null,reviewType:"peer-reviewed",abstract:"
\r\n\tTruth is the first casualty of war, they say, and war is one type of crisis in the world today. In war or any other crisis, information is power, and misinformation or disinformation empowers some and disempowers others. This volume will explore the use or the accusation of “fake news” and other kinds of false or falsified knowledge (conspiracy theories, hoaxes, suppression of facts, false flags, science denial, etc.) in the context of multiple concurrent crises in the contemporary world, from war and pandemics to climate change, economic emergencies, right-wing populism, and recurring gun violence. Contributions from a variety of disciplines and with an international perspective examine how fake information in all its forms is activated to outrage, confuse, and motivate the public, while accusations of fakery against scientists, journalists, and academics serve to discredit, marginalize, and silence potential opposition to the interests of corporate and governmental players. The studies illustrate that fake news, propaganda, strategic communication, and information warfare are exercises of power that create a fog of doubt and ignorance to interfere with public discourse and cripple public action.
",isbn:"978-1-83768-346-8",printIsbn:"978-1-83768-345-1",pdfIsbn:"978-1-83768-347-5",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,isSalesforceBook:!1,isNomenclature:!1,hash:"5f61f975031e13ee705d8b5853f1aa58",bookSignature:"Dr. David Eller",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11438.jpg",keywords:"Conspiracy Theory, Propaganda, Non-mainstream News, Social Media, Strategic Communication, Information Warfare, COVID, Anti-vaccination, Global Warming, Climate Change, Anti-immigration, Authoritarianism",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"June 8th 2022",dateEndSecondStepPublish:"July 6th 2022",dateEndThirdStepPublish:"September 4th 2022",dateEndFourthStepPublish:"November 23rd 2022",dateEndFifthStepPublish:"January 22nd 2023",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"a month",secondStepPassed:!0,areRegistrationsClosed:!1,currentStepOfPublishingProcess:3,editedByType:null,kuFlag:!1,biosketch:"Dr. Jack David Eller is a cultural anthropologist and Head of Global Anthropology of Religion for the Global Center for Religion Research. He is the author of numerous essays and book chapters as well as several books on cultural anthropology, religion and anthropology of religion, ethnicity and cultural diversity, ethnic and religious violence, psychological anthropology, and contemporary populism and authoritarianism.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"476616",title:"Dr.",name:"Jack",middleName:"David",surname:"Eller",slug:"jack-eller",fullName:"Jack Eller",profilePictureURL:"https://mts.intechopen.com/storage/users/476616/images/system/476616.jpg",biography:'Jack David Eller is a cultural anthropologist and Head of Global Anthropology of Religion for the Global Center for Religion Research. Since his fieldwork in Australia on Aboriginal culture and religion, his interests have grown to include religion and religious violence, ethnic conflict, culture theory and culture change, and political theology. He is the author of numerous essays and book chapters as well as several books on cultural anthropology, religion and anthropology of religion, ethnicity and cultural diversity, ethnic and religious violence, psychological anthropology, and contemporary populism and authoritarianism. Most recently, he authored "Trump and Political Theology: Unmaking Truth and Democracy" and edited "The Anthropology of Trump: Culture and the Exceptional Moment."',institutionString:"Global Center for Religion Research",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:null}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"23",title:"Social Sciences",slug:"social-sciences"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"225753",firstName:"Marina",lastName:"Dusevic",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/225753/images/7224_n.png",email:"marina.d@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6942",title:"Global Social Work",subtitle:"Cutting Edge Issues and Critical Reflections",isOpenForSubmission:!1,hash:"222c8a66edfc7a4a6537af7565bcb3de",slug:"global-social-work-cutting-edge-issues-and-critical-reflections",bookSignature:"Bala Raju Nikku",coverURL:"https://cdn.intechopen.com/books/images_new/6942.jpg",editedByType:"Edited by",editors:[{id:"263576",title:"Dr.",name:"Bala",surname:"Nikku",slug:"bala-nikku",fullName:"Bala Nikku"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6926",title:"Biological Anthropology",subtitle:"Applications and Case Studies",isOpenForSubmission:!1,hash:"5bbb192dffd37a257febf4acfde73bb8",slug:"biological-anthropology-applications-and-case-studies",bookSignature:"Alessio Vovlas",coverURL:"https://cdn.intechopen.com/books/images_new/6926.jpg",editedByType:"Edited by",editors:[{id:"313084",title:"Dr.",name:"Alessio",surname:"Vovlas",slug:"alessio-vovlas",fullName:"Alessio Vovlas"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2270",title:"Fourier Transform",subtitle:"Materials Analysis",isOpenForSubmission:!1,hash:"5e094b066da527193e878e160b4772af",slug:"fourier-transform-materials-analysis",bookSignature:"Salih Mohammed Salih",coverURL:"https://cdn.intechopen.com/books/images_new/2270.jpg",editedByType:"Edited by",editors:[{id:"111691",title:"Dr.Ing.",name:"Salih",surname:"Salih",slug:"salih-salih",fullName:"Salih Salih"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"117",title:"Artificial Neural Networks",subtitle:"Methodological Advances and Biomedical Applications",isOpenForSubmission:!1,hash:null,slug:"artificial-neural-networks-methodological-advances-and-biomedical-applications",bookSignature:"Kenji Suzuki",coverURL:"https://cdn.intechopen.com/books/images_new/117.jpg",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3828",title:"Application of Nanotechnology in Drug Delivery",subtitle:null,isOpenForSubmission:!1,hash:"51a27e7adbfafcfedb6e9683f209cba4",slug:"application-of-nanotechnology-in-drug-delivery",bookSignature:"Ali Demir Sezer",coverURL:"https://cdn.intechopen.com/books/images_new/3828.jpg",editedByType:"Edited by",editors:[{id:"62389",title:"PhD.",name:"Ali Demir",surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"64314",title:"Antigen Retrieval for Light and Electron Microscopy",doi:"10.5772/intechopen.80837",slug:"antigen-retrieval-for-light-and-electron-microscopy",body:'
1. Introduction
Immunohistochemistry is used for identifying the localization of cellular or tissue constituents (antigens) based on antigen-antibody interactions using labeled antibodies that can be visualized under light and electron microscopes. Therefore, the use of specific primary antibodies and tissue preparation techniques that conserve fine structures, the immobilization of antigens, and antigen-antibody interaction is essential. Until the end of the 1980s, the conservation of protein conformation was thought to be important for the immunohistochemistry of protein antigens for the following reasons. (1) The production and specificity of antibodies were mainly confirmed by immunoprecipitation using Ouchterlony double diffusion test and immunoelectrophoresis, in which native purified antigen proteins or tissue extracts were reacted with antisera to form precipitation lines at the proper antigen/antibody ratio in agar or agarose gels. (2) Strong immunoreactions were observed in tissues and cells that were fixed using formaldehyde within a short time or using other physical fixatives, such as cold acetone. (3) Frozen sections provided stronger immunostaining than paraffin sections, which denatured protein conformations during dehydration and embedding.
On the other hand, monoclonal antibodies began to be prepared in many laboratories in the 1980s, and commercially available monoclonal antibodies that recognized special cell types were being applied for pathological diagnosis. Western blotting and enzyme-linked immunosorbent assays (ELISAs) were introduced as the main techniques for detecting antigen-antibody reactions. Since these techniques involve the immobilization of both native and denatured antigens on membranes or plastic plates and antigen-antibody reactions are visualized using enzyme-labeled antibodies, these techniques have a higher sensitivity than immunoprecipitation methods independent of the antigen/antibody ratio. These new antibody preparation techniques and assay systems have gradually changed the concept that it is important to expose epitopes for immunoreactions rather than preserving the conformation of whole antigen molecules.
Histopathologists have made great efforts to use formalin-fixed and paraffin-embedded (FFPE) specimens for immunohistochemistry, since such specimens have long been used as the standard for light microscopy and are archived in many biological and clinical laboratories. In the early 1970s, treatments with enzymes such as proteases, nucleases, and hyaluronidase and with protein denaturants were introduced to enable the partial recovery of immunostaining. The development of heat-induced antigen retrieval (HIAR), as reported by Shi et al. in 1991 for FFPE specimens, completely changed the concept of immunohistochemistry [1]. Although the mechanism of HIAR was originally a mystery, several studies have elucidated that heating cleaves chemical crosslinks (methylene bridges) formed by formaldehyde and exposes epitopes in tissues [2, 3]. HIAR is now applied not only to FFPE sections but also to frozen sections, cultured cells, physically fixed materials, and plastic embedded specimens for both light and electron microscopy [4]. It is also applied to other histochemical fields, such as in situ hybridization and lectin histochemistry. Furthermore, FFPE specimens are recognized as useful resources to study protein expression, DNA aberrations, and RNA expression in normal and diseased tissues [5, 6].
In this chapter, the following topics will be described, focusing on a flexible reconsideration of the concept of immunohistochemistry: (1) antigen-antibody interactions in tissues, (2) mechanisms of chemical fixation, (3) mechanisms of HIAR in formaldehyde-fixed specimens including exposure of highly masked epitopes, (4) HIAR in immunoelectron microscopy including the use of conventionally processed specimens embedded in epoxy resins, and (5) effects of antibody diluents on immunohistochemistry.
2. Antigen-antibody reactions
Antibodies recognize epitopes, which are small areas of antigen proteins but not the entire antigen molecule. When purified proteins from tissues or recombinant proteins are injected into animals, polyclonal antibodies that react with multiple epitopes and have different affinities and immunoglobulin classes for each epitope are generated. If a synthesized linear peptide is used for the immunogens, generated antibodies with different affinities and classes and subclasses of immunoglobulins may react with a single epitope. Therefore, we should notice that a commercially available polyclonal antibody may show different immunoreactions when we use the antibody with different lot numbers. On the other hand, a monoclonal antibody reacts with a single epitope with a monovalent affinity and a single immunoglobulin class and subclass. Antibodies prepared using the phage display technique have almost the same characteristics as monoclonal antibodies.
There are two types of epitopes, i.e., linear and conformational epitopes [4]. Linear epitopes are composed of a particular stretch of 5–20 consecutive amino acids. Linear epitopes located on the surfaces of protein molecules can react with antibodies independent of whether the protein is in its native or denatured and extended states. Meanwhile, linear epitopes located on surfaces in contact with other proteins or the subunits and internal linear epitopes cannot bind to antibodies when the protein is in its native state and can only bind to antibodies when the polypeptides have been extended by heating or treatment with protein denaturants, such as sodium dodecyl sulfate (SDS) and urea. A few linear internal epitopes are rarely in contact with antibodies because the antigen proteins contain multiple disulfide bonds and the protein remains stable even after heating. The reduction of these disulfide bonds may be necessary for the exposure of such epitopes, as described later. Conformational epitopes are composed of amino acids that are located far apart in their linear sequence but become juxtaposed when the protein is folded into its native shape. Some conformational epitopes are stabilized by disulfide bonds and resistant to denaturation by heating and protein denaturants, but others associated with noncovalent forces may be sensitive to denaturation.
In immunohistochemistry, fixation is essential to conserve tissue structures and to prevent the diffusion of antigens. Chemical fixatives directly modify epitopes and crosslink proteins and nucleic acids to form gel-like structures that inhibit antigen-antibody interactions. The antigen-antibody reactions can be interfered with in special regions, such as cell organelles with intact membrane and secretory granules and deposits of protein fibrils that contain highly concentrated proteins, as well as in nuclei and extracellular matrices with highly negative electrostatic charges. Therefore, immunohistochemistry must be performed under conditions that promote the epitope-antibody association in the target tissues through the use of tissue-processing procedures, i.e., fixation, embedding, antigen retrieval, and the selection of suitable diluents for antibodies.
3. Mechanisms of chemical fixation
Chemical fixatives used for immunohistochemistry are limited to formaldehyde and glutaraldehyde. Formaldehyde is used for tissue fixation in both light and electron microscopy, while glutaraldehyde is used as a fixative only in electron microscopy. Although formaldehyde and glutaraldehyde are popular fixatives for histology and pathology, the characteristics and fixation mechanisms are assumed to be quite different. Since formalin is composed of about 35% formaldehyde aqueous solution containing about 10% methanol to prevent the polymerization of formaldehyde and is usually diluted 10-fold as 10% formalin, its fixation mechanisms should be the same as those for 4% formaldehyde.
3.1 Formaldehyde
The mechanism of fixation using formaldehyde is thought to be as follows. Formaldehyde forms an adduction of hydroxymethyl/methylol (CH2OH) to functional groups of amino acids (such as lysine, arginine, and cysteine) (Figure 1a,d, and f), the N-terminus of polypeptides, and bases of RNA and single strand DNA [7, 8]. A part of the methylol group of lysine and arginine forms imines (Schiff base) through the removal of H2O (Figure 1a and d), and the imines of lysine then combine with the side chains of amino acids, such as tyrosine (Figure 1b), tryptophan (Figure 1c), asparagine, glutamine, and histidine, and the imine of arginine (Figure 1e) to form approximately 0.25-nm methylene bridges (-CH2-). Although lysines are reported to be major reactive residues for formaldehyde in native proteins, only lysines located on the surface area are modified by formaldehyde [9]. Methylols of cysteine form methylene bridges with tyrosine (Figure 1g), arginine, and the N-terminus of peptides. These adductions, imine formations, and crosslinks progress in a time-dependent and temperature-dependent manner. Although formaldehyde is rapidly and freely permeable into cells and tissues blocks, the chemical reactions are relatively slow. Fox et al. reported that the binding of 14C formaldehyde to 16 μm of fresh frozen sections only reached a plateau after 24 h at 25°C [10].
Figure 1.
Reaction of formaldehyde with proteins.
Although formaldehyde forms intra- and intermolecular crosslinks in proteins, the tertiary structures of the proteins are almost completely preserved [9, 11]. The methylene bridges between lysine and the phenyl residue of tyrosine are stable but most methylene bridges are unstable and reversible. Since basic residues of amino acids are modified with formaldehyde and the isoelectric point of proteins shifts to acidic, basic proteins should be precipitated at around the pH of the buffer (pH 7.2–7.4) used to dissolve the formaldehyde, based on the principle of isoelectric precipitation. Formaldehyde may first produce crosslinks among proteins in relatively stable core complexes, such as cell organelles, filament proteins in the cytoplasm and extracellular matrix, and chromatin, and then soluble proteins attach to these complexes to form a gel-like structure. Thus, these crosslinks interfere with the access of antibodies to antigens even if the epitopes do not have functional groups of amino acids that are directly modified by formaldehyde, as demonstrated in the model system by Sompran et al. using peptide epitopes coupled to glass slides [12].
FFPE specimens are assumed to be highly cross-linked, compared with formalin-fixed frozen sections. Since ethanol accelerates the imine formation of methylol groups and causes the rearrangement of the β-sheet of polypeptides and the exposure of hydrophobic amino acids, which are hidden in aqueous solutions, both intra- and intermolecular crosslinking should advance during dehydration and clearing with ethanol and xylene [13], and immersion in paraffin at around 60°C facilitates further crosslinking. On the other hand, some antigens in cell organelles might come in contact with antibodies more easily than those in frozen sections because membrane lipids are extracted and barriers are destroyed during dehydration.
3.2 Glutaraldehyde
Glutaraldehyde has been widely used as the standard primary fixative for electron microscopy specimens since introduced by Sabatini et al. in 1963 [14]. A mixture of glutaraldehyde and formaldehyde is also a popular fixative for cytology, enzyme cytochemistry, and immunoelectron microscopy. Glutaraldehyde (Figure 2a) has two aldehydes that can directly crosslink with the ε-amino residues of lysine and the N-terminus of polypeptides by forming a Schiff base. However, most investigators think that the rapid and extremely stable crosslinks formed by glutaraldehyde are based on the oligomeric form of glutaraldehyde. Kawahara et al. demonstrated that protein crosslinkage by forming the Schiff base and the aldol condensation of glutaraldehyde monomers occur almost in parallel and result in the formation of a linear glutaraldehyde oligomer with several Schiff base linkages branching off forming (-CH=CH-CH=N-R)n (Figure 2b), since glutaraldehyde solution showed no absorbance at 235 nm caused by α,β-unsaturated bonds in the absence of amines [15]. The resulting resonance structures are extremely stable to both heat and acid treatments [16].
Figure 2.
Reaction of glutaraldehyde and osmium tetroxide with proteins and effect of heating. F-protein, fragmented protein by osmium tetroxide post-fixation.
Since the cross-linked proteins rapidly form harder gel-like structures, compared with those created by formaldehyde, only thin layers of tissues can be fixed well using immersion fixation. Since aldehyde residues remain in the tissues fixed with glutaraldehyde, the aldehyde should be quenched using amides, such as glycine, ammonium chloride, and tris(hydroxymethyl) aminomethane, or reduced to alcohols using sodium borohydride prior to immunostaining.
3.3 Osmium tetroxide
Since osmium tetroxide binds to the unsaturated bonds of fatty acids and fixes membrane lipids, providing contrast by scattering electron beams, it is used as the post-fixing reagent after glutaraldehyde fixation in electron microscopy. Osmium tetroxide should also bind to the carbon-carbon double bonds formed by glutaraldehyde fixation (Figure 2c). However, since osmium tetroxide cleaves polypeptides in tryptophan residues and oxidizes methionine to methionine sulfone and cysteine to cysteic acid [17], osmium tetroxide significantly inhibits immunoreactions.
4. Mechanisms of HIAR
After the first report for HIAR by Shi et al. [1], investigators have tried to select the most suitable heating conditions (heating devices, temperatures, kinds of solutions, solution pH, and additives). However, the total amount of applied heat energy is now recognized as being more important than the type of heating devices. In this section, the effects of pH and the ionic strength of retrieval solutions for HIAR will be reviewed, and the mechanisms of HIAR will be described.
4.1 Effects of pH on proteins treated with formaldehyde
When purified proteins are treated with formaldehyde and analyzed using SDS-PAGE (polyacrylamide gel electrophoresis), protein oligomers formed by intermolecular crosslinks were recognized. Monomer and oligomers treated with formaldehyde showed smaller apparent molecular weight compared with those of unmodified native proteins, since intramolecular crosslinks prevented the complete unfolding of proteins in the SDS solution [2, 18, 19]. The cleaving efficiency of the crosslinks was almost the same when the formaldehyde-treated proteins were heated for 5 min at 100°C in 10 mM Tris-HCl at pH 3.0, pH 6.0, pH 7.5, or pH 9.0 while analyzed with SDS-PAGE. When the proteins were drastically heated by autoclaving for 10 min at 120°C at a pH close to their respective isoelectric points, the proteins tended to produce insoluble protein precipitates [2]. However, many investigators have demonstrated that the efficiency of HIAR for immunohistochemistry is highly dependent on the pH of the retrieval solution.
4.2 Effect of pH of HIAR solutions on immunohistochemistry
Shi et al. systematically studied the effects of the pH of antigen retrieval solution on HIAR [20]. They classified the pH-influenced HIAR immunostaining patterns as follows: type A, in which staining was almost the same at any pH, with a slight decrease in intensity between pH 3.0 and pH 6.0; type B, in which a dramatic increase in immunostaining was observed at acidic and basic pH; and type C, in which the immunostaining intensity increased at basic pH. We re-examined the pH dependency of HIAR using 17 different antibodies and observed two immunostaining patterns for the pH dependency of HIAR [3]. The majority of the antibodies produced the first immunostaining pattern; that is, they yielded a positive immunoreaction when heated in buffers that had either an acidic pH or a basic pH. This HIAR pattern may correspond to the type-B pattern of the classification by Shi et al. If highly diluted antibodies had been used in the immunohistochemical studies, the type-A pattern described by Shi et al. might have become nearly equivalent to the type-B pattern. The second immunostaining pattern that we observed was a strong immunostaining reaction when heated in basic buffer, corresponding to the type-C pattern described by Shi et al. Pileri et al. and Kim et al. have also reported that a basic buffer is effective for HIAR for most antigens [21, 22]. On the other hand, Kajiya et al. reported that heating at an acidic pH (pH 3.0 or pH 6.0) frequently enabled excellent immunostaining for the detection of basic proteins or epitopes composed of basic amino acids [23].
4.3 pH-dependent reversibility of HIAR efficiency
Yamashita and Okada demonstrated that the intensities of the immunoreactions obtained by heating in a buffer are reversibly altered by successive heating in another buffer with a different pH [2]. For example, when the first heating in a buffer (pH 6.0) yielded a weak immunostaining in FFEP sections, a second heating at pH 9.0 significantly increased the immunostaining; however, the third heating in the acidic buffer weakened the immunostaining. These results indicate that the degradation or extraction of antigens is not a major factor in the pH dependency of HIAR and that the pH of the solution is a critical factor for the exposure of tissue epitopes in HIAR.
4.4 Effect of ionic strength of HIAR solution
We studied the effects of ionic strength on HIAR using 10 antibodies. Three buffer systems with different pH values were examined. When FFPE specimens were autoclaved for 10 min at 120°C in 20 mM Tris-HCl buffer (pH 9.0), 50 mM citraconic anhydride aqueous solution (pH 7.4), or 10 mM citrate buffer (pH 6.0) containing 0, 50, 100, or 200 mM NaCl, all the antibodies showed the strongest immunostaining while the sections were autoclaved in the NaCl-free solutions. The staining intensity decreased as the NaCl concentration increased in all antibodies examined [24]. These results demonstrated that the ionic strength of the solution is a critical factor for HIAR and that a high concentration of salt inhibits the exposure of epitopes.
4.5 Mechanisms of HIAR in FFPE sections
The results described above demonstrate that the fundamental mechanism of HIAR is based on the cleavage of protein-protein crosslinks and the exposure of epitopes. Heating destroys the gel-like structure formed by formaldehyde-fixation and partially extracts the macromolecules, enabling the antibodies to penetrate tissues easily; this process is similar to the effects of enzyme digestion. Western blot analyses have demonstrated that soluble, nuclear, and membrane proteins are extracted from FFPE specimens after heating but not from those without heat treatment [2]. Recent proteomics studies using a mass spectrum technique have also revealed that heating facilitates protein extraction from archived FFPE specimens [6]. Furthermore, heat-induced cleaving of the shortest crosslinks induced by formaldehyde can be applied to chromatin immunoprecipitation assays and to the crosslinks of adjacent proteins to investigate temporal interactions [8, 25, 26].
The second mechanism is assumed to be as follows based on the pH-dependent and ionic strength-dependent phenomena described above [3, 4]. When the methylene bridges are cleaved by heating, the higher order structure of the protein is destroyed and the polypeptide chains are extended, exposing both hydrophobic and hydrophilic regions and epitopes. The polypeptide chains then rapidly refold during the cooling process. In tissues, many kinds of proteins with different isoelectric points and molecular weights are tightly packed, and neighboring polypeptides can come in contact with each other. Therefore, epitopes should be concealed during the refolding of the proteins at around a neutral pH because a strong hydrophobic attractive force would randomly entangle the neighboring polypeptides: an electrostatic force may act locally as either an attractive or a repulsive force. At basic or acidic pH values, however, the majority of the extended polypeptides would be charged negatively or positively, and the electrostatic repulsive force would act to prevent random aggregation and entanglement with neighboring polypeptides caused by the hydrophobic force, thereby maintaining a suitable extend conformation for antigen-antibody interactions. When salt is added to the retrieval solutions, the electrostatic force between neighboring polypeptides is canceled, and the hydrophobic attractive force may cause the antigen proteins and neighboring proteins to aggregate, masking the epitopes. Namimatsu et al. reported that heating in citraconic anhydride solution at a neutral pH was useful as a universal antigen retrieval method [27]. Since citraconic anhydride binds to the ε-amino groups of lysine residues re-exposed after heating and places numerous negative charges on proteins, an electric repulsive force may help to keep polypeptides in an unfolded state.
On the other hand, strong heating at around the isoelectric points of proteins induces their coagulation [2], and increasing the ionic strength also promotes isoelectric precipitation. Therefore, many proteins with neutral isoelectric points can be precipitated in a solution with a neutral pH. The finding that an acidic buffer is effective for some basic antigens probably indicates that these antigens are precipitated by heating in basic buffers [23, 28]. Since heating may destroy the protein conformation, most conformational epitopes associated with noncovalent forces should lose their reactivity to antibodies. On the other hand, HIAR may be effective for conformational epitopes that have been stabilized by disulfide bonds.
Basic or acidic solutions are effective for HIAR as described above, whereas citrate buffer (pH 6.0) is frequently used in pathological studies. Citrate buffer may be suitable for examining detailed nuclear structures, since heating in basic solutions cleaves and extracts RNAs and reduces the nuclear stainability with hematoxylin. In practice, at least three antigen retrieval solutions at pH 3.0, pH 6.0, and pH 9.0 should be examined when studying the localization of unknown antigens for the first time.
4.6 HIAR in frozen sections
Fresh frozen sections are widely used for immunohistochemical studies, because (1) they preserve antigenicity well, (2) they provide reproducible results because the fixation time is precisely controlled and the fixation is uniform throughout the sections, and (3) they allow antigen localization within a short time for pathological diagnosis. We introduced new fixative, 10% formalin containing 25 mM CaCl2 in 0.1 M HEPES-NaOH buffer (pH 7.4) that is more appropriate for the fixation of fresh frozen sections compared with buffered 10% formalin, because it has a stronger fixation ability and can crosslink proteins more rapidly and stabilize membranes, the extraction of antigens during fixation is minimized, and an excellent tissue structure is maintained after HIAR [29]. After heating in 20 mM Tris-HCl (pH 9.0) for 30 min or in 20 mM citrate buffer (pH 3.0), antigens in the nuclei, other cell organelles, cytoplasm, membranes, and extracellular matrix were clearly visible, even if they showed no immunoreactions without heating.
4.7 Antigen retrieval for highly masked epitopes with disulfide bonds
Few antigens that reduced disulfide bonds react with antibodies when they are analyzed using Western blotting (Figure 3A), whereas they reveal negative immunostaining even if the tissues were fixed with formaldehyde or other physical fixatives followed by heating (Figure 3B and D). In such cases, the epitopes should be located in a highly folded portion of the antigen protein that may be stabilized with disulfide bonds to form stable secondary and tertiary structures. The reduction of disulfide bonds using dithiothreitol or 2-mercaptoethanol prior to heat treatment yields strong immunoreactions (Figure 3C and E) [28, 30]. In addition, when epitopes are covered by neighboring heat-resistant polypeptides, the accessibility of antibodies to the epitopes is also inhibited. When immunostaining is performed using old FFEP or using sections on a slide glass stored for a long time, the samples should be oxidized to produce many disulfide bonds in the tissues. The reduction and cleavage of disulfide bonds may be effective for such specimens (Figure 3F–I).
Figure 3.
Antigen retrieval for highly masked epitopes with disulfide bonds in paraffin and frozen sections. A. VEGFR1 and Tie 2 expressions in the uteri of 10-day-old mice were demonstrated using Western blotting. VEGFR1 and Tie 2 proteins were analyzed after treatment with 2-mercaptoethanol (lines 2 and 4) or without the treatment (lines 1 and 3), respectively. Membrane bound VEGFR1 (150 kD) shows no reaction to the antibody without reduction of disulfide bonds, whereas soluble VEGFR1 (100 kD) binds to the antibody independence of reduction (lines 1 and 2). Tie 2 antibody shows strong immunoreaction to Tie 2 protein-reduced disulfide bonds (lines 3 and 4). B–E. Immunostaining of VEGFR1 (B and C) and Tie 2 (D and E) in the frozen sections of 10-day-old mouse uteri. Fresh frozen sections were fixed with 10% formalin containing 25 mM CaCl2 in 0.1 M HEPES buffer (pH 7.4) for 5 min, treated with 0.1 M dithiothreitol (DTT)/20 mM Tris-HCl (pH 9.0) for 1 h and then with 0.1 M iodoacetamide/0.1 M Tris-HCl (pH 9.0) for 15 min (C and E); B and D, sections without reduction. The sections were then heated in 20 mM Tris-HCl (pH 9.0) for 30 min at 95°C and immunostained with the antibodies. The stroma shows diffuse VEGFR1 immunostaining which may be based on the soluble VEGFR1 in non-reduced section (B), while vasculatures (arrows) and basal membrane of epithelial cells exhibit positive VEGFR1-immunostaining which may be corresponded to the membrane-bound VEGFR1 (C). Clear Tie 2-immunostaining is recognized in the endothelial cells of vasculatures (arrows) in the reduced section (E) but not in the non-reduced section (D). F–I. Immunohistochemistry in paraffin sections. Clathrin was detected in the mouse pancreas after reduction with DTT (G) or without reduction (F) followed by heating in 20 mM Tris-HCl (pH 9.0). Tom 20 was immunostained in the mouse ovary after reduction with DTT (I) or without reduction (H) followed by heating. Bar = 50 μm.
5. HIAR in immunoelectron microscopy
Immunoelectron microscopy is a powerful technique for observing the localization of antigens in cell organelles and for studying the relationship between antigens and other macromolecules. Three main immunoelectron microscopy methods have been used to localize antigens: the pre-embedding method, the post-embedding method, and cryoultramicrotomy. Although fixation is one of the most important aspects of sample preparation for all three methods, the choices of fixatives and tissue processing procedures are limited unlike light microscopy, because of the need to satisfy compatible requirements, such as conservation of fine structure, immobilization of antigen minimizing the diffusion, and conservation of immunoreaction. In general, fixatives that allow good morphological findings and precise antigen localization through the rapid and tight crosslinking of macromolecules also severely inhibit antigen-antibody interactions.
Fixatives containing formaldehyde as the main crosslinking regent are popular for immunoelectron microscopy using the pre-embedding method, since antibody penetration into the cells is an important factor for this method; formaldehyde solution, PLP (periodate-lysine-paraformaldehyde) [31], and a mixture of formaldehyde and a low concentration (0.05–0.5%) of glutaraldehyde. For the post-embedding method, a mixture of formaldehyde and a low concentration of glutaraldehyde is frequently used to preserve the fine structure and membrane structures, since dehydration and resin embedding are performed without osmium tetroxide post-fixation. A short period of perfusion fixation with glutaraldehyde is also applied for the post-embedding method. The suitable fixatives, fixing periods, and temperatures of fixatives have been determined by trial and error for each antigen independent of the staining methods.
In this section, a standardized fixation method that yields positive immunoreactions for the pre-embedding and the post-embedding methods after HIAR will be described and discussed how HIAR is also effective for some routinely processed materials for the electron microscopy that are fixed with glutaraldehyde and osmium tetroxide and embedded in epoxy resins.
5.1 Standardized fixative
We introduced a standardized fixative that can yield positive immunoreactions for many antigens in electron microscopy after HIAR [32]. Tissues were fixed with 4% formaldehyde containing 2.5 mM CaCl2 and 1.25 mM MgCl2 in 0.1 M HEPES-NaOH buffer (pH 7.4) for 2 h at room temperature and then with the same fixative composition in 0.1 M HEPES buffer-NaOH buffer (pH 8.5) overnight at room temperature. The vehicle osmolarity of the fixatives was adjusted to 300–330 mOsm by adding sucrose or glucose. Formaldehyde containing CaCl2 and MgCl2 was shown to be the best fixative, producing a rapid and complete fixation that minimizes diffusion artifacts (the divalent cations are well known to act as stabilizers of membrane structures). In addition, tissues were fixed using two steps: first at pH 7.4 and then at pH 8.5. This method preserves the cellular fine structures because the crosslinking reaction produced by formaldehyde progresses rapidly at a basic pH. Fixation was then performed at room temperature to enable a faster reaction than that possible at 4°C.
5.2 Pre-embedding method
Although the pre-embedding method is the most popular and the simplest method for immunoelectron microscopy, HIAR has only been applied for the detection of a few antigens. Frozen sections or vibratome sections from specimens fixed with formaldehyde or a mixture of formaldehyde and glutaraldehyde were heated in various solutions such as citrate buffer (pH 6.0), Tris-HCl buffer (pH 9.0 or pH 10.0), or citraconic anhydride solution (pH 7.4) for different periods for each antigen [33, 34, 35, 36]. Yamashita reported that 4% formaldehyde containing 25 mM CaCl2 in 0.1 M cacodylate buffer (pH 7.4) was a suitable fixative for the pre-embedding method by applying HIAR for several antigens [4].
We applied the pre-embedding method to tissues fixed using the standardized fixative described above. Frozen sections (about 15 μm) were mounted on a slide glass and then heated in 20 mM Tris-HCl (pH 9.0) containing 10% sucrose for 2–4 h at 70°C. Immunostaining was performed using (horseradish peroxidase) HRP-labeled antibodies and antigen localization was visualized with 3,3′diaminobenzidine (DAB). Most of the antigens that were examined showed negative immunoreactions without heat treatment, but they produced strong immunoreaction after heating (Figure 4). Since endogenous immunoglobulins are inactivated after heat treatment (Figure 4A and B), the immunoreactions can be clearly detected even in the mouse tissues using mouse monoclonal antibodies. Tris-HCl buffer (pH 9.0) is effective for most antigens but citrate buffer (pH 6.0 or pH 3.0) yields strong reaction for a few antigens with basic isoelectric points, such as vascular endothelial cell growth factor (VEGF). Therefore, the selection of suitable solutions for each antigen should be examined using FFEP sections or frozen sections on light microscopy.
Figure 4.
HIAR in frozen sections form specimens fixed with the standardized fixative. Mouse tissues were fixed with the standardized fixative and immersed in 10, 15, and 20% sucrose and then frozen. Frozen sections (15 μm) were immunostained with anti-E-cadherin monoclonal antibody in the small intestine (A and B), anti-β-catenin monoclonal antibody in the pancreas (C and D), and anti-claudin 5 polyclonal antibody in the kidney (E and F) after heating in 10 mM Tris-HCl buffer (pH 9.0) containing 10% sucrose for 3 h at 70°C (B, D, and F) or without heating (A, C, and E). Endogenous mouse immunoglobulins are seen in the lamina propria mucosa (arrows) and plasma cells (outline arrows), but E-cadherin immunoreactions is not detected without heating (A). However, the endogenous immunoglobulin immunostaining is negative and E-cadherin is clearly localized along the lateral membrane of intestinal epithelium after heating; the junctional complexes show strong immunoreactions (B). β-Catenin immunoreaction is present along the lateral membrane of pancreatic acinar cells (D) but not in the section without heating (C). After heating, claudin-5 is localized in the glomeruli and distal tubules in the kidney (F). Bar = 50 μm.
The positively immunostained sections were then post-fixed with 1% osmium tetroxide in 0.1 M phosphate buffer (pH 7.4) for 30 min, dehydrated with ethanol, and then embedded in epoxy resin. All antigens detected in frozen sections on light microscopy were localized using the pre-embedding method preserving fine structures (Figure 5).
Figure 5.
HIAR for immunoelectron microscopy with the pre-embedding method. Frozen sections immunostained with anti-E-cadherin antibody (A) and anti-claudin-5 antibody (B) demonstrated in Figure 4 were post-fixed with osmium tetroxide, dehydrated in ethanol, and then embedded in the epoxy resin. A. Immunoreaction for E-cadherin is seen in the adherence junction (outline arrows) and spotty reaction (arrows) is present in the lateral membrane of intestinal epithelium. B. Claudin-5 is localized in the foot processes of podocyte (arrows) in the renal glomerulus: P, podocyte; E, endothelial cells; and M, mesangial cell. Bar = 2 μm.
5.3 Post-embedding method
The post-embedding method provides more reproducible and reliable immunostaining results than the pre-embedding method, which produces a limited and heterogeneous penetration of antibodies into the tissues, since immunoreactions occur on the surfaces of ultrathin sections. Furthermore, immunoreactions on ultrathin sections permit the counting of immunogold particles, enabling semi-quantitative analyses, and the simultaneous staining of multiple antigens. Although the post-embedding method has these advantages, it has only been used for a limited number of antigens because antigenicity is frequently lost during the dehydration and embedding procedures. Specimens embedded in acrylic resins without osmication show a disrupted membrane structure and poorly contrasted cell organelles.
Several investigators have applied HIAR to the post-embedding method and have reported its usefulness [37, 38, 39]. Tissues were fixed with a mixture of formaldehyde and glutaraldehyde or formaldehyde alone and embedded in acryl resins; then, ultrathin sections were heated in various solutions. We attempted to establish a standardized method for immunoelectron microscopy that would satisfy the following requirements: (1) the preservation of fine cell structures with good image contrast in tissues embedded in acryl resins without OsO4 post-fixation, (2) the application of HIAR to obtain a high labeling density, and (3) a simple and reproducible method that does not require special equipment [32, 39].
Tissues were fixed with the standardized fixative and dehydrated with dimethylformamide (DMF) on ice and embedded in the LR-White resin, since DMF may reduce abrupt osmotic pressure changes in the tissues and the extraction of membrane lipids. The resin was polymerized for 24 h at 55°C. Ultrathin sections mounted on a nickel grid were heated in 0.5 M Tris-HCl buffer (pH 9.0) for 1–2 h at 95°C. After immunogold labeling, the sections were treated with 2% glutaraldehyde containing 0.05% tannic acid in 0.1 M phosphate buffer (pH 5.5) for 5 min and with 1% OsO4/0.1 M phosphate buffer (pH 7.4) for 5 min and then double stained with uranyl acetate and lead citrate. This method yielded strong and reproducible immunoreactions for many soluble, membrane bound, and filamentous proteins (Figure 6), [32, 39]. Furthermore, tannic acid treatment followed by osmium tetroxide treatment produced good contrasted images. The cellular membranes produced a positive image and the cell organelles, such as mitochondria, the Golgi complexes, secretory granules, and lysosomes, were well contrasted. Nucleic acids (chromatins, nucleoli, and ribosomes), intracellular filaments (actin filaments, 10 nm filaments, and microtubules), and collagen fibers were well visualized.
Figure 6.
HIAR for immunoelectron microscopy with the post-embedding method. Mouse kidney was fixed with the standardized fixative and then embedded in LR-White resin. Ultrathin sections were heated in 0.5 M Tris-HCl (pH 9.0) for 1 h at 95°C and treated with anti-β-actin/TBS (A), Tom 20/10 mM Tris-HCl (pH 7.4) containing 50 mM NaCl (B), and anti-mortalin (mitochondrial 70 kD heat shock protein)/TBS (C) and then treated with colloidal gold-labeled secondary antibodies/TBS. A. Strong β-actin immunoreactions are seen in the foot processes of podocyte (P) (outline arrows) and in the cytoplasm of mesangial cell (M). Lymphocyte (L) shows potty reactions beneath the cell membrane (arrows). B. Tom 20 is localized along the mitochondria but not recognized in the lysosome (outline arrow). C. Mitochondria show mortalin immunoreaction, whereas lysosomes (outline arrows), apical canaliculi (arrows), and nucleus are negative for staining. Bars = 500 nm.
5.4 Osmicated and epon-embedded specimens
Archives of materials embedded in epoxy resins are collected in many histology and pathology laboratories and in hospitals for morphological analyses, and these archives are expected to provide valuable data if they can be used for immunohistochemical studies. However, conventionally processed specimens for transmission electron microscopy have been regarded as unsuitable for immunoelectron microscopy using post-embedding methods for the following reasons: (1) Glutaraldehyde significantly suppresses antigen-antibody interactions and HIAR is ineffective for most antigens. (2) Osmium tetroxide severely inhibits immunoreactions by cleaving polypeptides and oxidizing methionine and cysteine [17]. (3) Epoxy resins produce tight three-dimensional crosslinks that suppress antigen-antibody interactions.
A limited number of antigens can be successfully detected on sections from conventionally processed materials. One method involves the oxidation and removal of osmium by treating ultrathin sections with sodium metaperiodate aqueous solution [40]. Another method involves the partial removal of epoxy resins by treating the sections with hydrogen peroxide or sodium/potassium ethoxide [41, 42]. The combined use of partial deresination and heat treatment has also been examined. Borson and Skjorten polymerized the epoxy resin to reduce copolymerization between the proteins and the resin and to make a porous polymer for applying HIAR to glutaraldehyde-fixed and epon-embedded materials [43]. We have also demonstrated that HIAR is effective for post-embedding immunoelectron microscopy using conventionally processed epon blocks, contrary to presumptions that antigen detection would be a special case in these specimens [44].
5.4.1 Frozen sections fixed with glutaraldehyde and osmium tetroxide
The effectiveness of HIAR in the post-embedding method using conventionally processed epon-embedded specimens was systematically examined for 18 antibodies. Frozen sections fixed with 2% glutaraldehyde for 30 min at room temperature or with 2% glutaraldehyde for 30 min followed by 1% osmium tetroxide for 30 min at room temperature were dehydrated with ethanol and then rehydrated to elucidate the validity of HIAR for avoiding the effects of epoxy resin embedment. In another experiment, frozen sections fixed with glutaraldehyde and osmium tetroxide were treated with sodium metaperiodate, since this reagent has been reported to be effective for osmicated materials, as described above.
After autoclaving in Tris-HCl buffer (pH 9.0), 7 of the 18 antibodies exhibited a strong immunoreaction in frozen sections fixed with glutaraldehyde and osmium tetroxide, whereas heating revealed almost no effect on the sections fixed with glutaraldehyde alone (Table 1; Figure 7). Treatment with sodium metaperiodate was ineffective for the antigen retrieval of all the antibodies (Table 1). The mechanisms of HIAR in the frozen sections fixed with glutaraldehyde and osmium tetroxide were assumed to be as follows [44]. Osmium tetroxide binds to ethylene bonds formed by glutaraldehyde fixation, i.e., -CH=CH-CH=N-R (Figure 2c). Heat treatment removes the osmium tetroxide additives and forms 1, 2-diols (Figure 2d), since the black color fades in frozen sections fixed with glutaraldehyde and osmium tetroxide after autoclaving. The cleaving of the double bonds should extend the antigen polypeptides and increase the flexibility of the polypeptides. However, the morphology in the frozen tissues fixed with glutaraldehyde and osmium tetroxide was more disrupted after autoclaving, compared with those fixed with glutaraldehyde alone or 4% formaldehyde containing 25 mM CaCl2. The reason may be as follows. Osmium tetroxide treatment induces polypeptide fragmentation (Figure 2c and d), and heating extracts the fragments after crosslink cleavage by glutaraldehyde.
GA-EtOH
GA-OsO4-EtOH
Non
Autoclave
Non
NaIO4
Autoclave
PCNA
0
1
0
0
2
Clathrin
0
0–1
0
0
3
GFAP
0
0–1
0
0
3
Occludin
0
0–1
0
0
3
Tom 20
0
0–1
0
0
3
Claudin-5
0
0
0
0
2
α-Amylase
0–1
1
0
0–1
2
NRP1
0
0
0
1
β-Catenin
0–1
0
0
0
E-Cadherin
0
0–1
0
0
Desmin
0
0–1
0
0
Caveolin
0
0
0
0
VEGFR2
0–1
0
0
0
ERα
0
1–2
0
0–1
AnR
0
0
0
0
β-Actin
1
1
0
0
γ-GTP
1
1
0
0
Table 1.
HIAR in frozen sections prepared from specimens fixed with glutaraldehyde or glutaraldehyde and osmium tetroxide.
Fresh frozen sections were fixed with 2% glutaraldehyde/0.1 M phosphate buffer (pH 7.4) for 30 min (GA-EtOH) or fixed with 2% glutaraldehyde/0.1 M phosphate buffer (pH 7.4) for 30 min and further fixed with 1% osmium tetroxide/0.1 M phosphate buffer (pH 7.4) for 30 min (GA-OsO4-EtOH). Some sections fixed with glutaraldehyde and osmium tetroxide were further treated with 1% sodium metaperiodate aqueous solution for 5 min (NaIO4): all sections were hydrated with ethanol and then rehydrated after fixation. The fixed sections were immunostained after autoclaving in 20 mM Tris-HCl (pH 9.0) at 120°C for 10 min (autoclave) or without heat treatment (Non). Immunostaining was scored as followed: 3, strong; 2, moderate; 1, weak; 0–1, faint; and 0, negative.
Figure 7.
HIAR in frozen sections fixed with glutaraldehyde and osmium tetroxide. Fresh frozen sections (6 μm) from mouse tissues were fixed with 2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 30 min at room temperature (A, C, and E) and successively with 1% osmium tetroxide in 0.1 M phosphate buffer (pH 7.4) for 30 min at room temperature (B, D, and F). The sections were autoclaved in 20 mM Tris-HCl (pH 9.0) for 10 min at 120°C. They were then immunostained with anti-α-amylase antibody in the pancreas (A and B), anti-claudin-5 antibody in the kidney (C and D), and anti-clathrin antibody in the kidney (E and F). Although negative or weak immunostaining is seen in the sections fixed with glutaraldehyde after autoclave (A, C, and E), strong α-amylase immunoreactions are recognized in the apical cytoplasm of pancreatic acinar cells (B) and clear claudin-5 and clathrin immunoreactions are observed in the glomeruli (D) and in the apical cytoplasm of proximal tubular cells in the kidney (F), respectively. Bar = 50 μm.
5.4.2 HIAR in epon-embedded materials
Partial deresination with sodium ethoxide was required for light microscopy using semi-thin epon sections. After autoclaving in 100 m Tris-HCl (pH 9.0) for 10 min, six of the seven antibodies that showed positive immunoreactions in the frozen sections exhibited clear localizations in the semi-thin sections. α-Amylase (Figure 8A and B), clathrin (Figure 8C), and claudin-5 (Figure 8D), which all showed positive immunoreactions in the semi-thin sections, were localized on ultrathin sections using colloidal gold-labeled antibodies. For HIAR, ultrathin sections were heated in 500 mM Tris-HCl buffer (pH 9.0) for 1–3 h at 95°C. Although heat treatment was essential for the detection of antigens on ultrathin sections, heat treatment reduced the electron density of ribosomes, chromatins, intracellular membranes, and secretory granules in the exocrine pancreas. The partial removal of epoxy resins with sodium ethoxide followed by autoclaving revealed the disruption of the fine structure and no reproducible immunolabeling.
Figure 8.
HIAR for the specimens fixed with glutaraldehyde and osmium tetroxide, embedded in epoxy resin. Mouse tissues were fixed with 2% glutaraldehyde/0.1 M phosphate buffer (pH 7.4) for 3 h at 4°C and post-fixed with 1% osmium tetroxide/0.1 M phosphate buffer (pH 7.4) for 1 h and then embedded in the epoxy resin. Ultrathin sections were heated in 0.5 M Tris-HCl (pH 9.0) for 2 h at 95°C. α-Amylase is localized in the Golgi apparatus (G), condensing vacuole and secretory granules in the exocrine pancreas after heat treatment (B), whereas no reaction is seen in the sections without heating (A). Immunoreaction for clathrin is recognized in the apical canaliculi of renal proximal tubular cell (C). Claudin-5 is localized along the membrane of podocyte foot processes in the glomerulus (D). Bar = 500 nm.
These results indicated that archived epon-embedded specimens could be a useful resource for immunohistochemical studies at both the light and electron microscopy levels, since they provide excellent morphology and detailed antigen localization compared with paraffin-embedded materials.
6. Effects of diluents on antibodies in immunohistochemistry
The relationship between epitopes and paratopes of antibodies is thought to be similar to that between keys and keyholes. However, since these structures change their conformations to form a final specific and tight binding after antigen-antibody association, conservation of the flexibility of their polypeptide chains should be important. Although hydrogen bonds, hydrophobic forces, electrostatic forces, and van der Waals forces all participate in the final tight binding, electrostatic forces are important for the initial contact and association of antigen and antibody molecules (i.e., the net charges of each molecule and the neighboring charges of antigens). Buffer type, ionic strength, pH, and the presence of detergents in solutions are likely to exert strong influences on the antigen-antibody reaction. Although many kinds of diluents are commercially available for immunohistochemistry and Western blotting and yield good results with low background staining and a high sensitivity for some antigens, systematic studies of antibody diluents for immunohistochemistry have not been performed. In this section, the effects of dilution solutions for primary antibodies on immunostaining for light and electron microscopy are described.
6.1 Kind of dilution buffers
Fifteen monoclonal antibodies were diluted in 10 mM phosphate buffer (pH 7.4) containing 150 mM NaCl (PBS), 10 mM Tris-HCl buffer (pH 7.4) containing 150 mM NaCl (TBS), or 10 mM FEPES-NaOH buffer (pH 7.4) containing 150 mM NaCl (HBS); 1% bovine serum albumin (BSA) (final concentration) was added to each solution. Paraffin sections from mouse tissues fixed with formaldehyde were immunostained after autoclaving in 20 mM Tris-HCl buffer (pH 9.0) for 10 min. The sections were treated with the primary antibodies diluted with the solutions overnight at 4°C and successively with Envision HRR (Dakocytomation) for 1 h at room temperature. As shown in Table 2, all the antibodies diluted with TBS showed stronger immunoreactions than those diluted with PBS or HBS [45]. Although the reasons are unclear, the binding of phosphate ion (a larger ion) to positively charged regions of epitopes and paratopes may reduce the flexibility of peptide chains.
Antibodies
Clones and subclasses
Dilution buffer type
mM NaCl/10 mM TB
PBS
TBS
HBS
50
150
300
PCNA
PC10; IgG2a
1
2
2
1
2
2–3
ERα
D12; IgG2a
3
2
2
2
2
2
ERα
ID5; IgG1
1
1–2
1
2
1-2
1
S-100
M2A10; IgG1
1
2
1–2
3
2
1
Mortalin
JG1; IgG3
3
3
3
3
3
3
HSP 70
sc-27; IgG2a
1
2
2
3
2
1–2
α-Synuclein
42; IgG1
2
2
2
2
2
2
GFAP
6F2; IgG1
2
2
1
1
2
2
Desmin
D33; IgG1
1
2
1
1
2
2
β-Actin
AC-74; IgG2a
2
2
2
1
2
1–2
Clathrin
X22; IgG1
1
2
2–3
3
2
1
E-Cadherin
36B5; Ig1
1
2
2
3
2
1
β-Catenin
sc-763; IgG1
1
2
1
3
2
1
γ-GTP
5B9; IgG1
1
2
2
3
2
1
CASGM
170-5; IgG1
2
2
2
3
2
1
Table 2.
Effects of diluents for monoclonal antibodies on immunohistochemistry.
FFPE sections (6 μm) of mouse tissues were autoclaved in 20 mM Tris-HCl (pH 9.0) for 10 min and then immunostained with monoclonal antibodies. Antibodies were diluted with 150 mM NaCl/10 mM phosphate buffer (pH 7.4) (PBS), 150 mM NaCl/10 mM Tris-HCl (pH 7.4) (TBS), or 150 mM NaCl/10 mM HEPES buffer (pH 7.4) (HBS). The antibodies were also diluted with 10 mM Tris-HCl (pH 7.4) containing 50 mM, 150 mM, or 300 mM NaCl. Immunostaining was scored as followed: 3, strong; 2, moderate; and 1, weak.
6.2 Ionic strength of dilution solution
Fifteen monoclonal antibodies were diluted in 1% BSA/10 mM Tris-HCl buffer (pH 7.4) containing 50 mM NaCl, 150 mM NaCl, or 300 mM NaCl. After autoclaving, the paraffin sections were treated with the primary antibodies overnight and then with Envision HRR for 1 h at room temperature. The results are shown in Table 2. Most of the antibodies showed strong immunostaining when they were diluted with a buffer containing 50 mM NaCl [45]. However, monoclonal antibodies to proliferating cell nuclear antigen (PCNA) showed the strongest immunostaining when diluted with a buffer containing 300 mM NaCl, and monoclonal antibodies to glial fibrillary acidic protein (GFAP) and β-actin diluted with 150 mM yielded the strongest immunostaining. Polyclonal antibodies to nuclear transcription factors such as estrogen receptor (ER)α, androgen receptor (AnR), glucocorticoid receptor, and p300 yielded stronger immunostaining when diluted with a buffer containing 150 or 300 mM NaCl than that using a buffer containing 50 mM NaCl (not shown). These results suggest that the net charges of antibodies and antigens influence the contact of these proteins, and the net neighboring charges of antigens also affect the interactions. Nuclear antigens are associated with highly acidic nucleic acid, and β-actin and GFAP bundles are composed of β-actin and GFAP proteins with acidic isoelectric points. Dilution solution with a high ionic strength may reduce the net charges around the antigens and antigen molecules, allowing antibodies to come in contact with their respective antigens.
6.3 Immunoelectron microscopy
In immunohistochemistry using HRP-labeled antibodies, the staining intensity can be increased using highly sensitive reaction solutions and a longer enzyme reaction time. However, the intensification of immunoreactions is difficult in the post-embedding method and ultracryotomy using colloidal gold-labeled secondary antibody. Instead, the selection of diluents for the antibodies may be more important for obtaining a high labeling density with a low background staining compared with light microscopy, whereas almost no studies have been performed for immunoelectron microscopy.
We examined the effect of diluents of several antibodies for the post-embedding method using specimens fixed with the standardized fixative and embedded in LR-White resin [39, 41]. Glutaraldehyde and osmium tetroxide fixed and epon-embedded specimens were also used for a few antibodies. After HIAR, ultrathin sections were immunostained using antibodies diluted in the following solutions: PBS, TBS, 10 mM Tris-HCl (pH 7.4) containing 50 mM NaCl, Can Get Signal A (Toyobo Co.), and Can Get Signal B (Toyobo Co.); 1% BSA (final concentration) was then added to the diluents. In general, diluents that produced strong immunoreactions on light microscopy also produced a high labeling density of colloidal gold-labeled antibody. Anti-claudin-5 polyclonal antibody showed the strongest immunoreaction when it was diluted with Can Get Signal A for both LR-White-embedded materials and epon-embedded materials (Figure 8D). Can Get Signal A also showed the strongest immunoreactions when used as the diluent for E-cadherin monoclonal antibody. Monoclonal antibodies to β-catenin, β-actin, and clathrin showed a high labeling density when diluted in TBS. Polyclonal antibody to Tom 20 diluted with 50 mM NaCl/10 mM Tris-HCl (Figure 6B) or Can Get Signal B showed strong immunostaining. TBS was a better diluent for colloidal gold-labeled secondary antibodies than PBS.
7. Concluding remarks
The main mechanisms of HIAR are cleavage of chemical crosslinks formed by formaldehyde and extend of polypeptides chains to expose epitopes. Highly masked epitopes in heat-stable proteins can be exposed with reduction of disulfide bond followed by heating. Heating also cleaves crosslinks formed by double fixation with glutaraldehyde and osmium tetroxide. The principle of HIAR is applicable for immunoelectron microscopy using the post-embedding and pre-embedding methods, in which tissues are fixed with a standardized fixative described in this text. The association of exposed epitopes and antibodies under a suitable solution are also important for each immunohistochemical reaction.
Abbreviations
AnR
androgen receptor
BSA
bovine serum albumin
CAGSM
common antigen of secretory granule membrane
DAB
3,3′ diaminobenzidine
ERα
estrogen receptor α
FFPE
formalin-fixed and paraffin embedded
GFAP
glial fibrillary acidic protein
γ-GTP
γ-glutamyl transpeptidase
HIAR
heat-induced antigen retrieval
HRP
horseradish peroxidase
HSP
heat shock protein
NRP
neuropilin
PBS
phosphate-buffered saline (10 mM phosphate buffer (pH 7.4) containing 150 mM NaCl)
PCNA
proliferating cell nuclear antigen
Tom
translocase of outer mitochondrial protein
VEGF
vascular endothelial cell growth factor
VEGFR
VEGF receptor
TBS
Tris-buffered saline (10 mM Tris-HCl buffer (pH 7.4) containing 150 mM NaCl)
\n',keywords:"heat-induced antigen retrieval, antigen-antibody reaction, mechanism of chemical fixations, mechanisms of antigen retrieval, epitope exposure, immunoelectron microscopy, standardized fixative, osmicated specimens, antibody diluents",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/64314.pdf",chapterXML:"https://mts.intechopen.com/source/xml/64314.xml",downloadPdfUrl:"/chapter/pdf-download/64314",previewPdfUrl:"/chapter/pdf-preview/64314",totalDownloads:1183,totalViews:0,totalCrossrefCites:1,totalDimensionsCites:1,totalAltmetricsMentions:0,introChapter:null,impactScore:0,impactScorePercentile:36,impactScoreQuartile:2,hasAltmetrics:0,dateSubmitted:"May 10th 2018",dateReviewed:"August 10th 2018",datePrePublished:"November 7th 2018",datePublished:"March 4th 2020",dateFinished:"November 7th 2018",readingETA:"0",abstract:"Heat-induced antigen retrieval (HIAR) method reported by Shi et al. in 1991 has greatly contributed not only to immunohistochemistry but also to studying gene expressions using archived formalin-fixed and paraffin-embedded (FFPE) specimens. Heating cleaves crosslinks (methylene bridges) in formaldehyde-fixed proteins and extends polypeptides to expose epitopes hidden in the inner portion of antigens or covered by adjacent macromolecules. In this chapter, the following topics are described to reconsider the concept of immunohistochemistry flexibly and to apply HIAR for further immunological studies using a variety of specimens: (1) antigen-antibody interactions in tissues; (2) mechanisms of chemical fixation with formaldehyde, glutaraldehyde, and osmium tetroxide; (3) unmasking of epitopes using HIAR for specimens fixed with chemical fixatives, including highly masked epitopes; (4) a standardized fixative for immunoelectron microscopy-based HIAR; (5) HIAR for conventionally processed electron microscopy specimens embedded in epoxy resins; and (6) effects of antibody diluents on immunohistochemistry.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/64314",risUrl:"/chapter/ris/64314",book:{id:"7013",slug:"immunohistochemistry-the-ageless-biotechnology"},signatures:"Shuji Yamashita",authors:null,sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Antigen-antibody reactions",level:"1"},{id:"sec_3",title:"3. Mechanisms of chemical fixation",level:"1"},{id:"sec_3_2",title:"3.1 Formaldehyde",level:"2"},{id:"sec_4_2",title:"3.2 Glutaraldehyde",level:"2"},{id:"sec_5_2",title:"3.3 Osmium tetroxide",level:"2"},{id:"sec_7",title:"4. Mechanisms of HIAR",level:"1"},{id:"sec_7_2",title:"4.1 Effects of pH on proteins treated with formaldehyde",level:"2"},{id:"sec_8_2",title:"4.2 Effect of pH of HIAR solutions on immunohistochemistry",level:"2"},{id:"sec_9_2",title:"4.3 pH-dependent reversibility of HIAR efficiency",level:"2"},{id:"sec_10_2",title:"4.4 Effect of ionic strength of HIAR solution",level:"2"},{id:"sec_11_2",title:"4.5 Mechanisms of HIAR in FFPE sections",level:"2"},{id:"sec_12_2",title:"4.6 HIAR in frozen sections",level:"2"},{id:"sec_13_2",title:"4.7 Antigen retrieval for highly masked epitopes with disulfide bonds",level:"2"},{id:"sec_15",title:"5. HIAR in immunoelectron microscopy",level:"1"},{id:"sec_15_2",title:"5.1 Standardized fixative",level:"2"},{id:"sec_16_2",title:"5.2 Pre-embedding method",level:"2"},{id:"sec_17_2",title:"5.3 Post-embedding method",level:"2"},{id:"sec_18_2",title:"5.4 Osmicated and epon-embedded specimens",level:"2"},{id:"sec_18_3",title:"Table 1.",level:"3"},{id:"sec_19_3",title:"5.4.2 HIAR in epon-embedded materials",level:"3"},{id:"sec_22",title:"6. Effects of diluents on antibodies in immunohistochemistry",level:"1"},{id:"sec_22_2",title:"6.1 Kind of dilution buffers",level:"2"},{id:"sec_23_2",title:"6.2 Ionic strength of dilution solution",level:"2"},{id:"sec_24_2",title:"6.3 Immunoelectron microscopy",level:"2"},{id:"sec_26",title:"7. Concluding remarks",level:"1"},{id:"sec_29",title:"Abbreviations",level:"1"}],chapterReferences:[{id:"B1",body:'Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. Journal of Histochemistry and Cytochemistry. 1991;39:741-748'},{id:"B2",body:'Yamashita S, Okada Y. Mechanisms of heat-induced antigen retrieval: Analyses in vitro employing SDS-PAGE and immunohistochemistry. Journal of Histochemistry and Cytochemistry. 2005;53:13-21'},{id:"B3",body:'Emoto K, Yamashita S, Okada Y. Mechanisms of heat-induced antigen retrieval: Does pH or ionic strength of solution play a role for refolding of antigens? The Journal of Histochemistry and Cytochemistry. 2005;53:1311-1321'},{id:"B4",body:'Yamashita S. Heat-induced antigen retrieval: Mechanisms and application to histochemistry. Progress in Histochemistry and Cytochemistry. 2007;41:141-200'},{id:"B5",body:'Shi SR, Taylor CR. Extraction of DNA/RNA from formalin-fixed, paraffin-embedded formalin-fixed, paraffin-embedded tissues based on the antigen retrieval principle. In: Shi SR, Taylor CR, editors. Antigen Retrieval Immunohistochemistry Based Research and Diagnostics. New Jersey: John Wiley & Sons, Inc; 2012. pp. 47-71'},{id:"B6",body:'Gustafsson OJ, Arentz G, Hoffman P. Proteomic developments in the analysis of formalin-fixed tissue. Biochimica et Biophsysic Acta. 2015;1854:559-580'},{id:"B7",body:'Metz B, Kersten GFA, Hoogerhout P, Brugghet HF, Timmermans HAM, Jong A, et al. Identification of formaldehyde-induced modifications in proteins. Journal of Biological Chemistry. 2004;279:6235-6243'},{id:"B8",body:'Sutherland BS, Toews J, Kast J. Utility of formaldehyde cross-linking and mass spectrometry in the study of protein-protein interactions. Journal of Mass Spectrometry. 2008;43:699-713'},{id:"B9",body:'Toews J, Rogalski JC, Kast J. Accessibility governs the reactivity of basic residues in formaldehyde-induced protein modification. Analytica Chimica Acta. 2010;676:60-67'},{id:"B10",body:'Fox CH, Johnson FB, Roller PP. Formaldehyde fixation. Journal of Histochemistry and Cytochemistry. 1985;33:845-853'},{id:"B11",body:'Mason JT, O’Leary TJ. Effects of formaldehyde fixation on protein secondary structure: A calorimetric and infrared spectroscopic investigation. Journal of Histochemistry and Cytochemistry. 1991;39:225-229'},{id:"B12",body:'Sompuram SR, Vani K, Messana E, Bogen SA. A molecular mechanism of formalin fixation and antigen retrieval. American Journal of Clinical Pathology. 2004;121:190-199'},{id:"B13",body:'Fowler CB, O’Leary TJ, Mason JT. Modeling formalin fixation and histological processing with ribonuclease A: Effects of ethanol dehydration on reversal of formaldehyde cross-links. Laboratory Investigation. 2008;88:785-791'},{id:"B14",body:'Sabatini DD, Bensch K, Barrenett RJ. Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymimatic activity by aldehyde fixation. Journal of Cell Biolology;163(17):19-58'},{id:"B15",body:'Kawahara J, Ohmori T, Ohkubo T, Hattori S, Kawamura M. The structure of glutaraldehyde in aqueous solution determined by ultraviolet absorption and light scattering. Analytical Biochemistry. 1991;201:94-98'},{id:"B16",body:'Migneault I, Dartiguenave C, Bertrand MJ, Waldron KC. Glutaraldehyde: behavior in aqueous solution, reaction with proteins, and application to enzyme crosslinking. BioTechniques. 2004;37:798-802'},{id:"B17",body:'Deetz JS, Berhrman EJ. Reaction of osmium reagents with amino acids and proteins. Reactivity of amino acid residues and peptide bond cleavage. International Journal of Peptide and Protein Research. 1981;17:495-500'},{id:"B18",body:'Hopwood D, Yeaman G, Milne G. Differentiating the effects of microwave and heat on on tissue proteins and their crosslinking by formaldehyde. Histochemical Journal. 1988;20:341-346'},{id:"B19",body:'Rait VK, O’Leary TJ, Mason JT. Modeling formalin fixation and antigen retrieval with bovine pancreatic ribonuclease A: I-structural and functional alterations. Laboratory Investigation. 2004;84:292-299'},{id:"B20",body:'Shi SR, Imam SA, Young L, Cote RJ, Taylor CR. Antigen retrieval immunochemistry under the influence of pH using monoclonal antibodies. Journal of Histochemistry and Cytochemistry. 1995;43:193-201'},{id:"B21",body:'Pileri SA, Roncador G, Ceccarelli C, Piccioli M, Briskomatis A, Sabattini E, et al. Antigen retrieval techniques in immunohistochemistry: Comparison of different methods. Journal of Pathology. 1997;183:116-123'},{id:"B22",body:'Kim SH, Kook MC, Shin YK, Park SH, Song HG. Evaluation of antigen retrieval buffer systems. Journal of Molecular Histology. 2004;35:409-416'},{id:"B23",body:'Kajiya H, Takekoshi S, Egashira N, Miyakosh T, Serizawa T, Teramoto A, et al. Selection of buffer pH by the isoelectric point of antigen for the efficient heat-induced epitope retrieval; re-appraisal for nuclear protein pathobiology. Histochemistry and Cell Biology. 2009;132:659-667'},{id:"B24",body:'Yamashita S. pH or ionic strength of antigen retrieval solution: A potential role for refolding during feat treatment. In: Shi SR, Taylor CR, editors. Antigen Retrieval Immunohistochemistry Based Research and Diagnostics. New Jersey: John Wiley & Sons Inc; 2010. pp. 303-321'},{id:"B25",body:'Klockenbusch C, Kast J. Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin 𝛽 1. Journal of Biomedicine and Biotechnology. 2010;2010:927585. DOI: 1155/2010/927585'},{id:"B26",body:'Hoffman EA, Frey BL, Smith LM, Auble DT. Formaldehyde crosslinking: A tool for the study of chromatin complexes. Journal of Biological Chemistry. 2015;290:26404-26411'},{id:"B27",body:'Namimatsu S, Ghazizadeh M, Sugisaki Y. Reversing the effects of formalin fixation with citraconic anhydride and heat: A universal antigen retrieval method. Journal of Histochemistry and Cytochemistry. 2005;53:3-11'},{id:"B28",body:'Yamashita S, Kudo A, Kawakami H, Okada Y. Mechanisms of angiogenic suppression in uteri exposed to diethylstilbestrol neonatally in the mouse. Biology of Reproduction. 2013;88:116:1-13'},{id:"B29",body:'Yamashita S, Okada Y. Application of heat-induced antigen retrieval to aldehyde-fixed fresh frozen sections. Journal of Histochemistry and Cytochemistry. 2005;53:1421-1432'},{id:"B30",body:'Yamashita S, Katsumata O. Heat-induced antigen retrieval in immunohistochemistry. Mechanisms and applications. In: Pellicciari C, Biggiogera M, editors. Methods in Molecular Biology 1560, Histochemistry of Single Molecules, Methods and Protocols. New York: Humana Press; 2017. pp. 147-161'},{id:"B31",body:'McLean IW, Nakane PK. Peroxidase-lysine-paraformaldehyde fixative. The Journal of Histochemistry and Cytochemistry. 1974;22:1077-1083'},{id:"B32",body:'Yamashita S, Katsumata O, Okada Y. Establishment of a standardized post-embedding method for immunoelectron microscopy by applying heat-induced antigen retrieval. Journal of Electron Microscopy. 2009;58:267-279'},{id:"B33",body:'Dai W, Sato S, Ishizaki M, Wakamatsu K, Namimatsu S, Sugisaki Y, et al. A new antigen retrieval method using citraconic anhydride for immunoelectron microscopy: Localization of surfactant pro-protein C (proSP-C) in the type II alveolar epithelial cells. Journal of Submicroscopic Cytology and Pathology. 2004;36:219-222'},{id:"B34",body:'Ashour F, Deuchars J. Electron microscopic localisation of P2X4 receptor subunit immunoreactivity to pre- and post-synaptic neuronal elements and glial processes in the dorsal vagal complex of the rat. Brain Research. 2004;1026:44-55'},{id:"B35",body:'Katsumata O, Mori M, Sawane Y, Niimura T, Ito A, Okamoto H, et al. Cellular and subcellular localization of ADP-ribosylation factor 6 in mouse peripheral tissues. Histochemistry and Cell Biology. 2017;148:577-590'},{id:"B36",body:'Hann CR, Springett MJ, Johnson DH.Antigen retrieval of basement membrane proteins from archival eye tissues. Journal of Histochemistry and Cytochemistry. 2001;49:475-482'},{id:"B37",body:'Xiao JC, Adam A, Ruck P, Kaiserling E.A comparison of methods for heat-mediated antigen retrieval for immunoelectron microscopy: Demonstration of cytokeratin No. 18 in normal and neoplastic hepatocytes. Biotechnic and Histochemistry. 1996;71:278-285'},{id:"B38",body:'Saito N, Konishi K, Takeda H, Kato M, Sugiyama T, Asaka M. Antigen retrieval trial for post-embedding immunoelectron microscopy by heating with several unmasking solutions. Journal of Histochemistry and Cytochemistry. 2003;51:989-994'},{id:"B39",body:'Yamashita S. Post-embedding mammalian tissue for immunelectron microscopy: A standardized procedure based on heat-induced antigen retrieval. In: Schwartzbach SW, Skalli O, Schikorski T, editors. Methods in Molecular Biology 1474, High-Resolution Imaging of Cellular Proteins, Methods and Protocols. New York: Humana Press; 2016. pp. 279-290'},{id:"B40",body:'Bendayan M, Zollnger M. Ultrastructural localization of antigenic sites on osmium-fixed tissues applying the protein A-gold technique. Journal of Histochemistry and Cytochemistry. 1983;31:101-109'},{id:"B41",body:'Rocken C, Roessner A. An evaluation of antigen retrieval procedures for immunoelectron microscopic classification of amyloid deposits. Journal of Histochemistry and Cytochemistry. 1999;47:1385-1394'},{id:"B42",body:'Coleman RA, Liu J, Wade JB. Use of anti-fluorophore antibody to achieve high-sensitivity immunolocalizations of transporters and ion channels. Journal of Histochemistry and Cytochemistry. 2006;54:817-827'},{id:"B43",body:'Brorson SH, Skjorten F. Improved technique for immunoelectron microscopy. How to prepare epoxy resin to obtain approximately the same immunogold labeling for epoxy sections as for acrylic sections without any etching. Micron. 1996;27:203-209'},{id:"B44",body:'Yamashita S, Okada Y. Heat-induced antigen retrieval in conventionally processed epon-embedded specimens: Procedures and mechanisms. Journal of Histochemistry and Cytochemistry. 2014;62:584-597'},{id:"B45",body:'Yamashita S. Immunoelectron microscopy with the post-embedding method based on heat-induced antigen retrieval: Techniques and mechanisms. Kenbikyo. 2014;49:124-131 (in Japanese)'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Shuji Yamashita",address:"shuji@z5.keio.jp",affiliation:'
Keio University School of Medicine, Japan
'}],corrections:null},book:{id:"7013",type:"book",title:"Immunohistochemistry",subtitle:"The Ageless Biotechnology",fullTitle:"Immunohistochemistry - The Ageless Biotechnology",slug:"immunohistochemistry-the-ageless-biotechnology",publishedDate:"March 4th 2020",bookSignature:"Charles F. Streckfus",coverURL:"https://cdn.intechopen.com/books/images_new/7013.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83880-821-1",printIsbn:"978-1-83880-820-4",pdfIsbn:"978-1-83880-822-8",reviewType:"peer-reviewed",numberOfWosCitations:2,isAvailableForWebshopOrdering:!0,editors:[{id:"29033",title:"Prof.",name:"Charles",middleName:"F.",surname:"Streckfus",slug:"charles-streckfus",fullName:"Charles Streckfus"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"149"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"64808",type:"chapter",title:"Detection Systems in Immunohistochemistry",slug:"detection-systems-in-immunohistochemistry",totalDownloads:2078,totalCrossrefCites:1,signatures:"Sorour Shojaeian, Nasim Maslehat Lay and Amir-Hassan Zarnani",reviewType:"peer-reviewed",authors:[null]},{id:"64314",type:"chapter",title:"Antigen Retrieval for Light and Electron Microscopy",slug:"antigen-retrieval-for-light-and-electron-microscopy",totalDownloads:1183,totalCrossrefCites:1,signatures:"Shuji Yamashita",reviewType:"peer-reviewed",authors:[null]},{id:"63122",type:"chapter",title:"Immune Cell Profiling in Cancer Using Multiplex Immunofluorescence and Digital Analysis Approaches",slug:"immune-cell-profiling-in-cancer-using-multiplex-immunofluorescence-and-digital-analysis-approaches",totalDownloads:1701,totalCrossrefCites:0,signatures:"Edwin Roger Parra",reviewType:"peer-reviewed",authors:[null]},{id:"66392",type:"chapter",title:"Low-Specificity and High-Sensitivity Immunostaining for Demonstrating Pathogens in Formalin-Fixed, Paraffin-Embedded Sections",slug:"low-specificity-and-high-sensitivity-immunostaining-for-demonstrating-pathogens-in-formalin-fixed-pa",totalDownloads:1281,totalCrossrefCites:6,signatures:"Yutaka Tsutsumi",reviewType:"peer-reviewed",authors:[{id:"280338",title:"Dr.",name:"Yutaka",middleName:null,surname:"Tsutsumi",fullName:"Yutaka Tsutsumi",slug:"yutaka-tsutsumi"}]},{id:"65712",type:"chapter",title:"In Situ Identification of Ectoenzymes Involved in the Hydrolysis of Extracellular Nucleotides",slug:"in-situ-identification-of-ectoenzymes-involved-in-the-hydrolysis-of-extracellular-nucleotides",totalDownloads:957,totalCrossrefCites:0,signatures:"Mireia Martín-Satué, Aitor Rodríguez-Martínez and Carla Trapero",reviewType:"peer-reviewed",authors:[null]}]},relatedBooks:[{type:"book",id:"10874",title:"Insights on Antimicrobial Peptides",subtitle:null,isOpenForSubmission:!1,hash:"23ca26025e87356a7c2ffac365f73a22",slug:"insights-on-antimicrobial-peptides",bookSignature:"Shymaa Enany, Jorge Masso-Silva and Anna Savitskaya",coverURL:"https://cdn.intechopen.com/books/images_new/10874.jpg",editedByType:"Edited by",editors:[{id:"81926",title:"Dr.",name:"Shymaa",surname:"Enany",slug:"shymaa-enany",fullName:"Shymaa Enany"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"79614",title:"Introductory Chapter: Antimicrobial Peptides – Prodigious Therapeutic Strategies",slug:"introductory-chapter-antimicrobial-peptides-prodigious-therapeutic-strategies",signatures:"Jorge Masso-Silva, Anna Savitskaya and Shymaa Enany",authors:[{id:"81926",title:"Dr.",name:"Shymaa",middleName:null,surname:"Enany",fullName:"Shymaa Enany",slug:"shymaa-enany"},{id:"346088",title:"Ph.D.",name:"Anna",middleName:null,surname:"Savitskaya",fullName:"Anna Savitskaya",slug:"anna-savitskaya"},{id:"346095",title:"Dr.",name:"Jorge",middleName:"Adrian",surname:"Masso-Silva",fullName:"Jorge Masso-Silva",slug:"jorge-masso-silva"}]},{id:"78305",title:"Anti-Microbial Peptides: The Importance of Structure-Function Analysis in the Design of New AMPs",slug:"anti-microbial-peptides-the-importance-of-structure-function-analysis-in-the-design-of-new-amps",signatures:"Awatef Ouertani, Amor Mosbah and Ameur Cherif",authors:[{id:"342898",title:"Dr.",name:"Ameur",middleName:null,surname:"Cherif",fullName:"Ameur Cherif",slug:"ameur-cherif"},{id:"419738",title:"Dr.",name:"Awatef",middleName:null,surname:"Ouertani",fullName:"Awatef Ouertani",slug:"awatef-ouertani"},{id:"419745",title:"Dr.",name:"Amor",middleName:null,surname:"Mosbah",fullName:"Amor Mosbah",slug:"amor-mosbah"}]},{id:"78410",title:"Antimicrobial Peptides: Mechanism of Action",slug:"antimicrobial-peptides-mechanism-of-action",signatures:"Tanu Singh, Princy Choudhary and Sangeeta Singh",authors:[{id:"251063",title:"Dr.",name:"Sangeeta",middleName:null,surname:"Singh",fullName:"Sangeeta Singh",slug:"sangeeta-singh"},{id:"423051",title:"Ms.",name:"Tanu",middleName:null,surname:"Singh",fullName:"Tanu Singh",slug:"tanu-singh"},{id:"423052",title:"Ms.",name:"Princy",middleName:null,surname:"Choudhary",fullName:"Princy Choudhary",slug:"princy-choudhary"}]},{id:"78302",title:"Antimicrobial Peptides Derived from Ascidians and Associated Cyanobacteria",slug:"antimicrobial-peptides-derived-from-ascidians-and-associated-cyanobacteria",signatures:"Rajaian Pushpabai Rajesh and Grace Vanathi M",authors:[{id:"356405",title:"Dr.",name:"Rajaian",middleName:null,surname:"Pushpabai Rajesh",fullName:"Rajaian Pushpabai Rajesh",slug:"rajaian-pushpabai-rajesh"},{id:"422914",title:"Ms.",name:"Grace",middleName:null,surname:"Vanathi M",fullName:"Grace Vanathi M",slug:"grace-vanathi-m"}]},{id:"80915",title:"Molecular Pathogenesis of Inflammatory Cytokines in Insulin Resistance Diabetes Mellitus",slug:"molecular-pathogenesis-of-inflammatory-cytokines-in-insulin-resistance-diabetes-mellitus",signatures:"Haamid Bashir, Mohammad Hayat Bhat and Sabhiya Majid",authors:[{id:"337681",title:"Prof.",name:"Sabhiya Majid",middleName:null,surname:"Majid",fullName:"Sabhiya Majid Majid",slug:"sabhiya-majid-majid"},{id:"355877",title:"Dr.",name:"Haamid",middleName:null,surname:"Bashir",fullName:"Haamid Bashir",slug:"haamid-bashir"},{id:"423302",title:"Dr.",name:"Mohammad",middleName:null,surname:"Hayat Bhat",fullName:"Mohammad Hayat Bhat",slug:"mohammad-hayat-bhat"}]},{id:"79192",title:"Mass Spectrometry (Imaging) for Detection and Identification of Cyclic AMPs: Focus on Human Neutrophil Peptides (HNPs)",slug:"mass-spectrometry-imaging-for-detection-and-identification-of-cyclic-amps-focus-on-human-neutrophil-",signatures:"Eline Berghmans and Geert Baggerman",authors:[{id:"357016",title:"Prof.",name:"Geert",middleName:null,surname:"Baggerman",fullName:"Geert Baggerman",slug:"geert-baggerman"},{id:"357022",title:"Dr.",name:"Eline",middleName:null,surname:"Berghmans",fullName:"Eline Berghmans",slug:"eline-berghmans"}]},{id:"79773",title:"Cloning and Identification System of Apis mellifera Melittin cDNA in Escherichia coli",slug:"cloning-and-identification-system-of-em-apis-mellifera-em-melittin-cdna-in-em-escherichia-coli-em-",signatures:"Diego Jáuregui, Miquel Blasco and Santiago Mafla",authors:[{id:"258850",title:"Dr.",name:"Santiago",middleName:null,surname:"Mafla",fullName:"Santiago Mafla",slug:"santiago-mafla"},{id:"355862",title:"Ph.D.",name:"Miquel",middleName:null,surname:"Blasco",fullName:"Miquel Blasco",slug:"miquel-blasco"},{id:"355864",title:"Dr.",name:"Diego",middleName:null,surname:"Jáuregui",fullName:"Diego Jáuregui",slug:"diego-jauregui"}]},{id:"81299",title:"Peptides with Therapeutic Potential against Acinetobacter baumanii Infections",slug:"peptides-with-therapeutic-potential-against-em-acinetobacter-baumanii-em-infections",signatures:"Karyne Rangel and Salvatore Giovanni De-Simone",authors:[{id:"217006",title:"Prof.",name:"Salvatore",middleName:null,surname:"De-Simone",fullName:"Salvatore De-Simone",slug:"salvatore-de-simone"},{id:"423447",title:"Dr.",name:"Karyne",middleName:null,surname:"Rangel",fullName:"Karyne Rangel",slug:"karyne-rangel"}]}]}],publishedBooks:[{type:"book",id:"10874",title:"Insights on Antimicrobial Peptides",subtitle:null,isOpenForSubmission:!1,hash:"23ca26025e87356a7c2ffac365f73a22",slug:"insights-on-antimicrobial-peptides",bookSignature:"Shymaa Enany, Jorge Masso-Silva and Anna Savitskaya",coverURL:"https://cdn.intechopen.com/books/images_new/10874.jpg",editedByType:"Edited by",editors:[{id:"81926",title:"Dr.",name:"Shymaa",surname:"Enany",slug:"shymaa-enany",fullName:"Shymaa Enany"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],publishedBooksByAuthor:[]},onlineFirst:{chapter:{type:"chapter",id:"78376",title:"Ivermectin: Potential Repurposing of a Versatile Antiparasitic as a Novel Anticancer",doi:"10.5772/intechopen.99813",slug:"ivermectin-potential-repurposing-of-a-versatile-antiparasitic-as-a-novel-anticancer",body:'
1. Introduction
Avermectins are a complex of 16-membered macrocyclic lactones produced from soil fermentation of the actinomycete S. avermitilis [1, 2]. There exist eight avermectin compounds (A1a, A1b, A2a, A2b, B1a, B1b, B2a, and B2b), of which ivermectin is the most commonly employed due to its semi-synthetic mixture (80% B1a and 20% B1b), and its potent antiparasitic activity as well as its safety [3]. The family of compounds from which Ivermectin is derived was discovered by Nobel laureates Satoshi Omura and William Campbell in the 1970s. The chemical is effective against a wide number of parasites and arthropods - pinworms, mites, lice, heartworms and fleas in dogs, parasitic worms in pasture animals by disrupting the fluid exchange through the insect’s cell membrane, and in the past 40 years, ivermectin has been used extensively for agriculture and veterinary purposes [4, 5, 6, 7].
The success of ivermectin treatment as antiparasitic is due to its high affinity for the glutamate-gated chloride channels (Glu-Cl) present in parasite cells but absent in vertebrates. The ivermectin-channel-interaction prevents channel closure, leading to plasma membrane hyperpolarization, paralyzing the target parasite’s pharyngeal and somatic muscles, triggering its death [2]. In addition to activating the Glu-Cl parasites channels, ivermectin acts as a dose-dependent positive allosteric regulator of several vertebrate ligand-gated channels, including the γ-aminobutyric acid type-A receptor (GABA receptor), glycine receptor, neuronal α7-nicotinic receptor, and purinergic P2X4 receptor. The effects of ivermectin over these receptors include the potentiation of agonist-induced currents at low concentrations and channel opening at higher concentrations [8]. However, GABA-sensitive neurons are protected by the blood–brain barrier within the central nervous system, protecting vertebrates against the potentially harmful effects of Ivermectin [3, 6].
2. Drug repurposing in cancer therapy
Effective, safe, and affordable cancer drugs are highly needed to reduce cancer mortality. The field of drug repurposing emerged in the early 1990s as an alternative to the conventional drug discovery model. This model entails targeting discovery and validation, lead identification by high-throughput screening, and lead optimization by medicinal chemistry. Drug repurposing surged to overcome the pharmaceutical industry’s limited productivity regarding the number of approved drugs concerning the long time and huge money required to develop a drug. Classical drug discovery requires an average of 15 years of research, whereas drug development by repurposing is portended to be cheaper, faster, and safer. The significant advantage of drug repurposing is that the pharmacokinetics, pharmacodynamics, and toxicity profiles of drugs are, in general, well known; thus, its rapid translation into phase II and III clinical trials is feasible [9]. Among the different drugs currently studied under the focus of therapeutic repositioning, ivermectin is very promising. It has been shown to have antitumor effects in vitro and in vivo (Figure 1).
Figure 1.
Cancer targets of ivermectin. 1. Decreasing the function of the mitochondrial complex I, Ivermectin, limits the electronic movement in the oxidative phosphorylation pathway that stimulates oxygen consumption rate to generate ATP for the cell. Low ATP levels are related to a failure in the P-glycoprotein pump to extrude chemotherapy drugs. Concomitantly there is a reduction in the phosphorylation levels of Akt, impacting the mitochondrial biogenesis process. Furthermore, alterations in the mitochondrial machinery are related to increased levels of reactive oxygen species that damage DNA. 2. Ivermectin limits the function of the RNA helicases NS3 and DDX23, both of which are related to ribosome biogenesis and post-transcriptional modifications, as well as with mRNA degradation. DDX23 acts as a promoter of miR-21, which is a well-recognized stimulator of tumor progression. 3. The WNT-TCF pathway, involved in cancer progression and metastases, is inhibited by Ivermectin. Indeed, this compound represses AXIN2, LGR5, and ASCL2, all of them WNT-TCF targets. At the same time, it promotes the repressor of the WNT signaling FILIP1L. Both effects inhibit the ability of WNT-TCF to downregulate the tumor suppressor APC and limit the translocation of β–catenin to the nucleus for epithelial to mesenchymal transition in metastatic events. 4. Ivermectin acts as an ionophore by the up-regulation of chloride channels to generate apoptosis and osmotic cell death. 5. Ivermectin induces immunogenic cell death by stimulating an ATP- and HMGB1-enriched microenvironment, which promotes inflammation. This drug also increases ATP sensitivity and calcium signals in P2X membranal receptors, particularly P2X4 and P2X7, to induce ATP-dependent immune responses. 6. Ivermectin promotes the poly-ubiquitination of the kinase PAK1, which directs it to degradation in the proteasome. Defective PAK1, in turn, inhibits the Akt/mTOR pathway. At the same time, Ivermectin stimulates the expression of Beclin1 and Atg5, both related to induction of autophagy. Particularly, Beclin1 increases the expression of the positive autophagy regulators Atg14L and Vps34 and reduces the negative regulator of apoptosis Bcl-2. Together, this generates autophagy and apoptosis. 7,8. Ivermectin modifies the epigenetic signature and the self-renewal activity in the malignant cell due to its ability to mimic the SIN3-interaction that binds to the PAH2 motif of the ca.
3. Antitumor effects of Ivermectin-mechanisms of action and in vitro data
Ivermectin has demonstrated antitumor effects in different types of cancers. Among mechanisms of action reported, ivermectin interacts and affects the function of 1) mitochondrial I complex, the multidrug resistance protein (MDR), 2) RNA helicases, 3) the WNT-TCF pathway, 4) chloride channel receptor, 5) immunogenic cell death via ATP- and HMGB1, 6) PAK-1, 7,8) epigenetic signature and sel-renewal of stem cells [10]. Preclinical testing have demonstrated inhibition of cell growth, induction of apoptosis in different cancer cell lines and antitumor effects in murine models (Figure 1) [11, 12, 13, 14, 15, 16, 17, 18, 19]. The in vitro antitumor effects are observed at a median concentration of 5 μM (0.01–100 μM), which is clinically attainable according to the pharmacokinetic data in humans shown in Table 1. We present a review of the laboratory results of ivermectin on various cancer cell lines below.
Illness/Adverse effects
Mild
Intermediate
Severe
Onchocerciasis
Myalgia, skin eruptions, joints swelling, limbs or face, itching, fever and cold
Skin pain and edema, arthralgia, bone pain, severe dizziness, high fever, dyspnea, and hypotension
NA
Filariasis
Headache and nausea
NA
Encephalopathy
Scabies
Nausea
Severe headache, abdominal pain, and tachycardia
NA
Table 1.
Adverse effects caused by Ivermectin.
3.1 Ovarian cancer
Ivermectin blocks the oncogenic kinase PAK1 in human ovarian cancer and in NF2-deficient Schwannoma cell lines to suppress their PAK1-dependent growth in cell culture at a half maximal inhibitory concentration (IC50) between 5 and 20 μM [14]. PAK1 is involved in various signaling pathways that play an essential role in cytoskeletal dynamics, cell adhesion, migration, proliferation, apoptosis, and mitosis. It is required for the growth of approximately 70% of neoplasms [20]. Additionally, cancer stem-like cells derived from SKOV-3 cell line treated with 5 μM ivermectin showed a significant decrease in cell viability and clonogenic capacity. Also, the expression levels of Nanog, Sox2, and Oct4 are reduced after treatment with ivermectin 5 μM [11].
3.2 Breast cancer
Ivermectin inhibits the ATK/mTOR pathway in breast cancer cell lines by promoting ubiquitination of PAK1. Ivermectin disrupts the binding of PAK1 protein with AKT, and in turn hinders the phosphorylation and activation of AKT; resulting in AKT/mTOR pathway inactivation. These effects of ivermectin are observed at concentrations above 10 μM [15]. Additionally, ivermectin preferentially inhibits the viability of cancer stem-like cells enriched populations (CD44+/ CD24−) in the range of 0.2–8 μM via reducing the expression of maintenance of the pluripotency and self-renewal markers Nanog, Oct4, and Sox2 at both mRNA and protein levels [11]. Separately, a study demonstrated that 1 μM ivermectin treatment inhibits the function of SIN3 [16], which is part of a complex that positively regulates Nanog and Sox2, leading to a decrease in mammospheres number [21]. Furthermore, ivermectin was reported to induce E-cadherin and Estrogen Receptor 1 expression and the restoration of tamoxifen sensitivity in a triple-negative breast cancer model. According to these observations, ivermectin has potential antitumor effects in triple-negative breast cancer [16]. Another study demonstrated a synergy between ivermectin with docetaxel or cyclophosphamide in estrogen receptor-negative breast cancer cells and a synergistic effect with tamoxifen in estrogen receptor-positive breast cancer cell lines [22].
3.3 Liver cancer
In human combined hepatocellular-cholangiocarcinomas and intrahepatic cholangiocarcinomas (cHC-CCs and ICCs), there is robust YAP1 activation. YAP1 is a transcriptional regulator of genes involved in cell proliferation and suppression of apoptotic genes, and itis inhibited in the Hippo signaling pathway which allows tumor suppression. Nuclear translocation of YAP1/TAZ also increases transcription of TGF-βs [23]. Thus, it is possible that coordinated targeting of YAP1/TAZ and TGF-β signaling may be a treatment for cHC-CCs and ICCs displaying dysregulated Hippo signaling and meanwhile drug screening revealed ivermectin to inhibit YAP1 activation [23].
3.4 Cervical cancer
Ivermectin inhibits the viability of HeLa cells and induces a G1/S cell cycle arrest leading to apoptosis and morphological changes of DNA fragmentation and chromatin condensation of such cells. Additionally, ivermectin can significantly increase intracellular ROS content and inhibit the migration of HeLa cells [24].
3.5 Glioblastoma
Ivermectin inhibits the growth of glioma cells by inducing cell cycle arrest and apoptosis in vitro and in vivo [25]. Specifically, in glioblastoma and brain endothelial cells, ivermectin has been reported to induce mitochondrial dysfunction. It inhibits cell growth and colony formation and blocks the enzymatic activity of the respiratory chain complex I, thereby decreases mitochondrial respiration, membrane potential, and ATP levels while increasing the generation of superoxides that in turn induces cell death by caspase-dependent apoptosis. Additionally, ivermectin also inhibits angiogenesis at concentrations above 5 μM [12].
3.6 Leukemia and prostate cancer
The treatment of OCI-AML2 cells with ivermectin increased the concentration of intracellular chloride ions, leading to hyperpolarization of the plasma and mitochondrial membranes and ROS production [18]. In contrast, DU145 and PPC-1 cells and primary normal hematopoietic cells that were resistant to ivermectin did not demonstrate changes in their plasma membrane potential when treated with up to 6 μM ivermectin. Moreover, the in vitro antitumor effect of ivermectin on various cancer cell lines at a concentration of 5 μM showed that DU145 is only minimally reduced in viability and clonogenic capacity, but when it is treated in combination with docetaxel cells demonstrated strong inhibition [22]. In myeloid leukemia cells ivermectin strongly synergizes with daunorubicin and cytarabine [18].
3.7 Colon and lung cancer
The WNT/TCF signaling pathway is constitutively active in many tumors and it regulates genes for cell growth and proliferation. Ivermectin can inhibit the WNT-TCF signaling pathway by decreasing cyclin D1, which is a direct target in this pathway and ivermectin also affects the phosphorylation of β-catenin, which leads to inhibition of proliferation and increased apoptosis in lung and colon tumor cells at concentrations above 5 μM [13].
4. Antitumor effects of ivermectin-animal data
In a wide-range of pre-clinical studies, rodent models of human xenografts of glioblastoma, leukemia, breast and colon carcinomas, as well as a variety of murine cell lines in syngeneic models have consistently shown ivermectin to possess robust antitumor effect at a median dose of 5 mg/Kg [12, 13, 15, 17, 18]. We present a review of some results of anticancer studies of ivermectin in animal below.
4.1 Glioblastoma
Two independent glioblastoma xenograft SCID mice models were established by subcutaneous injection of U87 or T98G cells, and the rodents were subsequently treated with intraperitoneal ivermectin at 40 mg/Kg. The treated mice had demonstrated significant tumor growth inhibition but maintained normal behavior and retained their weight [12]. A separate study using 3 mg/Kg of ivermectin showed a 50% decrease in tumor size and there was near complete regression of tumors at 10 mg/Kg. Ki67 staining also confirmed that glioma cell proliferation was decreased in ivermectin-treated animals compared to controls [17].
4.2 Colon and lung cancers
Melotti et al. used H358 human metastatic lung bronchioalveolar carcinoma cells and DLD1 colorectal adenocarcinoma cells to test the antitumor effects of ivermectin. The animals received intraperitoneal injections of cyclodextrin-conjugated ivermectin daily at 10 mg/kg after tumor establishment. Subsequently, it was found that tumors responded to ivermectin with a near 50% reduction of growth and a repressed lung cancer WNT-TCF signature and enhanced p21 levels [13].
4.3 Breast cancer
Ivermectin was evaluated in an orthotopic breast cancer model with human MDA-MB-231 cells subcutaneously injected in the mammary fat pad of NOD-SCID mice. Xenografts treated with ivermectin grew at a slower rate than those of the control group, and the size and weight of control tumors were macroscopically larger than that of ivermectin-treated tumors [15]. Another study tested JC murine breast cancer cells in Balb/c mice treated with a dose of 3 mg/Kg of ivermectin. Treatment reduced tumor size more than 60% with no changes in weight or behavior of the study animals when compared with controls [22]. Recently it was demonstrated the ivermectin at a dose of 5 mg/Kg induces immunogenic cell death hallmarks with large numbers of intratumoral CDA4+ and CD8+ T cells in a 4 T1 murine tumor model. Thus, ivermectin turns cold tumors into hot ones which allows for marked synergy with check point inhibitor nivolumab, leading to major antitumor effects and most importantly, protective immunity [26].
4.4 Leukemia
Human leukemia (OCI-AML2 and K562) and murine leukemia (MDAY-D2) cells were injected subcutaneously into NOD/SCID mice which were subsequently treated with 3 mg/Kg (human equivalent dose of 0.240 mg/Kg) of ivermectin or control in water via oral gavage. Upon follow-up, the treated mice had up to 70% decrease in their tumor burden without any gross sign of organ toxicity, and treatment led to increased apoptosis in OCI-AML2 xenografts [18]. It must be remarked that most of the in vivo studies to evaluate the antitumor effects of ivermectin dose ranging from 3 to 10 mg/Kg. These mice doses translate into human to 0.240 to 0.810 mg/Kg which are clinically attainable [27].
5. Clinical experience with ivermectin
As mentioned above, there has been extensive clinical use of ivermectin as an anti-parasitic, and the drug has been repurposed for use against other pathogens and non-parasitic conditions in humans. However, despite considerable preclinical evidence of antitumor effects of ivermectin, it is curious that no clinical studies of ivermectin against cancer have been reported nor clinical trials launched. However, there is a case report on three children with refractory and heavily pretreated acute myeloblastyic leukemia. In the three cases, ivermectin was at 1 mg/Kg either alone or in combination with Ara-C. Two of them had clinical improvement with durable stable disease in one, a and complete hematological response the second. The third one receiving ivermectin alone had no response. Though anecdotic, these data demonstrate that ivermectin can be safely administered at dosis five times higher the recommended dose of 0.200 mg/Kg, and that can show efficacy combined with cytotoxics [28].
Here, we briefly review the clinical experience with ivermectin as an antiparasitic as well as in other repurposed indications, with special attention to its toxicities and safety and its clinical pharmacology, the data of which can be a basis for future clinical trials of ivermectin against cancer.
5.1 Ivermectin use as anti-parasitic
Because of its broad spectrum applicability, ivermectin can be applied to treat onchocerciasis, lymphatic filariasis, strongyloidiasis, ascariasis, scabiasis, and enterobiasis. Since its discovery, ivermectin has been administered to millions of patients with the above parasitic infections around the world. Mild adverse effects of oral ivermectin therapy against certain parasites are common; many of them appear within 24-48 hours of the onset of therapy and are related to ivermectin dose as well as the microfilariae load in the skin in case of filiariasis [29, 30]. Some of these adverse effects include myalgia, skin rashes, joints swelling, limbs or face itching, fever, and chills. These effects are usually transient and do not require treatment [31, 32]. Moderate to severe effects are less common and may include skin edema with the presence of pain, arthralgia, severe dizziness, high fever, dyspnea, and hypotension (Mazzotti’s Reaction). It is known that such reaction is not related to the administration of Ivermectin but with the parasite amount present in the host [30, 31]. In addition to Mazzotti’s reaction, there have been cases of severe encephalopathy that can be fatal in patients with onchocerciasis and filariasis after treatment with ivermectin. The symptoms of encephalopathy include altered mental status, incontinence, and difficulty standing or walking 48 hours after ivermectin treatment [32, 33]. This effect is again probably due to the obstruction of the cerebral microcirculation due to the accumulation of paralyzed or killed parasites and not by ivermectin itself [34, 35]. Also, toxic effects have been linked to ivermectin’s interaction with P-glycoprotein [8]. The absence of P-glycoprotein determines the accumulation of Ivermectin in the brain of transgenic mice who do not express it and dogs with impaired P-glycoprotein function (commonly a 4 base-pair deletion of the MDR-1 gene that produces a stop codon) have increased neurotoxicity to ivermectin [36]. Table 2 summarizes ivermectin’s adverse effects. The dose and schedules vary but human doses are standardized for approved indications within the range of 0.15 to 0.4 mg/Kg. For onchocerciasis, the recommended dose is 0.15 mg/Kg once every 12 months, though patients with heavy ocular infection may require retreatment every 3 or 6 months. Filariasis usually requires a single dose of 0.4 mg/Kg. In strongyloidiasis, a single dose of 0.2 mg/Kg is recommended; however, in immunocompromised (including HIV) patients, the treatment may require repeated administration (i.e. every two weeks) and continued suppressive therapy (i.e. once a month). A single dose of 0.2 mg/Kg is also used to treat ascariasis, while the same dose repeated once at two weeks is recommended for scabiasis [37].
Group
Dose (mg/kg)
Drug delivery
Cmax (ng/mL)
Tmax (h)
AUC μg/h/mL
Onchocercosis patients
0.1–0.2
Oral
52.0
5.2
2.852
Healthy volunteers
0.35–0.6
Oral
87.0
4.2
1.444
Healthy volunteers
0.7–1.1
Oral
165.2
3.6
2.099
Healthy volunteers
1.4–2.0
Oral
247.8
4.2
4.547
Table 2.
Pharmacokinetic data of Ivermectin in humans infected with parasites and in healthy volunteers.
Recently, there has been a growing interest in newer anti-parasitic indications of ivermectin such as against soil-transmitted helminths and malaria, hence doses above 0.4 mg/Kg are being evaluated for achieving higher plasma levels [38, 39].
An example is a pharmacokinetic trial using 18 mg ivermectin tablets in 54 healthy adult volunteers to evaluate the safety of fixed regimens of 18 and 36 mg [40]. A meta-analysis to investigate the safety of higher doses of ivermectin identified four studies for inclusion, and found no differences in the number of individuals experiencing adverse events at higher doses. A descriptive analysis of these clinical trials for a variety of indications also showed no difference in the severity of the adverse events between standard (up to 0.4 mg/Kg) and higher doses of Ivermectin (0.4-0.7 mg/Kg; 0.6 mg/Kg, and 0.8 mg/Kg). Only one trial showed an increase in transient and mild to moderate subjective ocular events such as transitory blurring of vision, itching or pain of the eye, and dyschromatopsia in the higher-dose group in a trial to treat onchocerciasis. Meanwhile, severe adverse events described as life-threatening, was reported in only one out of the four studies with one case of anaphylaxis at the standard dose and another case of QTc prolongation likely due to drug-drug interaction in a higher-dose group [41]. The result of this small meta-analysis is suggestive of relatively safety of higher doses of ivermectin.
5.2 Ivermectin’s potential as an anti-viral
Ivermectin exhibits anti-viral activity against viruses both in vitro and in vivo. The antiviral activity is thought to be related to tthe inhibition of nuclear translocation of viral proteins, facilitated by mammalian host importin also known as karyopherin α/β‐1 heterodimerization [42]. It is partially upon this basis that ivermectin has been tested as a treatment in the current COVID-19 pandemic. A recent meta-analysis and systematic review involving 629 COVID-19 patients from 4 observational studies (3 with control arms and 1 without) found that adding ivermectin led to significant clinical improvement compared to control (OR=1.98, 95% CI: 1.11 - 3.53, p=0.02) [43]. however, the authors did caution on the interpretation of their analysis because the low quality of evidence, and it should be noted that one of the trials included in the analysis was subsequently retracted. Meanwhile, several randomized studies evaluating ivermectin against COVID-19 have recently been published. An Iranian trial demonstrated that a single 0.2 mg/Kg dose of ivermectin was well-tolerated in symptomatic COVID-19 patients, and dyspnea, cough and lymphopenia associated with COVID-19 were significantly improved [44]. In two other randomized trials, the time to viral clearance was statistically reduced. The doses and schedules in these two trials were ivermectin at a fixed 12 mg daily for 5 days [45] and ivermectin at 0.1, 0.2, and 0.4 mg/Kg once at admission [46]. These were underpowered trials so that further evidence is still required to confirm the clinical usefulness of ivermectin under various COVID-19 clinical scenarios.
5.3 Other uses of ivermectin
Ivermectin possesses possible agonistic bioactivity against the γ-aminobutyric acid (GABA) receptor [47] and it was upon this premise that it was used in a patient with severe spasticity caused by spinal cord damage at a dose of 1.6 mg/Kg subcutaneously twice a week for 12 weeks. The patients had decreased spasm scores, suggesting that ivermectin may reduce spasticity in the spine without adverse effects at this high dose [48].
6. Pharmacokinetics and dose considerations for ivermectin as cancer therapy
Due to its relatively long history of extensive use, the pharmacokinetics of ivermectin has been well studied. The oral route is the only approved for ivermectin administration in humans although it can be given subcutaneously and the intravenous route of administration has also been investigated. Ivermectin is a fat-soluble compound and reaches a peak concentration 4-5 hours after oral administration, and it has a half-life of approximately 19 hours. After administration, it is subsequently extensively metabolized in human liver microsomes by cytochrome P-4503A4, converting the drug to at least ten metabolites, most of them hydroxylated and demethylated derivatives. Its excretion is mainly by the fecal route, and only 1% is excreted in the urine [49]. In healthy individuals and patients infected with onchocerciasis treated with a dose of 0.150 mg /Kg of Ivermectin, significant variability in pharmacokinetic parameters such as absorption, distribution, metabolism, and excretion is not observed [49].
The therapeutic dose for ivermectin as an anti-parasitic compound for human use is is between 0.1 and 0.4 mg/ Kg [4, 5, 6, 7], resulting in an AUC of 1,444 μg/h/mL. This drug exposure, which translates to a plasma concentration of 1.65 μM, is however less than concentrations of 5 μM or greater that has been found necessary to inhibit tumor cells in vitro In a phase I pharmacokinetic study done in healthy volunteers, it was demonstrated that doses up to 2 mg/Kg which leads to an AUC of 4,547 μg/h/mL can translate into a plasma concentration of 5 μM [50], thus the recommended dose for cancer therapy should likely be 2 mg/kg or higher.
7. Discussion
Currently, various efforts to facilitate the discovery of drug repurposing candidates for cancer and a large number of drug candidates do exist [51]. As an example, the Repurposing Drugs in Oncology (ReDO) Project, which is initiated by a non-profit international collaboration of researchers, clinicians, and cancer patient advocates whose goal is to find efficacious, minimally toxic, and affordable cancer treatments identified a total of 268 drugs that matched the following two criteria: i) the drug is licensed for non-cancer indications in at least one country in the world, and ii) the drug is the subject of one or more peer-reviewed publications showing a specific anticancer effect based on in vitro, in vivo, or clinical research in one or more malignancies. According to these criteria, ivermectin can be a potential repurposing candidate for cancer. Ivermectin has extensive preclinical in vitro and in vivo anticancer data and is thus an ideal candidate for clinical trials. An especially promising feature with ivermectin is that its anti-cancer concentration in vitro should be attainable clinically, inexpensively, and without undue toxicity.
8. Conclusion
Ivermectin has been administered to millions of patients as an anti-parasitic drug exhibiting a wide margin of clinical safety. There exists a large body of in vitroand in vivo evidence demonstrating ivermectin’s anti-tumor potential, and ivermectin’s anti-tumor efficacy can be demonstrated at concentrations that are clinically attainable based on clinical pharmacokinetics. We thus propose that ivermectin be considered urgently for clinical trials either as a single agent or in combination with existing antineoplastics for cancer.
\n',keywords:"Drug repurposing, ivermectin, cancer",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/78376.pdf",chapterXML:"https://mts.intechopen.com/source/xml/78376.xml",downloadPdfUrl:"/chapter/pdf-download/78376",previewPdfUrl:"/chapter/pdf-preview/78376",totalDownloads:369,totalViews:0,totalCrossrefCites:1,dateSubmitted:"June 5th 2021",dateReviewed:"August 5th 2021",datePrePublished:"September 1st 2021",datePublished:"June 1st 2022",dateFinished:"September 1st 2021",readingETA:"0",abstract:"Drug repositioning is a alternative strategy to discover and develop anticancer drugs based on identification of new mechanisms of actions and indications for existing compounds. Ivermectin belongs to the avermectin group of compounds, a series of 16-membered macrocyclic lactone moieties discovered in 1967 and FDA-approved for human use since 1987. Ivermectin has since been used by millions of people worldwide, and have demonstrated a wide margin of clinical safety. Here we summarize the in vitro and in vivo evidence demonstrating ivermectin\\'s potential as a multitargeting anticancer drug that exerts antitumor effects against different tumor types. Notably, the in vitro and in vivo antitumor activities of ivermectin are achieved at concentrations that can be clinically achieved based on human pharmacokinetic studies done in the clinical studies. Moreover, repurposed ivermectin safety has been well established recently in clinical studies against COVID-19. Consequently, we believe that ivermectin is an excellent potential candidate drug that can be repurposed for cancer and deserves rigorous evaluation against a variety of cancers in well-designed clinical trials.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/78376",risUrl:"/chapter/ris/78376",signatures:"Alfonso Dueñas-González and Mandy Juárez-Rodríguez",book:{id:"10881",type:"book",title:"Drug Repurposing",subtitle:"Molecular Aspects and Therapeutic Applications",fullTitle:"Drug Repurposing - Molecular Aspects and Therapeutic Applications",slug:"drug-repurposing-molecular-aspects-and-therapeutic-applications",publishedDate:"June 1st 2022",bookSignature:"Shailendra K. Saxena",coverURL:"https://cdn.intechopen.com/books/images_new/10881.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83969-958-0",printIsbn:"978-1-83969-957-3",pdfIsbn:"978-1-83969-959-7",isAvailableForWebshopOrdering:!0,editors:[{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"421841",title:"Prof.",name:"Alfonso",middleName:null,surname:"Dueñas-González",fullName:"Alfonso Dueñas-González",slug:"alfonso-duenas-gonzalez",email:"alfonso_duenasg@yahoo.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null},{id:"421846",title:"Dr.",name:"Mandy",middleName:null,surname:"Juárez-Rodríguez",fullName:"Mandy Juárez-Rodríguez",slug:"mandy-juarez-rodriguez",email:"mandy.juarezr@gmail.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Drug repurposing in cancer therapy",level:"1"},{id:"sec_3",title:"3. Antitumor effects of Ivermectin-mechanisms of action and in vitro data",level:"1"},{id:"sec_3_2",title:"3.1 Ovarian cancer",level:"2"},{id:"sec_4_2",title:"3.2 Breast cancer",level:"2"},{id:"sec_5_2",title:"3.3 Liver cancer",level:"2"},{id:"sec_6_2",title:"3.4 Cervical cancer",level:"2"},{id:"sec_7_2",title:"3.5 Glioblastoma",level:"2"},{id:"sec_8_2",title:"3.6 Leukemia and prostate cancer",level:"2"},{id:"sec_9_2",title:"3.7 Colon and lung cancer",level:"2"},{id:"sec_11",title:"4. Antitumor effects of ivermectin-animal data",level:"1"},{id:"sec_11_2",title:"4.1 Glioblastoma",level:"2"},{id:"sec_12_2",title:"4.2 Colon and lung cancers",level:"2"},{id:"sec_13_2",title:"4.3 Breast cancer",level:"2"},{id:"sec_14_2",title:"4.4 Leukemia",level:"2"},{id:"sec_16",title:"5. Clinical experience with ivermectin",level:"1"},{id:"sec_16_2",title:"5.1 Ivermectin use as anti-parasitic",level:"2"},{id:"sec_17_2",title:"5.2 Ivermectin’s potential as an anti-viral",level:"2"},{id:"sec_18_2",title:"5.3 Other uses of ivermectin",level:"2"},{id:"sec_20",title:"6. Pharmacokinetics and dose considerations for ivermectin as cancer therapy",level:"1"},{id:"sec_21",title:"7. Discussion",level:"1"},{id:"sec_22",title:"8. Conclusion",level:"1"}],chapterReferences:[{id:"B1",body:'Omura S, Crump A (2004) The life and times of Ivermectin - a success story. Nat Rev Microbiol 2 (12):984-989.'},{id:"B2",body:'Omura S (2008) Ivermectin: 25 years and still going strong. Int J Antimicrob Agents 31 (2):91-98.'},{id:"B3",body:'Chabala JC, Mrozik H, Tolman RL, Eskola P, Lusi A, Peterson LH, Woods MF, Fisher MH, Campbell WC, Egerton JR, Ostlind DA (1980) Ivermectin, a new broad-spectrum antiparasitic agent. J Med Chem 23 (10):1134-1136.'},{id:"B4",body:'Goa KL, McTavish D, Clissold SP (1991) Ivermectin. A review of its antifilarial activity, pharmacokinetic properties, and clinical efficacy in onchocerciasis. Drugs 42 (4):640-658.'},{id:"B5",body:'Kumaraswami V, Ottesen EA, Vijayasekaran V, Devi U, Swaminathan M, Aziz MA, Sarma GR, Prabhakar R, Tripathy SP (1988) Ivermectin for the treatment of Wuchereria bancrofti filariasis. efficacy and adverse reactions. JAMA 259 (21):3150-3153'},{id:"B6",body:'Marti H, Haji HJ, Savioli L, Chwaya HM, Mgeni AF, Ameir JS, Hatz C (1996) A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 55 (5):477-481.'},{id:"B7",body:'Whitworth JA, Morgan D, Maude GH, McNicholas AM, Taylor DW (1991) A field study of the effect of Ivermectin on intestinal helminths in man. Trans R Soc Trop Med Hyg 85 (2):232-234.'},{id:"B8",body:'Zemkova H, Tvrdonova V, Bhattacharya A, Jindrichova M (2014). Allosteric modulation of ligand gated ion channels by ivermectin. Physiol Res 63: S215-S224.'},{id:"B9",body:'Novac N. Challenges and opportunities of drug repositioning. Trends Pharmacol Sci 2013; 34: 267-72.'},{id:"B10",body:'Juarez M, Schcolnik-Cabrera A, Duenas-Gonzalez A (2018) The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. Am J Cancer Res 8(2):317-331'},{id:"B11",body:'Dominguez-Gomez G, Chavez-Blanco A, Medina-Franco JL, Saldivar-Gonzalez F, Flores-Torrontegui Y, Juarez M, Diaz- Chavez J, Gonzalez-Fierro A, Duenas-Gonzalez A (2018) Ivermectin as an inhibitor of cancer stem-like cells. Mol Med Rep 17(2):3397-3403. doi: 10.3892/mmr.2017.8231.'},{id:"B12",body:'Liu Y, Fang S, Sun Q, Liu B (2016) Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress. Biochem Biophys Res Commun 480(3):415-421.'},{id:"B13",body:'Melotti A, Mas C, Kuciak M, Lorente-Trigos A, Borges I, Ruiz I Altaba A (2014) The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer. EMBO Mol Med 6(10):1263-1278.'},{id:"B14",body:'Hashimoto H, Messerli SM, Sudo T, Maruta H (2009) Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines. Drug Discov Ther 3(6):243-246'},{id:"B15",body:'Dou Q, Chen HN, Wang K, Yuan K, Lei Y, Li K, Lan J, Chen Y, Huang Z, Xie N, Zhang L, Xiang R, Nice EC, Wei Y, Huang C (2016) Ivermectin induces cytostatic autophagy by blocking the PAK1/Akt axis in breast cancer. Cancer Res 76(15):4457-446'},{id:"B16",body:'Kwon YJ, Petrie K, Leibovitch BA, Zeng L, Mezei M, Howell L, Gil V, Christova R, Bansal N, Yang S, Sharma R, Ariztia EV, Frankum J, Brough R, Sbirkov Y, Ashworth A, Lord CJ, Zelent A, Farias E, Zhou MM, Waxman S (2015) Selective Inhibition of SIN3 corepressor with avermectins as a novel therapeutic strategy in triple-negative breast cancer. Mol Cancer Ther 14(8):1824-1836.'},{id:"B17",body:'Yin J, Park G, Lee JE, Choi EY, Park JY, Kim TH, Park N, Jin X, Jung JE, Shin D, Hong JH, Kim H, Yoo H, Lee SH, Kim YJ, Park JB, Kim JH (2015) DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis. Brain 138(Pt 9):2553-2570.'},{id:"B18",body:'Sharmeen S, Skrtic M, Sukhai MA, Hurren R, Gronda M, Wang X, Fonseca SB, Sun H, Wood TE, Ward R, Minden MD, Batey RA, Datti A, Wrana J, Kelley SO, Schimmer AD (2010) The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells. Blood 116(18):3593-3603.'},{id:"B19",body:'Draganov D, Gopalakrishna-Pillai S, Chen YR, Zuckerman N, Moeller S, Wang C, Ann D, Lee PP (2015) Modulation of P2X4/ P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death. Sci Rep 5:16222.'},{id:"B20",body:'Fang F, Pan J, Li YP, Li G, Xu LX, Su GH, Li ZH, Feng X, Wang J (2016) p21-activated kinase 1 (PAK1) expression correlates with prognosis in solid tumors: A systematic review and meta-analysis. Oncotarget 10;7(19):27422-9.'},{id:"B21",body:'Rosen JM, Jordan CT (2009) The increasing complexity of the cancer stem cell paradigm. Science 324:1670-1673.'},{id:"B22",body:'Juarez M, Schcolnik-Cabrera A, Dominguez-Gomez G, Chavez-Blanco A, Diaz-Chavez J, Duenas-Gonzalez A. (2019). Antitumor effects of Ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug. Cancer Chemother Pharmacol 85(6):1153-1163.'},{id:"B23",body:'Nishio, M. Sugimachi, K. Goto, H. Wang,J. Suzuki A. (2015). Dysregulated YAP/TAZ and TGF-B signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 10:1073-1090.'},{id:"B24",body:'Zhang P, Zhang Y, Liu K, Liu B, Xu W, Gao J, Ding L, Tao L (2019) Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway. Cell Prolif 52(2):e12543.'},{id:"B25",body:'Song D, Liang H, Qu B, Li Y, Liu J, Zhang Y, Li L, Hu L, Zhang X, Gao A (2019) Ivermectin inhibits the growth of glioma cells by inducing cell cycle arrest and apoptosis in vitro and in vivo. J Cell Biochem 120(1):622-633'},{id:"B26",body:'Draganov D, Han Z, Rana A, Bennett N, Irvine DJ, Lee PP (2021) Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer. NPJ Breast Cancer 7(1):22. doi: 10.1038/s41523-021-00229-5.'},{id:"B27",body:'Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22(3):659-61. doi: 10.1096/fj.07-9574LSF.'},{id:"B28",body:'de Castro CG Jr, Gregianin LJ, Burger JA. (2020). Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection. Leuk Lymphoma 61(10):2536-2537. doi: 10.1080/10428194.2020.1786559.'},{id:"B29",body:'De Sole, G., et al., (1989) A community trial of Ivermectin in the onchocerciasis focus of Asubende, Ghana. II. Adverse reactions. Trop Med Parasitol 40(3):375-82.'},{id:"B30",body:'De Sole, G., et al., (1990) Lack of adverse reactions in ivermectin treatment of onchocerciasis. Lancet 335(8697):1106-7.'},{id:"B31",body:'Boussinesq, M., et al., (2006) What are the mechanisms associated with post-ivermectin serious adverse events? Trends Parasitol 22(6):244-6.'},{id:"B32",body:'Boussinesq, M., et al., (2003) Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J Suppl 1: S4.'},{id:"B33",body:'Twum-Danso NA (2003) Serious adverse events following treatment with Ivermectin for onchocerciasis control: a review of reported cases. Filaria J. Suppl 1:S3.'},{id:"B34",body:'Madan V, Jaskiran K, Gupta U, Gupta DK. (2001) Oral Ivermectin in scabies patients: a comparison with 1% topical lindane lotion. J Dermatol 28(9):481-4.'},{id:"B35",body:'Sparsa A1, Bonnetblanc JM, Peyrot I, Loustaud-Ratti V, Vidal E, Bédane C (2006) Systemic adverse reactions with ivermectin treatment of scabies. Ann Dermatol Venereol 2006 Oct;133(10):784-7.'},{id:"B36",body:'Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 2001; 11: 727-33.'},{id:"B37",body:'Ashour DS (2019) Ivermectin: From theory to clinical application. Int J Antimicrob Agents 54(2):134-142. doi: 10.1016/j.ijantimicag.2019.05.003.'},{id:"B38",body:'Palmeirim MS, Hürlimann E, Knopp S, Speich B, Belizario V Jr, Joseph SA, Vaillant M, Olliaro P, Keiser J (2018) Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis. PLoS Negl Trop Dis 12(4):e0006458. doi: 10.1371/journal.pntd.0006458.'},{id:"B39",body:'Chaccour C, Hammann F, Rabinovich NR (2017) Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malar J 16(1):161. doi: 10.1186/s12936-017-1801-4.'},{id:"B40",body:'Muñoz J, Ballester MR, Antonijoan RM, Gich I, Rodríguez M, Colli E, Gold S, Krolewiecki AJ (2018) Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18 mg tablet in healthy adult volunteers. PLoS Negl Trop Dis 18;12(1):e0006020. doi: 10.1371/journal.pntd.0006020.'},{id:"B41",body:'Navarro M, Camprubí D, Requena-Méndez A, Buonfrate D, Giorli G, Kamgno J, Gardon J, Boussinesq M, Muñoz J, Krolewiecki A (2020) Safety of high-dose ivermectin: a systematic review and meta-analysis. J Antimicrob Chemother 75(4):827-834. doi: 10.1093/jac/dkz524.'},{id:"B42",body:'Kinobe RT, Owens L (2021) A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin’s possible mode of action against SARS-CoV-2. Fundam Clin Pharmacol 35(2):260-276. doi: 10.1111/fcp.12644.'},{id:"B43",body:'Padhy BM, Mohanty RR, Das S, Meher BR (2020) Therapeutic potential of Ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis. J Pharm Pharm Sci 23:462-469. DOI: 10.18433/jpps31457.'},{id:"B44",body:'Shahbaznejad L, Davoudi A, Eslami G, Markowitz JS, Navaeifar MR, Hosseinzadeh F, Movahedi FS, Rezai MS (2021) Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial. Clin Ther S0149-2918(21)00201-0. doi: 10.1016/j.clinthera.2021.04.007.'},{id:"B45",body:'Ahmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, Phru CS, Rahman M, Zaman K, Somani J, Yasmin R, Hasnat MA, Kabir A, Aziz AB, Khan WA (2020) A five-day course of Ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int J Infect Dis 103:214-216. DOI: 10.1016/j.ijid.2020.11.191.'},{id:"B46",body:'Pott-Junior H, Bastos Paoliello MM, Miguel AQC, da Cunha AF, de Melo Freire CC, Neves FF, da Silva de Avó LR, Roscani MG, Dos Santos SS, Chachá SGF (2021) Use of ivermectin in the treatment of Covid-19: A pilot trial. Toxicol Rep 8:505-510. doi: 10.1016/j.toxrep.2021.03.003.'},{id:"B47",body:'Zemkova H, Tvrdonova V, Bhattacharya A, Jindrichova M (2014) Allosteric Modulation of Ligand Gated Ion Channels by Ivermectin. Physiol Res 63: S215-S224.'},{id:"B48",body:'Costa JL, Diazgranados JA (1994) Ivermectin for spasticity in spinal-cord injury. Lancet 343 (8899): 739. doi: 10.1016/s0140-6736(94)91625-x.'},{id:"B49",body:'Baraka OZ, Mahmoud BM, Marschke CK, Geary TG, Homeida MM, Williams JF (1996) Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus. Eur J Clin Pharmacol 50(5):407-10.'},{id:"B50",body:'Guzzo CA, Furtek CI, Porras AG, Chen C, Tipping R, Clineschmidt CM, Sciberras DG, Hsieh JY, Lasseter KC (2002) Safety, tolerability, and pharmacokinetics of escalating high doses of Ivermectin in healthy adult subjects. J Clin Pharmacol 42 (10):1122-1133.'},{id:"B51",body:'Pantziarka PS, Meheus L, Sukhatme VP, Bouche G. Repurposing non-cancer drugs in oncology-How many drugs are out there? bioRxiv 2017; 197434.doi: https://doi.org/10.1101/197434'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Alfonso Dueñas-González",address:"alfonso_duenasg@yahoo.com",affiliation:'
Departamento de Medicina Genómica y Toxicologia Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autonoma de Mexico, Mexico
Subidreccion de Investigacion Básica, Instituto Nacional de Cancerología, Mexico
Desarrollos Especializados en Biotecnología y Diagnóstico Molecular, SA de CV, Mexico
'}],corrections:null},book:{id:"10881",type:"book",title:"Drug Repurposing",subtitle:"Molecular Aspects and Therapeutic Applications",fullTitle:"Drug Repurposing - Molecular Aspects and Therapeutic Applications",slug:"drug-repurposing-molecular-aspects-and-therapeutic-applications",publishedDate:"June 1st 2022",bookSignature:"Shailendra K. Saxena",coverURL:"https://cdn.intechopen.com/books/images_new/10881.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83969-958-0",printIsbn:"978-1-83969-957-3",pdfIsbn:"978-1-83969-959-7",isAvailableForWebshopOrdering:!0,editors:[{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"22569",title:"Dr.",name:"Raúl",middleName:null,surname:"Martín",email:"Raul.MMartin@uclm.es",fullName:"Raúl Martín",slug:"raul-martin",position:null,biography:null,institutionString:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:{name:"University of Castile-La Mancha",institutionURL:null,country:{name:"Spain"}}},booksEdited:[],chaptersAuthored:[{id:"14641",title:"Usefulness of Biometrics to Analyse Some Ecological Features of Birds",slug:"usefulness-of-biometrics-to-analyse-some-ecological-features-of-birds",abstract:null,signatures:"M. Ángeles Hernández, Francisco Campos, Raúl Martín and Tomás Santamaría",authors:[{id:"19420",title:"Dr.",name:"M. Angeles",surname:"Hernández",fullName:"M. Angeles Hernández",slug:"m.-angeles-hernandez",email:"mahermin@unav.es"},{id:"22568",title:"Dr.",name:"Francisco",surname:"Campos",fullName:"Francisco Campos",slug:"francisco-campos",email:"fcampos@uemc.es"},{id:"22569",title:"Dr.",name:"Raúl",surname:"Martín",fullName:"Raúl Martín",slug:"raul-martin",email:"Raul.MMartin@uclm.es"},{id:"22570",title:"Dr.",name:"Tomás",surname:"Santamaría",fullName:"Tomás Santamaría",slug:"tomas-santamaria",email:"Tomas.santamaria@ucavila.es"}],book:{id:"118",title:"Biometrics",slug:"biometrics-unique-and-diverse-applications-in-nature-science-and-technology",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"19420",title:"Dr.",name:"M. Angeles",surname:"Hernández",slug:"m.-angeles-hernandez",fullName:"M. Angeles Hernández",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20881",title:"Dr.",name:"Aparecido Nilceu",surname:"Marana",slug:"aparecido-nilceu-marana",fullName:"Aparecido Nilceu Marana",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"22568",title:"Dr.",name:"Francisco",surname:"Campos",slug:"francisco-campos",fullName:"Francisco Campos",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Miguel de Cervantes European University",institutionURL:null,country:{name:"Spain"}}},{id:"22570",title:"Dr.",name:"Tomás",surname:"Santamaría",slug:"tomas-santamaria",fullName:"Tomás Santamaría",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Catholic University of Ávila",institutionURL:null,country:{name:"Spain"}}},{id:"22698",title:"Dr.",name:"Kensuke",surname:"Baba",slug:"kensuke-baba",fullName:"Kensuke Baba",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Kyushu University",institutionURL:null,country:{name:"Japan"}}},{id:"23121",title:"Dr.",name:"Ali Ismail",surname:"Awad",slug:"ali-ismail-awad",fullName:"Ali Ismail Awad",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/23121/images/44_n.jpg",biography:null,institutionString:null,institution:{name:"Kyushu University",institutionURL:null,country:{name:"Japan"}}},{id:"23193",title:"Ms.",name:"Elizabeth Bonsaglia",surname:"Barboza",slug:"elizabeth-bonsaglia-barboza",fullName:"Elizabeth Bonsaglia Barboza",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"24291",title:"Dr.",name:"Denise Tostes",surname:"Oliveira",slug:"denise-tostes-oliveira",fullName:"Denise Tostes Oliveira",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Sao Paulo",institutionURL:null,country:{name:"Brazil"}}},{id:"24292",title:"Dr.",name:"João Paulo",surname:"Papa",slug:"joao-paulo-papa",fullName:"João Paulo Papa",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"30917",title:"Dr.",name:"Michael",surname:"Hofer",slug:"michael-hofer",fullName:"Michael Hofer",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Graz University of Technology",institutionURL:null,country:{name:"Austria"}}}]},generic:{page:{slug:"our-story",title:"Our story",intro:"
The company was founded in Vienna in 2004 by Alex Lazinica and Vedran Kordic, two PhD students researching robotics. While completing our PhDs, we found it difficult to access the research we needed. So, we decided to create a new Open Access publisher. A better one, where researchers like us could find the information they needed easily. The result is IntechOpen, an Open Access publisher that puts the academic needs of the researchers before the business interests of publishers.
",metaTitle:"Our story",metaDescription:"The company was founded in Vienna in 2004 by Alex Lazinica and Vedran Kordic, two PhD students researching robotics. While completing our PhDs, we found it difficult to access the research we needed. So, we decided to create a new Open Access publisher. A better one, where researchers like us could find the information they needed easily. The result is IntechOpen, an Open Access publisher that puts the academic needs of the researchers before the business interests of publishers.",metaKeywords:null,canonicalURL:"/page/our-story",contentRaw:'[{"type":"htmlEditorComponent","content":"
We started by publishing journals and books from the fields of science we were most familiar with - AI, robotics, manufacturing and operations research. Through our growing network of institutions and authors, we soon expanded into related fields like environmental engineering, nanotechnology, computer science, renewable energy and electrical engineering, Today, we are the world’s largest Open Access publisher of scientific research, with over 4,200 books and 54,000 scientific works including peer-reviewed content from more than 116,000 scientists spanning 161 countries. Our authors range from globally-renowned Nobel Prize winners to up-and-coming researchers at the cutting edge of scientific discovery.
\\n\\n
In the same year that IntechOpen was founded, we launched what was at the time the first ever Open Access, peer-reviewed journal in its field: the International Journal of Advanced Robotic Systems (IJARS).
\\n\\n
The IntechOpen timeline
\\n\\n
2004
\\n\\n
\\n\\t
Intech Open is founded in Vienna, Austria, by Alex Lazinica and Vedran Kordic, two PhD students, and their first Open Access journals and books are published.
\\n\\t
Alex and Vedran launch the first Open Access, peer-reviewed robotics journal and IntechOpen’s flagship publication, the International Journal of Advanced Robotic Systems (IJARS).
\\n
\\n\\n
2005
\\n\\n
\\n\\t
IntechOpen publishes its first Open Access book: Cutting Edge Robotics.
\\n
\\n\\n
2006
\\n\\n
\\n\\t
IntechOpen publishes a special issue of IJARS, featuring contributions from NASA scientists regarding the Mars Exploration Rover missions.
\\n
\\n\\n
2008
\\n\\n
\\n\\t
Downloads milestone: 200,000 downloads reached
\\n
\\n\\n
2009
\\n\\n
\\n\\t
Publishing milestone: the first 100 Open Access STM books are published
\\n
\\n\\n
2010
\\n\\n
\\n\\t
Downloads milestone: one million downloads reached
\\n\\t
IntechOpen expands its book publishing into a new field: medicine.
\\n
\\n\\n
2011
\\n\\n
\\n\\t
Publishing milestone: More than five million downloads reached
\\n\\t
IntechOpen publishes 1996 Nobel Prize in Chemistry winner Harold W. Kroto’s “Strategies to Successfully Cross-Link Carbon Nanotubes”. Find it here.
\\n\\t
IntechOpen and TBI collaborate on a project to explore the changing needs of researchers and the evolving ways that they discover, publish and exchange information. The result is the survey “Author Attitudes Towards Open Access Publishing: A Market Research Program”.
\\n\\t
IntechOpen hosts SHOW - Share Open Access Worldwide; a series of lectures, debates, round-tables and events to bring people together in discussion of open source principles, intellectual property, content licensing innovations, remixed and shared culture and free knowledge.
\\n
\\n\\n
2012
\\n\\n
\\n\\t
Publishing milestone: 10 million downloads reached
\\n\\t
IntechOpen holds Interact2012, a free series of workshops held by figureheads of the scientific community including Professor Hiroshi Ishiguro, director of the Intelligent Robotics Laboratory, who took the audience through some of the most impressive human-robot interactions observed in his lab.
\\n
\\n\\n
2013
\\n\\n
\\n\\t
IntechOpen joins the Committee on Publication Ethics (COPE) as part of a commitment to guaranteeing the highest standards of publishing.
\\n
\\n\\n
2014
\\n\\n
\\n\\t
IntechOpen turns 10, with more than 30 million downloads to date.
\\n\\t
IntechOpen appoints its first Regional Representatives - members of the team situated around the world dedicated to increasing the visibility of our authors’ published work within their local scientific communities.
\\n
\\n\\n
2015
\\n\\n
\\n\\t
Downloads milestone: More than 70 million downloads reached, more than doubling since the previous year.
\\n\\t
Publishing milestone: IntechOpen publishes its 2,500th book and 40,000th Open Access chapter, reaching 20,000 citations in Thomson Reuters ISI Web of Science.
\\n\\t
40 IntechOpen authors are included in the top one per cent of the world’s most-cited researchers.
\\n\\t
Thomson Reuters’ ISI Web of Science Book Citation Index begins indexing IntechOpen’s books in its database.
\\n
\\n\\n
2016
\\n\\n
\\n\\t
IntechOpen is identified as a world leader in Simba Information’s Open Access Book Publishing 2016-2020 report and forecast. IntechOpen came in as the world’s largest Open Access book publisher by title count.
\\n
\\n\\n
2017
\\n\\n
\\n\\t
Downloads milestone: IntechOpen reaches more than 100 million downloads
\\n\\t
Publishing milestone: IntechOpen publishes its 3,000th Open Access book, making it the largest Open Access book collection in the world
We started by publishing journals and books from the fields of science we were most familiar with - AI, robotics, manufacturing and operations research. Through our growing network of institutions and authors, we soon expanded into related fields like environmental engineering, nanotechnology, computer science, renewable energy and electrical engineering, Today, we are the world’s largest Open Access publisher of scientific research, with over 4,200 books and 54,000 scientific works including peer-reviewed content from more than 116,000 scientists spanning 161 countries. Our authors range from globally-renowned Nobel Prize winners to up-and-coming researchers at the cutting edge of scientific discovery.
\n\n
In the same year that IntechOpen was founded, we launched what was at the time the first ever Open Access, peer-reviewed journal in its field: the International Journal of Advanced Robotic Systems (IJARS).
\n\n
The IntechOpen timeline
\n\n
2004
\n\n
\n\t
Intech Open is founded in Vienna, Austria, by Alex Lazinica and Vedran Kordic, two PhD students, and their first Open Access journals and books are published.
\n\t
Alex and Vedran launch the first Open Access, peer-reviewed robotics journal and IntechOpen’s flagship publication, the International Journal of Advanced Robotic Systems (IJARS).
\n
\n\n
2005
\n\n
\n\t
IntechOpen publishes its first Open Access book: Cutting Edge Robotics.
\n
\n\n
2006
\n\n
\n\t
IntechOpen publishes a special issue of IJARS, featuring contributions from NASA scientists regarding the Mars Exploration Rover missions.
\n
\n\n
2008
\n\n
\n\t
Downloads milestone: 200,000 downloads reached
\n
\n\n
2009
\n\n
\n\t
Publishing milestone: the first 100 Open Access STM books are published
\n
\n\n
2010
\n\n
\n\t
Downloads milestone: one million downloads reached
\n\t
IntechOpen expands its book publishing into a new field: medicine.
\n
\n\n
2011
\n\n
\n\t
Publishing milestone: More than five million downloads reached
\n\t
IntechOpen publishes 1996 Nobel Prize in Chemistry winner Harold W. Kroto’s “Strategies to Successfully Cross-Link Carbon Nanotubes”. Find it here.
\n\t
IntechOpen and TBI collaborate on a project to explore the changing needs of researchers and the evolving ways that they discover, publish and exchange information. The result is the survey “Author Attitudes Towards Open Access Publishing: A Market Research Program”.
\n\t
IntechOpen hosts SHOW - Share Open Access Worldwide; a series of lectures, debates, round-tables and events to bring people together in discussion of open source principles, intellectual property, content licensing innovations, remixed and shared culture and free knowledge.
\n
\n\n
2012
\n\n
\n\t
Publishing milestone: 10 million downloads reached
\n\t
IntechOpen holds Interact2012, a free series of workshops held by figureheads of the scientific community including Professor Hiroshi Ishiguro, director of the Intelligent Robotics Laboratory, who took the audience through some of the most impressive human-robot interactions observed in his lab.
\n
\n\n
2013
\n\n
\n\t
IntechOpen joins the Committee on Publication Ethics (COPE) as part of a commitment to guaranteeing the highest standards of publishing.
\n
\n\n
2014
\n\n
\n\t
IntechOpen turns 10, with more than 30 million downloads to date.
\n\t
IntechOpen appoints its first Regional Representatives - members of the team situated around the world dedicated to increasing the visibility of our authors’ published work within their local scientific communities.
\n
\n\n
2015
\n\n
\n\t
Downloads milestone: More than 70 million downloads reached, more than doubling since the previous year.
\n\t
Publishing milestone: IntechOpen publishes its 2,500th book and 40,000th Open Access chapter, reaching 20,000 citations in Thomson Reuters ISI Web of Science.
\n\t
40 IntechOpen authors are included in the top one per cent of the world’s most-cited researchers.
\n\t
Thomson Reuters’ ISI Web of Science Book Citation Index begins indexing IntechOpen’s books in its database.
\n
\n\n
2016
\n\n
\n\t
IntechOpen is identified as a world leader in Simba Information’s Open Access Book Publishing 2016-2020 report and forecast. IntechOpen came in as the world’s largest Open Access book publisher by title count.
\n
\n\n
2017
\n\n
\n\t
Downloads milestone: IntechOpen reaches more than 100 million downloads
\n\t
Publishing milestone: IntechOpen publishes its 3,000th Open Access book, making it the largest Open Access book collection in the world
\n
\n"}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"396",title:"Dr.",name:"Vedran",middleName:null,surname:"Kordic",slug:"vedran-kordic",fullName:"Vedran Kordic",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/396/images/7281_n.png",biography:"After obtaining his Master's degree in Mechanical Engineering he continued his education at the Vienna University of Technology where he obtained his PhD degree in 2004. He worked as a researcher at the Automation and Control Institute, Faculty of Electrical Engineering, Vienna University of Technology until 2008. His studies in robotics lead him not only to a PhD degree but also inspired him to co-found and build the International Journal of Advanced Robotic Systems - world's first Open Access journal in the field of robotics.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"441",title:"Ph.D.",name:"Jaekyu",middleName:null,surname:"Park",slug:"jaekyu-park",fullName:"Jaekyu Park",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/441/images/1881_n.jpg",biography:null,institutionString:null,institution:{name:"LG Corporation (South Korea)",country:{name:"Korea, South"}}},{id:"465",title:"Dr.",name:"Christian",middleName:null,surname:"Martens",slug:"christian-martens",fullName:"Christian Martens",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Rheinmetall (Germany)",country:{name:"Germany"}}},{id:"479",title:"Dr.",name:"Valentina",middleName:null,surname:"Colla",slug:"valentina-colla",fullName:"Valentina Colla",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/479/images/358_n.jpg",biography:null,institutionString:null,institution:{name:"Sant'Anna School of Advanced Studies",country:{name:"Italy"}}},{id:"494",title:"PhD",name:"Loris",middleName:null,surname:"Nanni",slug:"loris-nanni",fullName:"Loris Nanni",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/494/images/system/494.jpg",biography:"Loris Nanni received his Master Degree cum laude on June-2002 from the University of Bologna, and the April 26th 2006 he received his Ph.D. in Computer Engineering at DEIS, University of Bologna. On September, 29th 2006 he has won a post PhD fellowship from the university of Bologna (from October 2006 to October 2008), at the competitive examination he was ranked first in the industrial engineering area. He extensively served as referee for several international journals. He is author/coauthor of more than 100 research papers. He has been involved in some projects supported by MURST and European Community. His research interests include pattern recognition, bioinformatics, and biometric systems (fingerprint classification and recognition, signature verification, face recognition).",institutionString:null,institution:null},{id:"496",title:"Dr.",name:"Carlos",middleName:null,surname:"Leon",slug:"carlos-leon",fullName:"Carlos Leon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Seville",country:{name:"Spain"}}},{id:"512",title:"Dr.",name:"Dayang",middleName:null,surname:"Jawawi",slug:"dayang-jawawi",fullName:"Dayang Jawawi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"528",title:"Dr.",name:"Kresimir",middleName:null,surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/528/images/system/528.jpg",biography:"K. Delac received his B.Sc.E.E. degree in 2003 and is currentlypursuing a Ph.D. degree at the University of Zagreb, Faculty of Electrical Engineering andComputing. His current research interests are digital image analysis, pattern recognition andbiometrics.",institutionString:null,institution:{name:"University of Zagreb",country:{name:"Croatia"}}},{id:"557",title:"Dr.",name:"Andon",middleName:"Venelinov",surname:"Topalov",slug:"andon-topalov",fullName:"Andon Topalov",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/557/images/1927_n.jpg",biography:"Dr. Andon V. Topalov received the MSc degree in Control Engineering from the Faculty of Information Systems, Technologies, and Automation at Moscow State University of Civil Engineering (MGGU) in 1979. He then received his PhD degree in Control Engineering from the Department of Automation and Remote Control at Moscow State Mining University (MGSU), Moscow, in 1984. From 1985 to 1986, he was a Research Fellow in the Research Institute for Electronic Equipment, ZZU AD, Plovdiv, Bulgaria. In 1986, he joined the Department of Control Systems, Technical University of Sofia at the Plovdiv campus, where he is presently a Full Professor. He has held long-term visiting Professor/Scholar positions at various institutions in South Korea, Turkey, Mexico, Greece, Belgium, UK, and Germany. And he has coauthored one book and authored or coauthored more than 80 research papers in conference proceedings and journals. His current research interests are in the fields of intelligent control and robotics.",institutionString:null,institution:{name:"Technical University of Sofia",country:{name:"Bulgaria"}}},{id:"585",title:"Prof.",name:"Munir",middleName:null,surname:"Merdan",slug:"munir-merdan",fullName:"Munir Merdan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/585/images/system/585.jpg",biography:"Munir Merdan received the M.Sc. degree in mechanical engineering from the Technical University of Sarajevo, Bosnia and Herzegovina, in 2001, and the Ph.D. degree in electrical engineering from the Vienna University of Technology, Vienna, Austria, in 2009.Since 2005, he has been at the Automation and Control Institute, Vienna University of Technology, where he is currently a Senior Researcher. His research interests include the application of agent technology for achieving agile control in the manufacturing environment.",institutionString:null,institution:null},{id:"605",title:"Prof",name:"Dil",middleName:null,surname:"Hussain",slug:"dil-hussain",fullName:"Dil Hussain",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/605/images/system/605.jpg",biography:"Dr. Dil Muhammad Akbar Hussain is a professor of Electronics Engineering & Computer Science at the Department of Energy Technology, Aalborg University Denmark. Professor Akbar has a Master degree in Digital Electronics from Govt. College University, Lahore Pakistan and a P-hD degree in Control Engineering from the School of Engineering and Applied Sciences, University of Sussex United Kingdom. Aalborg University has Two Satellite Campuses, one in Copenhagen (Aalborg University Copenhagen) and the other in Esbjerg (Aalborg University Esbjerg).\n· He is a member of prestigious IEEE (Institute of Electrical and Electronics Engineers), and IAENG (International Association of Engineers) organizations. \n· He is the chief Editor of the Journal of Software Engineering.\n· He is the member of the Editorial Board of International Journal of Computer Science and Software Technology (IJCSST) and International Journal of Computer Engineering and Information Technology. \n· He is also the Editor of Communication in Computer and Information Science CCIS-20 by Springer.\n· Reviewer For Many Conferences\nHe is the lead person in making collaboration agreements between Aalborg University and many universities of Pakistan, for which the MOU’s (Memorandum of Understanding) have been signed.\nProfessor Akbar is working in Academia since 1990, he started his career as a Lab demonstrator/TA at the University of Sussex. After finishing his P. hD degree in 1992, he served in the Industry as a Scientific Officer and continued his academic career as a visiting scholar for a number of educational institutions. In 1996 he joined National University of Science & Technology Pakistan (NUST) as an Associate Professor; NUST is one of the top few universities in Pakistan. In 1999 he joined an International Company Lineo Inc, Canada as Manager Compiler Group, where he headed the group for developing Compiler Tool Chain and Porting of Operating Systems for the BLACKfin processor. The processor development was a joint venture by Intel and Analog Devices. In 2002 Lineo Inc., was taken over by another company, so he joined Aalborg University Denmark as an Assistant Professor.\nProfessor Akbar has truly a multi-disciplined career and he continued his legacy and making progress in many areas of his interests both in teaching and research. He has contributed in stochastic estimation of control area especially, in the Multiple Target Tracking and Interactive Multiple Model (IMM) research, Ball & Beam Control Problem, Robotics, Levitation Control. He has contributed in developing Algorithms for Fingerprint Matching, Computer Vision and Face Recognition. He has been supervising Pattern Recognition, Formal Languages and Distributed Processing projects for several years. He has reviewed many books on Management, Computer Science. Currently, he is an active and permanent reviewer for many international conferences and symposia and the program committee member for many international conferences.\nIn teaching he has taught the core computer science subjects like, Digital Design, Real Time Embedded System Programming, Operating Systems, Software Engineering, Data Structures, Databases, Compiler Construction. In the Engineering side, Digital Signal Processing, Computer Architecture, Electronics Devices, Digital Filtering and Engineering Management.\nApart from his Academic Interest and activities he loves sport especially, Cricket, Football, Snooker and Squash. He plays cricket for Esbjerg city in the second division team as an opener wicket keeper batsman. He is a very good player of squash but has not played squash since his arrival in Denmark.",institutionString:null,institution:null},{id:"611",title:"Prof.",name:"T",middleName:null,surname:"Nagarajan",slug:"t-nagarajan",fullName:"T Nagarajan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Teknologi Petronas",country:{name:"Malaysia"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:13404},{group:"region",caption:"Middle and South America",value:2,count:11681},{group:"region",caption:"Africa",value:3,count:4213},{group:"region",caption:"Asia",value:4,count:22423},{group:"region",caption:"Australia and Oceania",value:5,count:2020},{group:"region",caption:"Europe",value:6,count:33699}],offset:12,limit:12,total:135704},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"-dateEndThirdStepPublish",topicId:"11"},books:[{type:"book",id:"12058",title:"Future Housing",subtitle:null,isOpenForSubmission:!0,hash:"e7f4a1e57fab392b61156956c1247b9e",slug:null,bookSignature:"Dr. Ivan Oropeza-Perez and Dr. Astrid Helena Petzold-Rodríguez",coverURL:"https://cdn.intechopen.com/books/images_new/12058.jpg",editedByType:null,editors:[{id:"282172",title:"Dr.",name:"Ivan",surname:"Oropeza-Perez",slug:"ivan-oropeza-perez",fullName:"Ivan Oropeza-Perez"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12050",title:"Advanced Biodiesel - Technological Advances, Challenges, and Sustainability Considerations",subtitle:null,isOpenForSubmission:!0,hash:"bb86ab5c5ca0dab95f01941eb350f920",slug:null,bookSignature:"Dr. IMR Fattah",coverURL:"https://cdn.intechopen.com/books/images_new/12050.jpg",editedByType:null,editors:[{id:"463663",title:"Dr.",name:"IMR",surname:"Fattah",slug:"imr-fattah",fullName:"IMR Fattah"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12059",title:"Hydraulic Structures - Impact on River Flow and Sediment Transport-Dimensioning",subtitle:null,isOpenForSubmission:!0,hash:"8e41aab8223c29ce69c00e8c8f6f560d",slug:null,bookSignature:"Prof. Vlassios Hrissanthou and Assistant Prof. Vasilis Bellos",coverURL:"https://cdn.intechopen.com/books/images_new/12059.jpg",editedByType:null,editors:[{id:"37707",title:"Prof.",name:"Vlassios",surname:"Hrissanthou",slug:"vlassios-hrissanthou",fullName:"Vlassios Hrissanthou"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12061",title:"Masonry for Sustainable Construction",subtitle:null,isOpenForSubmission:!0,hash:"85ef86d046d15e7d4b1988f1ec5dd750",slug:null,bookSignature:"Prof. Amjad Almusaed and Prof. Asaad Almssad",coverURL:"https://cdn.intechopen.com/books/images_new/12061.jpg",editedByType:null,editors:[{id:"446856",title:"Prof.",name:"Amjad",surname:"Almusaed",slug:"amjad-almusaed",fullName:"Amjad Almusaed"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12060",title:"Offshore Constructions",subtitle:null,isOpenForSubmission:!0,hash:"49597ed093ff245b2d778203a084e84c",slug:null,bookSignature:"Dr. Tien Anh Tran and Dr. Rutvij H Jhaveri",coverURL:"https://cdn.intechopen.com/books/images_new/12060.jpg",editedByType:null,editors:[{id:"222497",title:"Dr.",name:"Tien Anh",surname:"Tran",slug:"tien-anh-tran",fullName:"Tien Anh Tran"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12037",title:"The Dynamics of Vehicles - Basics, Simulation and Autonomous Systems",subtitle:null,isOpenForSubmission:!0,hash:"397e4307b5e1b0bd29b7ed7806c55346",slug:null,bookSignature:"Dr. Hüseyin Turan Arat",coverURL:"https://cdn.intechopen.com/books/images_new/12037.jpg",editedByType:null,editors:[{id:"201245",title:"Dr.",name:"Hüseyin Turan",surname:"Arat",slug:"huseyin-turan-arat",fullName:"Hüseyin Turan Arat"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11941",title:"Advances in Turbomachinery",subtitle:null,isOpenForSubmission:!0,hash:"d350df308adb3d3bc4f7a054bf081d8c",slug:null,bookSignature:"Dr. Melih Cemal Kushan and Dr. Isil Yazar",coverURL:"https://cdn.intechopen.com/books/images_new/11941.jpg",editedByType:null,editors:[{id:"185873",title:"Dr.",name:"Melih",surname:"Kushan",slug:"melih-kushan",fullName:"Melih Kushan"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12043",title:"Biodegradation - New Insights",subtitle:null,isOpenForSubmission:!0,hash:"8241477a4a935c8c292902d2768f4581",slug:null,bookSignature:"Dr. Vasudeo Zambare and Dr. Mohd Fadhil Md Din",coverURL:"https://cdn.intechopen.com/books/images_new/12043.jpg",editedByType:null,editors:[{id:"174690",title:"Dr.",name:"Vasudeo",surname:"Zambare",slug:"vasudeo-zambare",fullName:"Vasudeo Zambare"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12403",title:"Propulsion",subtitle:null,isOpenForSubmission:!0,hash:"a9e8214677aa585a0695eb08e09c41d0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12403.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12035",title:"Next-Generation Metrology",subtitle:null,isOpenForSubmission:!0,hash:"c7927d3200003ddd41ff22a82608c952",slug:null,bookSignature:"Dr. Luigi Cocco",coverURL:"https://cdn.intechopen.com/books/images_new/12035.jpg",editedByType:null,editors:[{id:"112023",title:"Dr.",name:"Luigi",surname:"Cocco",slug:"luigi-cocco",fullName:"Luigi Cocco"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11452",title:"Cryopreservation - Applications and Challenges",subtitle:null,isOpenForSubmission:!0,hash:"a6c3fd4384ff7deeab32fc82722c60e0",slug:null,bookSignature:"Dr. Marian Quain",coverURL:"https://cdn.intechopen.com/books/images_new/11452.jpg",editedByType:null,editors:[{id:"300385",title:"Dr.",name:"Marian",surname:"Quain",slug:"marian-quain",fullName:"Marian Quain"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11943",title:"Denoising - New Insights",subtitle:null,isOpenForSubmission:!0,hash:"9885534183ae520bcc63a91d4d083390",slug:null,bookSignature:"Dr. Mourad Talbi",coverURL:"https://cdn.intechopen.com/books/images_new/11943.jpg",editedByType:null,editors:[{id:"104874",title:"Dr.",name:"Mourad",surname:"Talbi",slug:"mourad-talbi",fullName:"Mourad Talbi"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:22},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:6},{group:"topic",caption:"Business, Management and Economics",value:7,count:4},{group:"topic",caption:"Chemistry",value:8,count:15},{group:"topic",caption:"Computer and Information Science",value:9,count:18},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:8},{group:"topic",caption:"Engineering",value:11,count:37},{group:"topic",caption:"Environmental Sciences",value:12,count:5},{group:"topic",caption:"Immunology and Microbiology",value:13,count:8},{group:"topic",caption:"Materials Science",value:14,count:15},{group:"topic",caption:"Mathematics",value:15,count:8},{group:"topic",caption:"Medicine",value:16,count:61},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:2},{group:"topic",caption:"Neuroscience",value:18,count:2},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:7},{group:"topic",caption:"Physics",value:20,count:5},{group:"topic",caption:"Psychology",value:21,count:5},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:8},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:55},popularBooks:{featuredBooks:[{type:"book",id:"10827",title:"Oral Health Care",subtitle:"An Important Issue of the Modern Society",isOpenForSubmission:!1,hash:"9a0ceb9ced4598aea3f3723f6dc4ea04",slug:"oral-health-care-an-important-issue-of-the-modern-society",bookSignature:"Lavinia Cosmina Ardelean and Laura Cristina Rusu",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",editors:[{id:"180569",title:"Dr.",name:"Lavinia",middleName:null,surname:"Ardelean",slug:"lavinia-ardelean",fullName:"Lavinia Ardelean"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10780",title:"Current Trends in Orthodontics",subtitle:null,isOpenForSubmission:!1,hash:"badce0e23eb5176fd653b049d5295c0a",slug:"current-trends-in-orthodontics",bookSignature:"Farid Bourzgui",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",editors:[{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8452",title:"Organizational Conflict",subtitle:"New Insights",isOpenForSubmission:!1,hash:"96bdaaba38a7850a7e7379aa5a505748",slug:"organizational-conflict-new-insights",bookSignature:"Josiane Fahed-Sreih",coverURL:"https://cdn.intechopen.com/books/images_new/8452.jpg",editors:[{id:"103784",title:"Dr.",name:"Josiane",middleName:null,surname:"Fahed-Sreih",slug:"josiane-fahed-sreih",fullName:"Josiane Fahed-Sreih"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10206",title:"Terahertz Technology",subtitle:null,isOpenForSubmission:!1,hash:"2cdb79bf6297623f1d6202ef11f099c4",slug:"terahertz-technology",bookSignature:"Borwen You and Ja-Yu Lu",coverURL:"https://cdn.intechopen.com/books/images_new/10206.jpg",editors:[{id:"191131",title:"Dr.",name:"Borwen",middleName:null,surname:"You",slug:"borwen-you",fullName:"Borwen You"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11331",title:"Secondary Metabolites",subtitle:"Trends and Reviews",isOpenForSubmission:!1,hash:"7d6274f42d5441e537c5fa744bc84523",slug:"secondary-metabolites-trends-and-reviews",bookSignature:"Ramasamy Vijayakumar and Suresh Selvapuram Sudalaimuthu Raja",coverURL:"https://cdn.intechopen.com/books/images_new/11331.jpg",editors:[{id:"176044",title:"Dr.",name:"Ramasamy",middleName:null,surname:"Vijayakumar",slug:"ramasamy-vijayakumar",fullName:"Ramasamy Vijayakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10793",title:"Molecular Mechanisms in Cancer",subtitle:null,isOpenForSubmission:!1,hash:"3ed2817275edb3de6f5683602314706e",slug:"molecular-mechanisms-in-cancer",bookSignature:"Metin Budak and Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/10793.jpg",editors:[{id:"226275",title:"Ph.D.",name:"Metin",middleName:null,surname:"Budak",slug:"metin-budak",fullName:"Metin Budak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10957",title:"Liquid Crystals",subtitle:null,isOpenForSubmission:!1,hash:"7a2d81fa4893fcf74e7b3823a3e4f385",slug:"liquid-crystals",bookSignature:"Pankaj Kumar Choudhury and Abdel-Baset M.A. Ibrahim",coverURL:"https://cdn.intechopen.com/books/images_new/10957.jpg",editors:[{id:"205744",title:"Dr.",name:"Pankaj",middleName:null,surname:"Kumar Choudhury",slug:"pankaj-kumar-choudhury",fullName:"Pankaj Kumar Choudhury"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10652",title:"Information Extraction and Object Tracking in Digital Video",subtitle:null,isOpenForSubmission:!1,hash:"d13718b2d986d058d55cf91e69bf21c0",slug:"information-extraction-and-object-tracking-in-digital-video",bookSignature:"Antonio José Ribeiro Neves and Francisco Javier Gallegos-Funes",coverURL:"https://cdn.intechopen.com/books/images_new/10652.jpg",editors:[{id:"1177",title:"Prof.",name:"António",middleName:"J. R.",surname:"José Ribeiro Neves",slug:"antonio-jose-ribeiro-neves",fullName:"António José Ribeiro Neves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10820",title:"Data Clustering",subtitle:null,isOpenForSubmission:!1,hash:"086d299ffd05aacd2311c3ca4ebf0d3a",slug:"data-clustering",bookSignature:"Niansheng Tang",coverURL:"https://cdn.intechopen.com/books/images_new/10820.jpg",editors:[{id:"221831",title:"Prof.",name:"Niansheng",middleName:null,surname:"Tang",slug:"niansheng-tang",fullName:"Niansheng Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10728",title:"Blood Groups",subtitle:"More than Inheritance of Antigenic Substances",isOpenForSubmission:!1,hash:"b5e79b54a382651f3130c9ee5ab862b4",slug:"blood-groups-more-than-inheritance-of-antigenic-substances",bookSignature:"Kaneez Fatima Shad",coverURL:"https://cdn.intechopen.com/books/images_new/10728.jpg",editors:[{id:"31988",title:"Prof.",name:"Kaneez",middleName:null,surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4810},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10827",title:"Oral Health Care",subtitle:"An Important Issue of the Modern Society",isOpenForSubmission:!1,hash:"9a0ceb9ced4598aea3f3723f6dc4ea04",slug:"oral-health-care-an-important-issue-of-the-modern-society",bookSignature:"Lavinia Cosmina Ardelean and Laura Cristina Rusu",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",publishedDate:"August 17th 2022",numberOfDownloads:2310,editors:[{id:"180569",title:"Dr.",name:"Lavinia",middleName:null,surname:"Ardelean",slug:"lavinia-ardelean",fullName:"Lavinia Ardelean"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",publishedDate:"August 17th 2022",numberOfDownloads:2095,editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10780",title:"Current Trends in Orthodontics",subtitle:null,isOpenForSubmission:!1,hash:"badce0e23eb5176fd653b049d5295c0a",slug:"current-trends-in-orthodontics",bookSignature:"Farid Bourzgui",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",publishedDate:"August 17th 2022",numberOfDownloads:2079,editors:[{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8452",title:"Organizational Conflict",subtitle:"New Insights",isOpenForSubmission:!1,hash:"96bdaaba38a7850a7e7379aa5a505748",slug:"organizational-conflict-new-insights",bookSignature:"Josiane Fahed-Sreih",coverURL:"https://cdn.intechopen.com/books/images_new/8452.jpg",publishedDate:"August 17th 2022",numberOfDownloads:1987,editors:[{id:"103784",title:"Dr.",name:"Josiane",middleName:null,surname:"Fahed-Sreih",slug:"josiane-fahed-sreih",fullName:"Josiane Fahed-Sreih"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10206",title:"Terahertz Technology",subtitle:null,isOpenForSubmission:!1,hash:"2cdb79bf6297623f1d6202ef11f099c4",slug:"terahertz-technology",bookSignature:"Borwen You and Ja-Yu Lu",coverURL:"https://cdn.intechopen.com/books/images_new/10206.jpg",publishedDate:"August 17th 2022",numberOfDownloads:1528,editors:[{id:"191131",title:"Dr.",name:"Borwen",middleName:null,surname:"You",slug:"borwen-you",fullName:"Borwen You"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11331",title:"Secondary Metabolites",subtitle:"Trends and Reviews",isOpenForSubmission:!1,hash:"7d6274f42d5441e537c5fa744bc84523",slug:"secondary-metabolites-trends-and-reviews",bookSignature:"Ramasamy Vijayakumar and Suresh Selvapuram Sudalaimuthu Raja",coverURL:"https://cdn.intechopen.com/books/images_new/11331.jpg",publishedDate:"August 17th 2022",numberOfDownloads:932,editors:[{id:"176044",title:"Dr.",name:"Ramasamy",middleName:null,surname:"Vijayakumar",slug:"ramasamy-vijayakumar",fullName:"Ramasamy Vijayakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10793",title:"Molecular Mechanisms in Cancer",subtitle:null,isOpenForSubmission:!1,hash:"3ed2817275edb3de6f5683602314706e",slug:"molecular-mechanisms-in-cancer",bookSignature:"Metin Budak and Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/10793.jpg",publishedDate:"August 17th 2022",numberOfDownloads:700,editors:[{id:"226275",title:"Ph.D.",name:"Metin",middleName:null,surname:"Budak",slug:"metin-budak",fullName:"Metin Budak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10957",title:"Liquid Crystals",subtitle:null,isOpenForSubmission:!1,hash:"7a2d81fa4893fcf74e7b3823a3e4f385",slug:"liquid-crystals",bookSignature:"Pankaj Kumar Choudhury and Abdel-Baset M.A. Ibrahim",coverURL:"https://cdn.intechopen.com/books/images_new/10957.jpg",publishedDate:"August 17th 2022",numberOfDownloads:676,editors:[{id:"205744",title:"Dr.",name:"Pankaj",middleName:null,surname:"Kumar Choudhury",slug:"pankaj-kumar-choudhury",fullName:"Pankaj Kumar Choudhury"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",publishedDate:"July 27th 2022",numberOfDownloads:7215,editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10652",title:"Information Extraction and Object Tracking in Digital Video",subtitle:null,isOpenForSubmission:!1,hash:"d13718b2d986d058d55cf91e69bf21c0",slug:"information-extraction-and-object-tracking-in-digital-video",bookSignature:"Antonio José Ribeiro Neves and Francisco Javier Gallegos-Funes",coverURL:"https://cdn.intechopen.com/books/images_new/10652.jpg",publishedDate:"August 17th 2022",numberOfDownloads:602,editors:[{id:"1177",title:"Prof.",name:"António",middleName:"J. R.",surname:"José Ribeiro Neves",slug:"antonio-jose-ribeiro-neves",fullName:"António José Ribeiro Neves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"8452",title:"Organizational Conflict",subtitle:"New Insights",isOpenForSubmission:!1,hash:"96bdaaba38a7850a7e7379aa5a505748",slug:"organizational-conflict-new-insights",bookSignature:"Josiane Fahed-Sreih",coverURL:"https://cdn.intechopen.com/books/images_new/8452.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"103784",title:"Dr.",name:"Josiane",middleName:null,surname:"Fahed-Sreih",slug:"josiane-fahed-sreih",fullName:"Josiane Fahed-Sreih"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10778",title:"Model-Based Control Engineering",subtitle:"Recent Design and Implementations for Varied Applications",isOpenForSubmission:!1,hash:"e39a567d9b6d2a45d0a1d927362c9005",slug:"model-based-control-engineering-recent-design-and-implementations-for-varied-applications",bookSignature:"Umar Zakir Abdul Hamid and Ahmad `Athif Mohd Faudzi",coverURL:"https://cdn.intechopen.com/books/images_new/10778.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"268173",title:"Dr.",name:"Umar Zakir Abdul",middleName:null,surname:"Hamid",slug:"umar-zakir-abdul-hamid",fullName:"Umar Zakir Abdul Hamid"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10780",title:"Current Trends in Orthodontics",subtitle:null,isOpenForSubmission:!1,hash:"badce0e23eb5176fd653b049d5295c0a",slug:"current-trends-in-orthodontics",bookSignature:"Farid Bourzgui",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10793",title:"Molecular Mechanisms in Cancer",subtitle:null,isOpenForSubmission:!1,hash:"3ed2817275edb3de6f5683602314706e",slug:"molecular-mechanisms-in-cancer",bookSignature:"Metin Budak and Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/10793.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"226275",title:"Ph.D.",name:"Metin",middleName:null,surname:"Budak",slug:"metin-budak",fullName:"Metin Budak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11308",title:"Selected Topics on Infant Feeding",subtitle:null,isOpenForSubmission:!1,hash:"213c3e403327a2919eca1dc5e82a0ec3",slug:"selected-topics-on-infant-feeding",bookSignature:"Isam Jaber AL-Zwaini and Haider Hadi AL-Musawi",coverURL:"https://cdn.intechopen.com/books/images_new/11308.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"30993",title:"Prof.",name:"Isam Jaber",middleName:null,surname:"Al-Zwaini",slug:"isam-jaber-al-zwaini",fullName:"Isam Jaber Al-Zwaini"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11331",title:"Secondary Metabolites",subtitle:"Trends and Reviews",isOpenForSubmission:!1,hash:"7d6274f42d5441e537c5fa744bc84523",slug:"secondary-metabolites-trends-and-reviews",bookSignature:"Ramasamy Vijayakumar and Suresh Selvapuram Sudalaimuthu Raja",coverURL:"https://cdn.intechopen.com/books/images_new/11331.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"176044",title:"Dr.",name:"Ramasamy",middleName:null,surname:"Vijayakumar",slug:"ramasamy-vijayakumar",fullName:"Ramasamy Vijayakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10820",title:"Data Clustering",subtitle:null,isOpenForSubmission:!1,hash:"086d299ffd05aacd2311c3ca4ebf0d3a",slug:"data-clustering",bookSignature:"Niansheng Tang",coverURL:"https://cdn.intechopen.com/books/images_new/10820.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"221831",title:"Prof.",name:"Niansheng",middleName:null,surname:"Tang",slug:"niansheng-tang",fullName:"Niansheng Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10827",title:"Oral Health Care",subtitle:"An Important Issue of the Modern Society",isOpenForSubmission:!1,hash:"9a0ceb9ced4598aea3f3723f6dc4ea04",slug:"oral-health-care-an-important-issue-of-the-modern-society",bookSignature:"Lavinia Cosmina Ardelean and Laura Cristina Rusu",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"180569",title:"Dr.",name:"Lavinia",middleName:null,surname:"Ardelean",slug:"lavinia-ardelean",fullName:"Lavinia Ardelean"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11139",title:"Geochemistry and Mineral Resources",subtitle:null,isOpenForSubmission:!1,hash:"928cebbdce21d9b3f081267b24f12dfb",slug:"geochemistry-and-mineral-resources",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11139.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"81",title:"Analytical Chemistry",slug:"chemistry-analytical-chemistry",parent:{id:"8",title:"Chemistry",slug:"chemistry"},numberOfBooks:36,numberOfSeries:0,numberOfAuthorsAndEditors:819,numberOfWosCitations:1350,numberOfCrossrefCitations:641,numberOfDimensionsCitations:1738,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"81",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"10696",title:"Applications of Calorimetry",subtitle:null,isOpenForSubmission:!1,hash:"8c87f7e2199db33b5dd7181f56973a97",slug:"applications-of-calorimetry",bookSignature:"José Luis Rivera-Armenta and Cynthia Graciela Flores-Hernández",coverURL:"https://cdn.intechopen.com/books/images_new/10696.jpg",editedByType:"Edited by",editors:[{id:"107855",title:"Dr.",name:"Jose Luis",middleName:null,surname:"Rivera Armenta",slug:"jose-luis-rivera-armenta",fullName:"Jose Luis Rivera Armenta"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9937",title:"Recent Advances in Gas Chromatography",subtitle:null,isOpenForSubmission:!1,hash:"2d37a39be8412d39e729669c9c73ebb8",slug:"recent-advances-in-gas-chromatography",bookSignature:"Fabrice Mutelet",coverURL:"https://cdn.intechopen.com/books/images_new/9937.jpg",editedByType:"Edited by",editors:[{id:"186677",title:"Dr.",name:"Fabrice",middleName:null,surname:"Mutelet",slug:"fabrice-mutelet",fullName:"Fabrice Mutelet"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11072",title:"Sample Preparation Techniques for Chemical Analysis",subtitle:null,isOpenForSubmission:!1,hash:"38fecf7570774c29c22a0cbca58ba570",slug:"sample-preparation-techniques-for-chemical-analysis",bookSignature:"Massoud Kaykhaii",coverURL:"https://cdn.intechopen.com/books/images_new/11072.jpg",editedByType:"Edited by",editors:[{id:"349151",title:"Prof.",name:"Massoud",middleName:null,surname:"Kaykhaii",slug:"massoud-kaykhaii",fullName:"Massoud Kaykhaii"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9932",title:"Analytical Chemistry",subtitle:"Advancement, Perspectives and Applications",isOpenForSubmission:!1,hash:"18f54a89cdbbafde70f56e55e122171a",slug:"analytical-chemistry-advancement-perspectives-and-applications",bookSignature:"Abhay Nanda Srivastva",coverURL:"https://cdn.intechopen.com/books/images_new/9932.jpg",editedByType:"Edited by",editors:[{id:"293623",title:"Dr.",name:"Abhay Nanda",middleName:null,surname:"Srivastva",slug:"abhay-nanda-srivastva",fullName:"Abhay Nanda Srivastva"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10387",title:"Mass Spectrometry in Life Sciences and Clinical Laboratory",subtitle:null,isOpenForSubmission:!1,hash:"5f2fa81e1939bbe34ac689fb983ca4c1",slug:"mass-spectrometry-in-life-sciences-and-clinical-laboratory",bookSignature:"Goran Mitulović",coverURL:"https://cdn.intechopen.com/books/images_new/10387.jpg",editedByType:"Edited by",editors:[{id:"212804",title:"Dr.",name:"Goran",middleName:null,surname:"Mitulović",slug:"goran-mitulovic",fullName:"Goran Mitulović"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7319",title:"Color Detection",subtitle:null,isOpenForSubmission:!1,hash:"6c3c446db0a120cfd1f2697760e7d784",slug:"color-detection",bookSignature:"Ling-Wen Zeng and Shi-Lin Cao",coverURL:"https://cdn.intechopen.com/books/images_new/7319.jpg",editedByType:"Edited by",editors:[{id:"173972",title:"Dr.",name:"Lingwen",middleName:null,surname:"Zeng",slug:"lingwen-zeng",fullName:"Lingwen Zeng"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8380",title:"Mass Spectrometry",subtitle:"Future Perceptions and Applications",isOpenForSubmission:!1,hash:"662bbebeab1942b6710f413e2b217004",slug:"mass-spectrometry-future-perceptions-and-applications",bookSignature:"Ganesh Shamrao Kamble",coverURL:"https://cdn.intechopen.com/books/images_new/8380.jpg",editedByType:"Edited by",editors:[{id:"236420",title:"Dr.",name:"Ganesh",middleName:"Shamrao",surname:"Kamble",slug:"ganesh-kamble",fullName:"Ganesh Kamble"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6831",title:"Gas Chromatography",subtitle:"Derivatization, Sample Preparation, Application",isOpenForSubmission:!1,hash:"b9ef7d64ef66b65cb3245157db815577",slug:"gas-chromatography-derivatization-sample-preparation-application",bookSignature:"Peter Kusch",coverURL:"https://cdn.intechopen.com/books/images_new/6831.jpg",editedByType:"Edited by",editors:[{id:"254714",title:"Dr.",name:"Peter",middleName:null,surname:"Kusch",slug:"peter-kusch",fullName:"Peter Kusch"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7348",title:"Voltammetry",subtitle:null,isOpenForSubmission:!1,hash:"27acad9579f166df001d24b28c720e55",slug:"voltammetry",bookSignature:"Nobanathi Wendy Maxakato, Sandile Surprise Gwebu and Gugu Hlengiwe Mhlongo",coverURL:"https://cdn.intechopen.com/books/images_new/7348.jpg",editedByType:"Edited by",editors:[{id:"259515",title:"Dr.",name:"Nobanathi Wendy",middleName:null,surname:"Maxakato",slug:"nobanathi-wendy-maxakato",fullName:"Nobanathi Wendy Maxakato"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8637",title:"Recent Advances in Analytical Chemistry",subtitle:null,isOpenForSubmission:!1,hash:"9d61b693f14e24d81342f6c36fc5ba32",slug:"recent-advances-in-analytical-chemistry",bookSignature:"Muharrem Ince and Olcay Kaplan Ince",coverURL:"https://cdn.intechopen.com/books/images_new/8637.jpg",editedByType:"Edited by",editors:[{id:"258431",title:"Prof.",name:"Muharrem",middleName:null,surname:"Ince",slug:"muharrem-ince",fullName:"Muharrem Ince"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6697",title:"Chemometrics and Data Analysis in Chromatography",subtitle:null,isOpenForSubmission:!1,hash:"513cf51c1f8851d3a5fde73daa281571",slug:"chemometrics-and-data-analysis-in-chromatography",bookSignature:"Vu Dang Hoang",coverURL:"https://cdn.intechopen.com/books/images_new/6697.jpg",editedByType:"Edited by",editors:[{id:"199907",title:"Associate Prof.",name:"Vu Dang",middleName:null,surname:"Hoang",slug:"vu-dang-hoang",fullName:"Vu Dang Hoang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7488",title:"Analytical Pyrolysis",subtitle:null,isOpenForSubmission:!1,hash:"30a667792c3a70b53d30fb6e9e1e7b4d",slug:"analytical-pyrolysis",bookSignature:"Peter Kusch",coverURL:"https://cdn.intechopen.com/books/images_new/7488.jpg",editedByType:"Edited by",editors:[{id:"254714",title:"Dr.",name:"Peter",middleName:null,surname:"Kusch",slug:"peter-kusch",fullName:"Peter Kusch"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:36,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"32817",doi:"10.5772/33098",title:"Derivatization Reactions and Reagents for Gas Chromatography Analysis",slug:"derivatization-reactions-and-reagents-for-gas-chromatography-analysis",totalDownloads:70679,totalCrossrefCites:38,totalDimensionsCites:102,abstract:null,book:{id:"2114",slug:"advanced-gas-chromatography-progress-in-agricultural-biomedical-and-industrial-applications",title:"Advanced Gas Chromatography",fullTitle:"Advanced Gas Chromatography - Progress in Agricultural, Biomedical and Industrial Applications"},signatures:"Francis Orata",authors:[{id:"94007",title:"Dr.",name:"Francis",middleName:null,surname:"Orata",slug:"francis-orata",fullName:"Francis Orata"}]},{id:"26356",doi:"10.5772/33411",title:"Drift Correction Methods for Gas Chemical Sensors in Artificial Olfaction Systems: Techniques and Challenges",slug:"drift-correction-methods-for-gas-chemical-sensors-in-artificial-olfaction-systems-techniques-and-cha",totalDownloads:4663,totalCrossrefCites:8,totalDimensionsCites:57,abstract:null,book:{id:"589",slug:"advances-in-chemical-sensors",title:"Advances in Chemical Sensors",fullTitle:"Advances in Chemical Sensors"},signatures:"S. Di Carlo and M. Falasconi",authors:[{id:"50412",title:"Prof.",name:"Stefano",middleName:null,surname:"Di Carlo",slug:"stefano-di-carlo",fullName:"Stefano Di Carlo"},{id:"95331",title:"Dr.",name:"Matteo",middleName:null,surname:"Falasconi",slug:"matteo-falasconi",fullName:"Matteo Falasconi"}]},{id:"29012",doi:"10.5772/32108",title:"Identifying and Overcoming Matrix Effects in Drug Discovery and Development",slug:"identifying-and-overcoming-matrix-effects-in-drug-discovery-and-development",totalDownloads:18711,totalCrossrefCites:7,totalDimensionsCites:47,abstract:null,book:{id:"818",slug:"tandem-mass-spectrometry-applications-and-principles",title:"Tandem Mass Spectrometry",fullTitle:"Tandem Mass Spectrometry - Applications and Principles"},signatures:"Terence G. Hall, Inese Smukste, Karen R. Bresciano, Yunxia Wang, David McKearn and Ronald E. Savage",authors:[{id:"90202",title:"Dr",name:"Ronald",middleName:null,surname:"Savage",slug:"ronald-savage",fullName:"Ronald Savage"},{id:"90209",title:"Dr.",name:"Terence",middleName:null,surname:"Hall",slug:"terence-hall",fullName:"Terence Hall"},{id:"136599",title:"BSc.",name:"Karen",middleName:null,surname:"Bresciano",slug:"karen-bresciano",fullName:"Karen Bresciano"}]},{id:"46058",doi:"10.5772/57341",title:"Limit of Detection and Limit of Quantification Determination in Gas Chromatography",slug:"limit-of-detection-and-limit-of-quantification-determination-in-gas-chromatography",totalDownloads:18548,totalCrossrefCites:16,totalDimensionsCites:45,abstract:null,book:{id:"3822",slug:"advances-in-gas-chromatography",title:"Advances in Gas Chromatography",fullTitle:"Advances in Gas Chromatography"},signatures:"Ernesto Bernal",authors:[{id:"88572",title:"MSc.",name:"Ernesto",middleName:null,surname:"Bernal",slug:"ernesto-bernal",fullName:"Ernesto Bernal"}]},{id:"58596",doi:"10.5772/intechopen.72932",title:"Linearity of Calibration Curves for Analytical Methods: A Review of Criteria for Assessment of Method Reliability",slug:"linearity-of-calibration-curves-for-analytical-methods-a-review-of-criteria-for-assessment-of-method",totalDownloads:8122,totalCrossrefCites:20,totalDimensionsCites:45,abstract:"Calibration curve is a regression model used to predict the unknown concentrations of analytes of interest based on the response of the instrument to the known standards. Some statistical analyses are required to choose the best model fitting to the experimental data and also evaluate the linearity and homoscedasticity of the calibration curve. Using an internal standard corrects for the loss of analyte during sample preparation and analysis provided that it is selected appropriately. After the best regression model is selected, the analytical method needs to be validated using quality control (QC) samples prepared and stored in the same temperature as intended for the study samples. Most of the international guidelines require that the parameters, including linearity, specificity, selectivity, accuracy, precision, lower limit of quantification (LLOQ), matrix effect and stability, be assessed during validation. Despite the highly regulated area, some challenges still exist regarding the validation of some analytical methods including methods when no analyte-free matrix is available.",book:{id:"6379",slug:"calibration-and-validation-of-analytical-methods-a-sampling-of-current-approaches",title:"Calibration and Validation of Analytical Methods",fullTitle:"Calibration and Validation of Analytical Methods - A Sampling of Current Approaches"},signatures:"Seyed Mojtaba Moosavi and Sussan Ghassabian",authors:[{id:"216099",title:"Dr.",name:"Sussan",middleName:null,surname:"Ghassabian",slug:"sussan-ghassabian",fullName:"Sussan Ghassabian"},{id:"216101",title:"Mr.",name:"Seyed Mojtaba",middleName:null,surname:"Moosavi",slug:"seyed-mojtaba-moosavi",fullName:"Seyed Mojtaba Moosavi"}]}],mostDownloadedChaptersLast30Days:[{id:"55500",title:"Interpretation of Mass Spectra",slug:"interpretation-of-mass-spectra",totalDownloads:12525,totalCrossrefCites:12,totalDimensionsCites:25,abstract:"The chapter includes an introduction to the main ionisation techniques in mass spectrometry and the way the resulting fragments can be analysed. First, the fundamental notions of mass spectrometry are explained, so that the reader can easily cover this chapter (graphs, main pick, molecular ion, illogical pick, nitrogen rule, etc.). Isotopic percentage and nominal mass calculation are also explained along with fragmentation mechanism. A paragraph emphasises the ionisation energy issues, the basics of ionisation voltage, the developing potential and the energy balance. A frame time of the main theoretical milestones in both theory and experimental mass spectrometry is highlighted here. In the second part of the chapter, the molecular fragmentation for alkanes, iso-alkanes, cycloalkanes, halogen, alcohols, phenols, ethers, carbonyl compounds, carboxylic acids and functional derivatives, nitrogen compounds (amines, nitro compounds), sulphur compounds, heterocycles and biomolecules (amino acids, steroids, triglycerides) is explained. Fragmentation schemes are followed by the simplified spectra, which help the understanding of such complex phenomena. At the end of the chapter, acquisition of mass spectrum is discussed. The chapter presented here is an introduction to mass spectrometry, which, we think, helps the understanding of the mechanism of fragmentation corroborating spectral data and molecular structures.",book:{id:"5735",slug:"mass-spectrometry",title:"Mass Spectrometry",fullTitle:"Mass Spectrometry"},signatures:"Teodor Octavian Nicolescu",authors:[{id:"196775",title:"Dr.",name:"Teodor Octavian",middleName:"Octavian",surname:"Nicolescu",slug:"teodor-octavian-nicolescu",fullName:"Teodor Octavian Nicolescu"}]},{id:"57909",title:"Validation of Analytical Methods",slug:"validation-of-analytical-methods",totalDownloads:7023,totalCrossrefCites:13,totalDimensionsCites:23,abstract:"Method validation is a key element in the establishment of reference methods and within the assessment of a laboratory’s competence in generating dependable analytical records. Validation has been placed within the context of the procedure, generating chemical data. Analytical method validation, thinking about the maximum relevant processes for checking the best parameters of analytical methods, using numerous relevant overall performance indicators inclusive of selectivity, specificity, accuracy, precision, linearity, range, limit of detection (LOD), limit of quantification (LOQ), ruggedness, and robustness are severely discussed in an effort to prevent their misguided utilization and ensure scientific correctness and consistency among publications.",book:{id:"6379",slug:"calibration-and-validation-of-analytical-methods-a-sampling-of-current-approaches",title:"Calibration and Validation of Analytical Methods",fullTitle:"Calibration and Validation of Analytical Methods - A Sampling of Current Approaches"},signatures:"Tentu Nageswara Rao",authors:[{id:"220824",title:"Dr.",name:"Tentu",middleName:null,surname:"Nageswara Rao",slug:"tentu-nageswara-rao",fullName:"Tentu Nageswara Rao"}]},{id:"58596",title:"Linearity of Calibration Curves for Analytical Methods: A Review of Criteria for Assessment of Method Reliability",slug:"linearity-of-calibration-curves-for-analytical-methods-a-review-of-criteria-for-assessment-of-method",totalDownloads:8116,totalCrossrefCites:20,totalDimensionsCites:45,abstract:"Calibration curve is a regression model used to predict the unknown concentrations of analytes of interest based on the response of the instrument to the known standards. Some statistical analyses are required to choose the best model fitting to the experimental data and also evaluate the linearity and homoscedasticity of the calibration curve. Using an internal standard corrects for the loss of analyte during sample preparation and analysis provided that it is selected appropriately. After the best regression model is selected, the analytical method needs to be validated using quality control (QC) samples prepared and stored in the same temperature as intended for the study samples. Most of the international guidelines require that the parameters, including linearity, specificity, selectivity, accuracy, precision, lower limit of quantification (LLOQ), matrix effect and stability, be assessed during validation. Despite the highly regulated area, some challenges still exist regarding the validation of some analytical methods including methods when no analyte-free matrix is available.",book:{id:"6379",slug:"calibration-and-validation-of-analytical-methods-a-sampling-of-current-approaches",title:"Calibration and Validation of Analytical Methods",fullTitle:"Calibration and Validation of Analytical Methods - A Sampling of Current Approaches"},signatures:"Seyed Mojtaba Moosavi and Sussan Ghassabian",authors:[{id:"216099",title:"Dr.",name:"Sussan",middleName:null,surname:"Ghassabian",slug:"sussan-ghassabian",fullName:"Sussan Ghassabian"},{id:"216101",title:"Mr.",name:"Seyed Mojtaba",middleName:null,surname:"Moosavi",slug:"seyed-mojtaba-moosavi",fullName:"Seyed Mojtaba Moosavi"}]},{id:"64643",title:"Derivatization Methods in GC and GC/MS",slug:"derivatization-methods-in-gc-and-gc-ms",totalDownloads:6052,totalCrossrefCites:19,totalDimensionsCites:35,abstract:"The first part of this chapter presents the main objectives for performing derivatization of a sample to be analyzed by gas chromatography (GC) or gas chromatography/mass spectrometry (GC/MS). The derivatization is typically done to change the analyte properties for a better separation and also for enhancing the method sensitivity. In GC/MS, derivatization may improve the capability of compound identification. Examples illustrating such improvements are included. The second part describes several types of derivatization that are more frequently used in analytical practice. These include alkylation (e.g., methylation), formation of aryl derivatives, silylation (e.g., formation of trimethylsilyl derivatives), acylation (e.g., reactions with acyl chlorides or with chloroformates), and several other types of derivatizations. The chapter also presents typical derivatizations for analytes with specific functional groups and discusses artifact formation in certain derivatization reactions.",book:{id:"6831",slug:"gas-chromatography-derivatization-sample-preparation-application",title:"Gas Chromatography",fullTitle:"Gas Chromatography - Derivatization, Sample Preparation, Application"},signatures:"Serban C. Moldoveanu and Victor David",authors:[{id:"91597",title:"Dr.",name:"Serban",middleName:null,surname:"Moldoveanu",slug:"serban-moldoveanu",fullName:"Serban Moldoveanu"},{id:"278733",title:"Prof.",name:"Victor",middleName:null,surname:"David",slug:"victor-david",fullName:"Victor David"}]},{id:"40712",title:"Analytical Chemistry Today and Tomorrow",slug:"analytical-chemistry-today-and-tomorrow",totalDownloads:9147,totalCrossrefCites:1,totalDimensionsCites:5,abstract:null,book:{id:"2717",slug:"analytical-chemistry",title:"Analytical Chemistry",fullTitle:"Analytical Chemistry"},signatures:"Miguel Valcárcel",authors:[{id:"149298",title:"Dr.",name:null,middleName:null,surname:"Valcarcel",slug:"valcarcel",fullName:"Valcarcel"}]}],onlineFirstChaptersFilter:{topicId:"81",limit:6,offset:0},onlineFirstChaptersCollection:[{id:"82536",title:"Perspective Chapter: Multi-Dimensional Liquid Chromatography - Principles and Applications",slug:"perspective-chapter-multi-dimensional-liquid-chromatography-principles-and-applications",totalDownloads:20,totalDimensionsCites:0,doi:"10.5772/intechopen.104767",abstract:"Many complex mixtures usually constitute hundreds or even thousands of individual components of interest. Such mixtures are much too complicated to be separated for analytical duties in a reasonable period of time using only a single-dimensional chromatographic method. However, if a complex mixture is separated by an initial dimension using multi-dimensional liquid chromatography, a simpler portion of that separation is collected and goes to the second dimension. Each of these fractions will be analyzed separately, allowing exceedingly complex mixtures to be resolved in a short period of time. This chapter explains the fundamental principles, theoretical discussions as well as various applications with typical examples of multi-dimensional liquid chromatography in different fields.",book:{id:"11204",title:"Analytical Liquid Chromatography - New Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11204.jpg"},signatures:"Esayas Tesfaye, Tadele Eticha, Ariaya Hymete and Ayenew Ashenef"},{id:"81761",title:"Progress in Technology of the Chromatographic Columns in HPLC",slug:"progress-in-technology-of-the-chromatographic-columns-in-hplc",totalDownloads:22,totalDimensionsCites:0,doi:"10.5772/intechopen.104123",abstract:"Chromatographic column is an essential part of a any HPLC separation, and significant progress has been made in developing columns with better performance to provide better separation, a shorter separation time, resilience to a wider pH range of the mobile phase, longer lifetime, use of lower volumes of mobile phase, etc. All these characteristics were achieved by the introduction of novel technologies and improvements of the older ones. These include smaller particle used to fill the column, more homogeneous spherical particles, core-shell particles, monolithic columns, more pure silica as a stationary phase support, use of ethylene bridge silica, a wider variety of active phases, use of mixed mode stationary phases, use of polymers as stationary phase, use of various endcapping techniques, etc. Miniaturization and progress in the instrumentation played an important role for the chromatographic column development. All these aspects are summarized in the present chapter.",book:{id:"11204",title:"Analytical Liquid Chromatography - New Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11204.jpg"},signatures:"Serban C. Moldoveanu and Victor David"},{id:"81479",title:"Perspective Chapter: Mixed-Mode Chromatography",slug:"perspective-chapter-mixed-mode-chromatography",totalDownloads:32,totalDimensionsCites:0,doi:"10.5772/intechopen.104545",abstract:"In this chapter, we present mixed-mode stationary phases and their applications in the determination of nonpolar, polar, and charged compounds, as well as larger molecules such as peptides or proteins using a single column. Mixed-mode chromatography (MMC) has been growing rapidly in recent years, owing to the new generation of mixed-mode stationary phases and a better understanding of multimode interactions. Mixed-mode chromatography provides a wide range of selectivities and adequate retention of a variety of compounds, especially polar and charged molecules. In summary, this technique is particularly useful in the pharmaceutical analysis of drugs, impurities, biopharmaceuticals, and polar compounds in natural products.",book:{id:"11204",title:"Analytical Liquid Chromatography - New Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11204.jpg"},signatures:"Ngoc-Van Thi Nguyen"},{id:"81368",title:"Ionic Liquids in Liquid Chromatography",slug:"ionic-liquids-in-liquid-chromatography",totalDownloads:41,totalDimensionsCites:1,doi:"10.5772/intechopen.104122",abstract:"Ionic liquids (ILs) are salts of organic cations that are present in liquid state. They can be used as alternative to organic solvents for various analytical processes such as extracting solvents in sample preparation, or as mobile phase or components of the mobile phase in high performance liquid chromatography (HPLC). Also they can be used as stationary phase in gas chromatography (GC), or attached to a solid support as stationary phase in HPLC. Ils are typically more environmentally-friendly solvents than the classic organic solvents having low volatility, flammability and toxicity. The chapter presents various applications of ILs in liquid chromatography.",book:{id:"11204",title:"Analytical Liquid Chromatography - New Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11204.jpg"},signatures:"Victor David and Serban C. Moldoveanu"},{id:"80336",title:"Perspective Chapter: Advantages of Ion Mobility Coupled with HPLC/UPLC",slug:"perspective-chapter-advantages-of-ion-mobility-coupled-with-hplc-uplc",totalDownloads:59,totalDimensionsCites:0,doi:"10.5772/intechopen.102380",abstract:"Ion mobility is a new separation technique that can be coupled with high performance liquid chromatography (HPLC) or ultra-performance liquid chromatography (UPLC). Variances in cross-sectional ionic areas of different molecules create differential speeds through a gas allowing for millisecond separations. Combining ion mobility with both liquid chromatography and mass spectrometry with fragmentation, separations can be achieved on the second (HPLC), millisecond (ion mobility), and microsecond (mass spectrometry) timescales. This orthogonal separation greatly cleans up mass spectral data of co-eluting peaks from the liquid chromatography and adds to the descriptive data of each ion. With descriptive data such as retention time, cross-sectional area, m/z ratio, and mass spectral fragmentation, many options become available for analytical analysis. Options ranging from descriptive data collation into instrument libraries to sensitivity enhancement for trace analysis will be explored in this chapter along with the description of different forms of ion mobility.",book:{id:"11204",title:"Analytical Liquid Chromatography - New Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11204.jpg"},signatures:"Robert Owen Bussey III"}],onlineFirstChaptersTotal:5},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:11,numberOfPublishedChapters:91,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:109,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:333,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:11,numberOfPublishedChapters:144,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:126,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:23,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:13,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}},{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}}]},series:{item:{id:"24",title:"Sustainable Development",doi:"10.5772/intechopen.100361",issn:"2753-6580",scope:"
\r\n\tTransforming our World: the 2030 Agenda for Sustainable Development endorsed by United Nations and 193 Member States, came into effect on Jan 1, 2016, to guide decision making and actions to the year 2030 and beyond. Central to this Agenda are 17 Goals, 169 associated targets and over 230 indicators that are reviewed annually. The vision envisaged in the implementation of the SDGs is centered on the five Ps: People, Planet, Prosperity, Peace and Partnership. This call for renewed focused efforts ensure we have a safe and healthy planet for current and future generations.
\r\n
\r\n\t
\r\n
\r\n\tThis Series focuses on covering research and applied research involving the five Ps through the following topics:
\r\n
\r\n\t
\r\n
\r\n\t1. Sustainable Economy and Fair Society that relates to SDG 1 on No Poverty, SDG 2 on Zero Hunger, SDG 8 on Decent Work and Economic Growth, SDG 10 on Reduced Inequalities, SDG 12 on Responsible Consumption and Production, and SDG 17 Partnership for the Goals
\r\n
\r\n\t
\r\n
\r\n\t2. Health and Wellbeing focusing on SDG 3 on Good Health and Wellbeing and SDG 6 on Clean Water and Sanitation
\r\n
\r\n\t
\r\n
\r\n\t3. Inclusivity and Social Equality involving SDG 4 on Quality Education, SDG 5 on Gender Equality, and SDG 16 on Peace, Justice and Strong Institutions
\r\n
\r\n\t
\r\n
\r\n\t4. Climate Change and Environmental Sustainability comprising SDG 13 on Climate Action, SDG 14 on Life Below Water, and SDG 15 on Life on Land
\r\n
\r\n\t
\r\n
\r\n\t5. Urban Planning and Environmental Management embracing SDG 7 on Affordable Clean Energy, SDG 9 on Industry, Innovation and Infrastructure, and SDG 11 on Sustainable Cities and Communities.
\r\n
\r\n\t
\r\n
\r\n\tThe series also seeks to support the use of cross cutting SDGs, as many of the goals listed above, targets and indicators are all interconnected to impact our lives and the decisions we make on a daily basis, making them impossible to tie to a single topic.
",coverUrl:"https://cdn.intechopen.com/series/covers/24.jpg",latestPublicationDate:"August 2nd, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:1,editor:{id:"262440",title:"Prof.",name:"Usha",middleName:null,surname:"Iyer-Raniga",slug:"usha-iyer-raniga",fullName:"Usha Iyer-Raniga",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRYSXQA4/Profile_Picture_2022-02-28T13:55:36.jpeg",biography:"Usha Iyer-Raniga is a professor in the School of Property and Construction Management at RMIT University. Usha co-leads the One Planet Network’s Sustainable Buildings and Construction Programme (SBC), a United Nations 10 Year Framework of Programmes on Sustainable Consumption and Production (UN 10FYP SCP) aligned with Sustainable Development Goal 12. The work also directly impacts SDG 11 on Sustainable Cities and Communities. She completed her undergraduate degree as an architect before obtaining her Masters degree from Canada and her Doctorate in Australia. Usha has been a keynote speaker as well as an invited speaker at national and international conferences, seminars and workshops. Her teaching experience includes teaching in Asian countries. She has advised Austrade, APEC, national, state and local governments. She serves as a reviewer and a member of the scientific committee for national and international refereed journals and refereed conferences. She is on the editorial board for refereed journals and has worked on Special Issues. Usha has served and continues to serve on the Boards of several not-for-profit organisations and she has also served as panel judge for a number of awards including the Premiers Sustainability Award in Victoria and the International Green Gown Awards. Usha has published over 100 publications, including research and consulting reports. Her publications cover a wide range of scientific and technical research publications that include edited books, book chapters, refereed journals, refereed conference papers and reports for local, state and federal government clients. She has also produced podcasts for various organisations and participated in media interviews. She has received state, national and international funding worth over USD $25 million. Usha has been awarded the Quarterly Franklin Membership by London Journals Press (UK). Her biography has been included in the Marquis Who's Who in the World® 2018, 2016 (33rd Edition), along with approximately 55,000 of the most accomplished men and women from around the world, including luminaries as U.N. Secretary-General Ban Ki-moon. In 2017, Usha was awarded the Marquis Who’s Who Lifetime Achiever Award.",institutionString:null,institution:{name:"RMIT University",institutionURL:null,country:{name:"Australia"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:5,paginationItems:[{id:"91",title:"Sustainable Economy and Fair Society",coverUrl:"https://cdn.intechopen.com/series_topics/covers/91.jpg",isOpenForSubmission:!0,editor:{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo",profilePictureURL:"https://mts.intechopen.com/storage/users/181603/images/system/181603.jpg",biography:"Antonella Petrillo, Ph.D., is a professor in the Department of Engineering, University of Naples “Parthenope,” Italy. She received her Ph.D. in Mechanical Engineering from the University of Cassino and Southern Lazio, Italy. Her research interests include multi-criteria decision analysis, industrial plants, logistics, manufacturing, and safety. She serves as an associate editor for the International Journal of the Analytic Hierarchy Process and is an editorial board member for several other journals. She is also a member of the Analytic Hierarchy Process (AHP) Academy.",institutionString:"Parthenope University of Naples, Italy",institution:{name:"Parthenope University of Naples",institutionURL:null,country:{name:"Italy"}}},editorTwo:null,editorThree:null},{id:"92",title:"Health and Wellbeing",coverUrl:"https://cdn.intechopen.com/series_topics/covers/92.jpg",isOpenForSubmission:!0,editor:{id:"348225",title:"Prof.",name:"Ann",middleName:null,surname:"Hemingway",slug:"ann-hemingway",fullName:"Ann Hemingway",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035LZFoQAO/Profile_Picture_2022-04-11T14:55:40.jpg",biography:"Professor Hemingway is a public health researcher, Bournemouth University, undertaking international and UK research focused on reducing inequalities in health outcomes for marginalised and excluded populations and more recently focused on equine assisted interventions.",institutionString:null,institution:{name:"Bournemouth University",institutionURL:null,country:{name:"United Kingdom"}}},editorTwo:null,editorThree:null},{id:"93",title:"Inclusivity and Social Equity",coverUrl:"https://cdn.intechopen.com/series_topics/covers/93.jpg",isOpenForSubmission:!0,editor:{id:"210060",title:"Prof. Dr.",name:"Ebba",middleName:null,surname:"Ossiannilsson",slug:"ebba-ossiannilsson",fullName:"Ebba Ossiannilsson",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6LkBQAU/Profile_Picture_2022-02-28T13:31:48.png",biography:"Professor Dr. Ebba Ossiannilsson is an independent researcher, expert, consultant, quality auditor and influencer in the fields of open, flexible online and distance learning (OFDL) and the 'new normal'. Her focus is on quality, innovation, leadership, and personalised learning. She works primarily at the strategic and policy levels, both nationally and internationally, and with key international organisations. She is committed to promoting and improving OFDL in the context of SDG4 and the future of education. Ossiannilsson has more than 20 years of experience in her current field, but more than 40 years in the education sector. She works as a reviewer and expert for the European Commission and collaborates with the Joint Research Centre for Quality in Open Education. Ossiannilsson also collaborates with ITCILO and ICoBC (International Council on Badges and Credentials). She is a member of the ICDE Board of Directors and has previously served on the boards of EDEN and EUCEN. Ossiannilsson is a quality expert and reviewer for ICDE, EDEN and the EADTU. She chairs the ICDE OER Advocacy Committee and is a member of the ICDE Quality Network. She is regularly invited as a keynote speaker at conferences. She is a guest editor for several special issues and a member of the editorial board of several scientific journals. She has published more than 200 articles and is currently working on book projects in the field of OFDL. Ossiannilsson is a visiting professor at several international universities and was recently appointed Professor and Research Fellow at Victoria University of Wellington, NZ. Ossiannilsson has been awarded the following fellowships: EDEN Fellows, EDEN Council of Fellows, and Open Education Europe. She is a ICDE OER Ambassador, Open Education Europe Ambassador, GIZ Ambassador for Quality in Digital Learning, and part of the Globe-Community of Digital Learning and Champion of SPARC Europe. On a national level, she is a quality developer at the Swedish Institute for Standards (SIS) and for ISO. She is a member of the Digital Skills and Jobs Coalition Sweden and Vice President of the Swedish Association for Distance Education. She is currently working on a government initiative on quality in distance education at the National Council for Higher Education. She holds a Ph.D. from the University of Oulu, Finland.",institutionString:"Swedish Association for Distance Education, Sweden",institution:null},editorTwo:null,editorThree:null},{id:"94",title:"Climate Change and Environmental Sustainability",coverUrl:"https://cdn.intechopen.com/series_topics/covers/94.jpg",isOpenForSubmission:!0,editor:{id:"61855",title:"Dr.",name:"Yixin",middleName:null,surname:"Zhang",slug:"yixin-zhang",fullName:"Yixin Zhang",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYWJgQAO/Profile_Picture_2022-06-09T11:36:35.jpg",biography:"Professor Yixin Zhang is an aquatic ecologist with over 30 years of research and teaching experience in three continents (Asia, Europe, and North America) in Stream Ecology, Riparian Ecology, Urban Ecology, and Ecosystem Restoration and Aquatic Conservation, Human-Nature Interactions and Sustainability, Urbanization Impact on Aquatic Ecosystems. He got his Ph.D. in Animal Ecology at Umeå University in Sweden in 1998. He conducted postdoc research in stream ecology at the University of California at Santa Barbara in the USA. After that, he was a postdoc research fellow at the University of British Columbia in Canada to do research on large-scale stream experimental manipulation and watershed ecological survey in temperate rainforests of BC. He was a faculty member at the University of Hong Kong to run ecological research projects on aquatic insects, fishes, and newts in Tropical Asian streams. He also conducted research in streams, rivers, and caves in Texas, USA, to study the ecology of macroinvertebrates, big-claw river shrimp, fish, turtles, and bats. Current research interests include trophic flows across ecosystems; watershed impacts of land-use change on biodiversity and ecosystem functioning; ecological civilization and water resource management; urban ecology and urban/rural sustainable development.",institutionString:null,institution:{name:"Soochow University",institutionURL:null,country:{name:"China"}}},editorTwo:null,editorThree:null},{id:"95",title:"Urban Planning and Environmental Management",coverUrl:"https://cdn.intechopen.com/series_topics/covers/95.jpg",isOpenForSubmission:!0,editor:{id:"181079",title:"Dr.",name:"Christoph",middleName:null,surname:"Lüthi",slug:"christoph-luthi",fullName:"Christoph Lüthi",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRHSqQAO/Profile_Picture_2022-04-12T15:51:33.png",biography:"Dr. Christoph Lüthi is an urban infrastructure planner with over 25 years of experience in planning and design of urban infrastructure in middle and low-income countries. He holds a Master’s Degree in Urban Development Planning from the University College of London (UCL), and a Ph.D. in Urban Planning & Engineering from TU Berlin. He has conducted applied research on urban planning and infrastructure issues in over 20 countries in Africa and Asia. In 2005 he joined Eawag-Sandec as Leader of the Strategic Environmental Sanitation Planning Group. Since 2015 he heads the research department Sanitation, Water and Solid Waste for Development (Sandec) at the Swiss Federal Institute of Aquatic Research and Technology (Eawag).",institutionString:"Swiss Federal Institute of Aquatic Science and Technology, Switzerland",institution:{name:"Swiss Federal Institute of Aquatic Science and Technology",institutionURL:null,country:{name:"Switzerland"}}},editorTwo:{id:"290571",title:"Dr.",name:"Rui Alexandre",middleName:null,surname:"Castanho",slug:"rui-alexandre-castanho",fullName:"Rui Alexandre Castanho",profilePictureURL:"https://mts.intechopen.com/storage/users/290571/images/system/290571.jpg",biography:"Rui Alexandre Castanho has a master\\'s degree in Planning, Audit, and Control in Urban Green Spaces and an international Ph.D. in Sustainable Planning in Borderlands. Currently, he is a professor at WSB University, Poland, and a visiting professor at the University of Johannesburg, South Africa. Dr. Castanho is a post-doc researcher on the GREAT Project, University of Azores, Ponta Delgada, Portugal. He collaborates with the Environmental Resources Analysis Research Group (ARAM), University of Extremadura (UEx), Spain; VALORIZA - Research Center for the Enhancement of Endogenous Resources, Polytechnic Institute of Portalegre (IPP), Portugal; Centre for Tourism Research, Development and Innovation (CITUR), Madeira, Portugal; and AQUAGEO Research Group, University of Campinas (UNICAMP), Brazil.",institutionString:"University of Johannesburg, South Africa and WSB University, Poland",institution:{name:"University of Johannesburg",institutionURL:null,country:{name:"South Africa"}}},editorThree:null}]},overviewPageOFChapters:{paginationCount:9,paginationItems:[{id:"82936",title:"Soil Degradation Processes Linked to Long-Term Forest-Type Damage",doi:"10.5772/intechopen.106390",signatures:"Pavel Samec, Aleš Kučera and Gabriela Tomášová",slug:"soil-degradation-processes-linked-to-long-term-forest-type-damage",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Forest Degradation Under Global Change",coverURL:"https://cdn.intechopen.com/books/images_new/11457.jpg",subseries:{id:"94",title:"Climate Change and Environmental Sustainability"}}},{id:"82777",title:"Sustainability and Social Investment: Community Microhydropower Systems in the Dominican Republic",doi:"10.5772/intechopen.105995",signatures:"Michela Izzo, Alberto Sánchez and Rafael Fonseca",slug:"sustainability-and-social-investment-community-microhydropower-systems-in-the-dominican-republic",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Globalization and Sustainability - Recent Advances, New Perspectives and Emerging Issues",coverURL:"https://cdn.intechopen.com/books/images_new/11476.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"82387",title:"Kept Promises? The Evolution of the EU Financial Contribution to Climate Change",doi:"10.5772/intechopen.105541",signatures:"Cecilia Camporeale, Roberto Del Ciello and Mario Jorizzo",slug:"kept-promises-the-evolution-of-the-eu-financial-contribution-to-climate-change",totalDownloads:11,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Mario",surname:"Jorizzo"},{name:"Cecilia",surname:"Camporeale"},{name:"ROBERTO",surname:"DEL CIELLO"}],book:{title:"Globalization and Sustainability - Recent Advances, New Perspectives and Emerging Issues",coverURL:"https://cdn.intechopen.com/books/images_new/11476.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"82524",title:"Italy’s Small Exporting Companies: Globalization and Sustainability Issues",doi:"10.5772/intechopen.105542",signatures:"Roberta Pace and Francesca Mandanici",slug:"italy-s-small-exporting-companies-globalization-and-sustainability-issues",totalDownloads:15,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Globalization and Sustainability - Recent Advances, New Perspectives and Emerging Issues",coverURL:"https://cdn.intechopen.com/books/images_new/11476.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}}]},overviewPagePublishedBooks:{paginationCount:1,paginationItems:[{type:"book",id:"10897",title:"Food Systems Resilience",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",slug:"food-systems-resilience",publishedDate:"July 13th 2022",editedByType:"Edited by",bookSignature:"Ana I. Ribeiro-Barros, Daniel S. Tevera, Luís F. Goulao and Lucas D. Tivana",hash:"ae9dd92f53433e4607f1db188dc649b4",volumeInSeries:1,fullTitle:"Food Systems Resilience",editors:[{id:"171036",title:"Dr.",name:"Ana I.",middleName:null,surname:"Ribeiro-Barros",slug:"ana-i.-ribeiro-barros",fullName:"Ana I. Ribeiro-Barros",profilePictureURL:"https://mts.intechopen.com/storage/users/171036/images/system/171036.jpg",biography:"Ana I. Ribeiro-Barros, Ph.D., is the director of the Tropical College, University of Lisbon (ULisboa). She obtained a Ph.D. in Plant Molecular Biology from Wageningen University, the Netherlands. She is also a senior researcher, head of the lab, and professor at the School of Agriculture, ULisboa, and an invited professor at Nova University Lisbon (NOVA), Eduardo Mondlane University (UEM), and Gorongosa National Park (GNP). She is a member of the Coordination and Scientific Committees of the doctoral program “Tropical Knowledge and Management” (NOVA), Master in Biotechnology (UEM), and Master in Conservation Biology (GNP); and a national expert for Food and Nutrition Security and Sustainable Agriculture - High-Level Policy Dialogue EU-Africa. Her research expertise and interests are centered on biodiversity, environmental sustainability, agro-ecological approaches, and food and nutritional security.",institutionString:"University of Lisbon",institution:{name:"University of Lisbon",institutionURL:null,country:{name:"Portugal"}}}]}]},openForSubmissionBooks:{paginationCount:2,paginationItems:[{id:"11673",title:"Stem Cell Research",coverURL:"https://cdn.intechopen.com/books/images_new/11673.jpg",hash:"13092df328080c762dd9157be18ca38c",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"July 13th 2022",isOpenForSubmission:!0,editors:[{id:"203598",title:"Ph.D.",name:"Diana",surname:"Kitala",slug:"diana-kitala",fullName:"Diana Kitala"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"12215",title:"Cell Death and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/12215.jpg",hash:"dfd456a29478fccf4ebd3294137eb1e3",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"July 29th 2022",isOpenForSubmission:!0,editors:[{id:"59529",title:"Dr.",name:"Ke",surname:"Xu",slug:"ke-xu",fullName:"Ke Xu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:16,paginationItems:[{id:"82135",title:"Carotenoids in Cassava (Manihot esculenta Crantz)",doi:"10.5772/intechopen.105210",signatures:"Lovina I. Udoh, Josephine U. Agogbua, Eberechi R. Keyagha and Itorobong I. Nkanga",slug:"carotenoids-in-cassava-manihot-esculenta-crantz",totalDownloads:15,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"82112",title:"Comparative Senescence and Lifespan",doi:"10.5772/intechopen.105137",signatures:"Hassan M. Heshmati",slug:"comparative-senescence-and-lifespan",totalDownloads:17,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Hassan M.",surname:"Heshmati"}],book:{title:"Mechanisms and Management of Senescence",coverURL:"https://cdn.intechopen.com/books/images_new/10935.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81796",title:"Apoptosis-Related Diseases and Peroxisomes",doi:"10.5772/intechopen.105052",signatures:"Meimei Wang, Yakun Liu, Ni Chen, Juan Wang and Ye Zhao",slug:"apoptosis-related-diseases-and-peroxisomes",totalDownloads:11,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"The Metabolic Role of Peroxisome in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/10837.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81723",title:"Peroxisomal Modulation as Therapeutic Alternative for Tackling Multiple Cancers",doi:"10.5772/intechopen.104873",signatures:"Shazia Usmani, Shadma Wahab, Abdul Hafeez, Shabana Khatoon and Syed Misbahul Hasan",slug:"peroxisomal-modulation-as-therapeutic-alternative-for-tackling-multiple-cancers",totalDownloads:18,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"The Metabolic Role of Peroxisome in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/10837.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81638",title:"Aging and Neuropsychiatric Disease: A General Overview of Prevalence and Trends",doi:"10.5772/intechopen.103102",signatures:"Jelena Milić",slug:"aging-and-neuropsychiatric-disease-a-general-overview-of-prevalence-and-trends",totalDownloads:30,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Mechanisms and Management of Senescence",coverURL:"https://cdn.intechopen.com/books/images_new/10935.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81576",title:"Carotenoids in Thermal Adaptation of Plants and Animals",doi:"10.5772/intechopen.104537",signatures:"Ivan M. Petyaev",slug:"carotenoids-in-thermal-adaptation-of-plants-and-animals",totalDownloads:28,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Ivan",surname:"Petyaev"}],book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81358",title:"New Insights on Carotenoid Production by Gordonia alkanivorans Strain 1B",doi:"10.5772/intechopen.103919",signatures:"Tiago P. Silva, Susana M. Paixão, Ana S. Fernandes, José C. Roseiro and Luís Alves",slug:"new-insights-on-carotenoid-production-by-gordonia-alkanivorans-strain-1b",totalDownloads:22,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81290",title:"Musculoskeletal Abnormalities Caused by Cystic Fibrosis",doi:"10.5772/intechopen.104591",signatures:"Mark Lambrechts",slug:"musculoskeletal-abnormalities-caused-by-cystic-fibrosis",totalDownloads:30,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Advances in Skeletal Muscle Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/11675.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81246",title:"Role of Carotenoids in Cardiovascular Disease",doi:"10.5772/intechopen.102750",signatures:"Arslan Ahmad, Sakhawat Riaz, Muhammad Shahzaib Nadeem, Umber Mubeen and Khadija Maham",slug:"role-of-carotenoids-in-cardiovascular-disease",totalDownloads:44,totalCrossrefCites:1,totalDimensionsCites:1,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81226",title:"Computational Methods for the Study of Peroxisomes in Health and Disease",doi:"10.5772/intechopen.103178",signatures:"Naomi van Wijk and Michal Linial",slug:"computational-methods-for-the-study-of-peroxisomes-in-health-and-disease",totalDownloads:32,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"The Metabolic Role of Peroxisome in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/10837.jpg",subseries:{id:"11",title:"Cell Physiology"}}}]},subseriesFiltersForOFChapters:[{caption:"Plant Physiology",value:13,count:6,group:"subseries"},{caption:"Cell Physiology",value:11,count:10,group:"subseries"}],publishedBooks:{paginationCount:11,paginationItems:[{type:"book",id:"10664",title:"Animal Reproduction",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10664.jpg",slug:"animal-reproduction",publishedDate:"May 25th 2022",editedByType:"Edited by",bookSignature:"Yusuf Bozkurt and Mustafa Numan Bucak",hash:"2d66af42fb17d0a6556bb9ef28e273c7",volumeInSeries:11,fullTitle:"Animal Reproduction",editors:[{id:"90846",title:"Prof.",name:"Yusuf",middleName:null,surname:"Bozkurt",slug:"yusuf-bozkurt",fullName:"Yusuf Bozkurt",profilePictureURL:"https://mts.intechopen.com/storage/users/90846/images/system/90846.jpg",institutionString:"İskenderun Technical University",institution:{name:"İskenderun Technical University",institutionURL:null,country:{name:"Turkey"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10830",title:"Animal Feed Science and Nutrition",subtitle:"Production, Health and Environment",coverURL:"https://cdn.intechopen.com/books/images_new/10830.jpg",slug:"animal-feed-science-and-nutrition-production-health-and-environment",publishedDate:"May 18th 2022",editedByType:"Edited by",bookSignature:"Amlan Kumar Patra",hash:"79944fc8fbbaa329aed6fde388154832",volumeInSeries:10,fullTitle:"Animal Feed Science and Nutrition - Production, Health and Environment",editors:[{id:"310962",title:"Dr.",name:"Amlan",middleName:"Kumar",surname:"Patra",slug:"amlan-patra",fullName:"Amlan Patra",profilePictureURL:"https://mts.intechopen.com/storage/users/310962/images/system/310962.jpg",institutionString:null,institution:{name:"West Bengal University of Animal and Fishery Sciences",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8737",title:"Rabies Virus at the Beginning of 21st Century",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8737.jpg",slug:"rabies-virus-at-the-beginning-of-21st-century",publishedDate:"May 11th 2022",editedByType:"Edited by",bookSignature:"Sergey Tkachev",hash:"49cce3f548da548c718c865feb343509",volumeInSeries:9,fullTitle:"Rabies Virus at the Beginning of 21st Century",editors:[{id:"61139",title:"Dr.",name:"Sergey",middleName:null,surname:"Tkachev",slug:"sergey-tkachev",fullName:"Sergey Tkachev",profilePictureURL:"https://mts.intechopen.com/storage/users/61139/images/system/61139.png",institutionString:"Russian Academy of Sciences",institution:{name:"Russian Academy of Sciences",institutionURL:null,country:{name:"Russia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10496",title:"Advanced Studies in the 21st Century Animal Nutrition",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10496.jpg",slug:"advanced-studies-in-the-21st-century-animal-nutrition",publishedDate:"December 8th 2021",editedByType:"Edited by",bookSignature:"László Babinszky, Juliana Oliveira and Edson Mauro Santos",hash:"8ffe43a82ac48b309abc3632bbf3efd0",volumeInSeries:8,fullTitle:"Advanced Studies in the 21st Century Animal Nutrition",editors:[{id:"53998",title:"Prof.",name:"László",middleName:null,surname:"Babinszky",slug:"laszlo-babinszky",fullName:"László Babinszky",profilePictureURL:"https://mts.intechopen.com/storage/users/53998/images/system/53998.png",institutionString:"University of Debrecen",institution:{name:"University of Debrecen",institutionURL:null,country:{name:"Hungary"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10497",title:"Canine Genetics, Health and Medicine",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10497.jpg",slug:"canine-genetics-health-and-medicine",publishedDate:"June 2nd 2021",editedByType:"Edited by",bookSignature:"Catrin Rutland",hash:"b91512e31ce34032e560362e6cbccc1c",volumeInSeries:7,fullTitle:"Canine Genetics, Health and Medicine",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",slug:"animal-reproduction-in-veterinary-medicine",publishedDate:"January 20th 2021",editedByType:"Edited by",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",hash:"13aaddf5fdbbc78387e77a7da2388bf6",volumeInSeries:6,fullTitle:"Animal Reproduction in Veterinary Medicine",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral",profilePictureURL:"https://mts.intechopen.com/storage/users/25600/images/system/25600.jpg",institutionString:"Independent Researcher",institution:{name:"Harran University",institutionURL:null,country:{name:"Turkey"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9081",title:"Equine Science",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9081.jpg",slug:"equine-science",publishedDate:"September 23rd 2020",editedByType:"Edited by",bookSignature:"Catrin Rutland and Albert Rizvanov",hash:"ac415ef2f5450fa80fdb9cf6cf32cd2d",volumeInSeries:5,fullTitle:"Equine Science",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8460",title:"Reproductive Biology and Technology in Animals",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8460.jpg",slug:"reproductive-biology-and-technology-in-animals",publishedDate:"April 15th 2020",editedByType:"Edited by",bookSignature:"Juan Carlos Gardón Poggi and Katy Satué Ambrojo",hash:"32ef5fe73998dd723d308225d756fa1e",volumeInSeries:4,fullTitle:"Reproductive Biology and Technology in Animals",editors:[{id:"251314",title:"Dr.",name:"Juan Carlos",middleName:null,surname:"Gardón Poggi",slug:"juan-carlos-gardon-poggi",fullName:"Juan Carlos Gardón Poggi",profilePictureURL:"https://mts.intechopen.com/storage/users/251314/images/system/251314.jpeg",institutionString:null,institution:{name:"Valencia Catholic University Saint Vincent Martyr",institutionURL:null,country:{name:"Spain"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8524",title:"Lactation in Farm Animals",subtitle:"Biology, Physiological Basis, Nutritional Requirements, and Modelization",coverURL:"https://cdn.intechopen.com/books/images_new/8524.jpg",slug:"lactation-in-farm-animals-biology-physiological-basis-nutritional-requirements-and-modelization",publishedDate:"January 22nd 2020",editedByType:"Edited by",bookSignature:"Naceur M'Hamdi",hash:"2aa2a9a0ec13040bbf0455e34625504e",volumeInSeries:3,fullTitle:"Lactation in Farm Animals - Biology, Physiological Basis, Nutritional Requirements, and Modelization",editors:[{id:"73376",title:"Dr.",name:"Naceur",middleName:null,surname:"M'Hamdi",slug:"naceur-m'hamdi",fullName:"Naceur M'Hamdi",profilePictureURL:"https://mts.intechopen.com/storage/users/73376/images/system/73376.jpg",institutionString:null,institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7144",title:"Veterinary Anatomy and Physiology",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7144.jpg",slug:"veterinary-anatomy-and-physiology",publishedDate:"March 13th 2019",editedByType:"Edited by",bookSignature:"Catrin Sian Rutland and Valentina Kubale",hash:"75cdacb570e0e6d15a5f6e69640d87c9",volumeInSeries:2,fullTitle:"Veterinary Anatomy and Physiology",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7233",title:"New Insights into Theriogenology",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7233.jpg",slug:"new-insights-into-theriogenology",publishedDate:"December 5th 2018",editedByType:"Edited by",bookSignature:"Rita Payan-Carreira",hash:"74f4147e3fb214dd050e5edd3aaf53bc",volumeInSeries:1,fullTitle:"New Insights into Theriogenology",editors:[{id:"38652",title:"Prof.",name:"Rita",middleName:null,surname:"Payan-Carreira",slug:"rita-payan-carreira",fullName:"Rita Payan-Carreira",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRiFPQA0/Profile_Picture_1614601496313",institutionString:null,institution:{name:"University of Évora",institutionURL:null,country:{name:"Portugal"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Animal Nutrition",value:20,count:2},{group:"subseries",caption:"Animal Reproductive Biology and Technology",value:28,count:4},{group:"subseries",caption:"Animal Science",value:19,count:5}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:3},{group:"publicationYear",caption:"2021",value:2021,count:3},{group:"publicationYear",caption:"2020",value:2020,count:3},{group:"publicationYear",caption:"2019",value:2019,count:1},{group:"publicationYear",caption:"2018",value:2018,count:1}],authors:{paginationCount:303,paginationItems:[{id:"280338",title:"Dr.",name:"Yutaka",middleName:null,surname:"Tsutsumi",slug:"yutaka-tsutsumi",fullName:"Yutaka Tsutsumi",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/280338/images/7961_n.jpg",biography:null,institutionString:null,institution:{name:"Fujita Health University",country:{name:"Japan"}}},{id:"116250",title:"Dr.",name:"Nima",middleName:null,surname:"Rezaei",slug:"nima-rezaei",fullName:"Nima Rezaei",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/116250/images/system/116250.jpg",biography:"Professor Nima Rezaei obtained an MD from Tehran University of Medical Sciences, Iran. He also obtained an MSc in Molecular and Genetic Medicine, and a Ph.D. in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also completed a short-term fellowship in Pediatric Clinical Immunology and Bone Marrow Transplantation at Newcastle General Hospital, England. Dr. Rezaei is a Full Professor of Immunology and Vice Dean of International Affairs and Research, at the School of Medicine, Tehran University of Medical Sciences, and the co-founder and head of the Research Center for Immunodeficiencies. He is also the founding president of the Universal Scientific Education and Research Network (USERN). Dr. Rezaei has directed more than 100 research projects and has designed and participated in several international collaborative projects. He is an editor, editorial assistant, or editorial board member of more than forty international journals. He has edited more than 50 international books, presented more than 500 lectures/posters in congresses/meetings, and published more than 1,100 scientific papers in international journals.",institutionString:"Tehran University of Medical Sciences",institution:{name:"Tehran University of Medical Sciences",country:{name:"Iran"}}},{id:"180733",title:"Dr.",name:"Jean",middleName:null,surname:"Engohang-Ndong",slug:"jean-engohang-ndong",fullName:"Jean Engohang-Ndong",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/180733/images/system/180733.png",biography:"Dr. Jean Engohang-Ndong was born and raised in Gabon. After obtaining his Associate Degree of Science at the University of Science and Technology of Masuku, Gabon, he continued his education in France where he obtained his BS, MS, and Ph.D. in Medical Microbiology. He worked as a post-doctoral fellow at the Public Health Research Institute (PHRI), Newark, NJ for four years before accepting a three-year faculty position at Brigham Young University-Hawaii. Dr. Engohang-Ndong is a tenured faculty member with the academic rank of Full Professor at Kent State University, Ohio, where he teaches a wide range of biological science courses and pursues his research in medical and environmental microbiology. Recently, he expanded his research interest to epidemiology and biostatistics of chronic diseases in Gabon.",institutionString:"Kent State University",institution:{name:"Kent State University",country:{name:"United States of America"}}},{id:"188773",title:"Prof.",name:"Emmanuel",middleName:null,surname:"Drouet",slug:"emmanuel-drouet",fullName:"Emmanuel Drouet",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/188773/images/system/188773.png",biography:"Emmanuel Drouet, PharmD, is a Professor of Virology at the Faculty of Pharmacy, the University Grenoble-Alpes, France. As a head scientist at the Institute of Structural Biology in Grenoble, Dr. Drouet’s research investigates persisting viruses in humans (RNA and DNA viruses) and the balance with our host immune system. He focuses on these viruses’ effects on humans (both their impact on pathology and their symbiotic relationships in humans). He has an excellent track record in the herpesvirus field, and his group is engaged in clinical research in the field of Epstein-Barr virus diseases. He is the editor of the online Encyclopedia of Environment and he coordinates the Universal Health Coverage education program for the BioHealth Computing Schools of the European Institute of Science.",institutionString:null,institution:{name:"Grenoble Alpes University",country:{name:"France"}}},{id:"131400",title:"Prof.",name:"Alfonso J.",middleName:null,surname:"Rodriguez-Morales",slug:"alfonso-j.-rodriguez-morales",fullName:"Alfonso J. Rodriguez-Morales",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/131400/images/system/131400.png",biography:"Dr. Rodriguez-Morales is an expert in tropical and emerging diseases, particularly zoonotic and vector-borne diseases (especially arboviral diseases). He is the president of the Travel Medicine Committee of the Pan-American Infectious Diseases Association (API), as well as the president of the Colombian Association of Infectious Diseases (ACIN). He is a member of the Committee on Tropical Medicine, Zoonoses, and Travel Medicine of ACIN. He is a vice-president of the Latin American Society for Travel Medicine (SLAMVI) and a Member of the Council of the International Society for Infectious Diseases (ISID). Since 2014, he has been recognized as a Senior Researcher, at the Ministry of Science of Colombia. He is a professor at the Faculty of Medicine of the Fundacion Universitaria Autonoma de las Americas, in Pereira, Risaralda, Colombia. He is an External Professor, Master in Research on Tropical Medicine and International Health, Universitat de Barcelona, Spain. He is also a professor at the Master in Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru. In 2021 he has been awarded the “Raul Isturiz Award” Medal of the API. Also, in 2021, he was awarded with the “Jose Felix Patiño” Asclepius Staff Medal of the Colombian Medical College, due to his scientific contributions to COVID-19 during the pandemic. He is currently the Editor in Chief of the journal Travel Medicine and Infectious Diseases. His Scopus H index is 47 (Google Scholar H index, 68).",institutionString:"Institución Universitaria Visión de las Américas, Colombia",institution:null},{id:"332819",title:"Dr.",name:"Chukwudi Michael",middleName:"Michael",surname:"Egbuche",slug:"chukwudi-michael-egbuche",fullName:"Chukwudi Michael Egbuche",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/332819/images/14624_n.jpg",biography:"I an Dr. Chukwudi Michael Egbuche. I am a Senior Lecturer in the Department of Parasitology and Entomology, Nnamdi Azikiwe University, Awka.",institutionString:null,institution:{name:"Nnamdi Azikiwe University",country:{name:"Nigeria"}}},{id:"284232",title:"Mr.",name:"Nikunj",middleName:"U",surname:"Tandel",slug:"nikunj-tandel",fullName:"Nikunj Tandel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/284232/images/8275_n.jpg",biography:'Mr. Nikunj Tandel has completed his Master\'s degree in Biotechnology from VIT University, India in the year of 2012. He is having 8 years of research experience especially in the field of malaria epidemiology, immunology, and nanoparticle-based drug delivery system against the infectious diseases, autoimmune disorders and cancer. He has worked for the NIH funded-International Center of Excellence in Malaria Research project "Center for the study of complex malaria in India (CSCMi)" in collaboration with New York University. The preliminary objectives of the study are to understand and develop the evidence-based tools and interventions for the control and prevention of malaria in different sites of the INDIA. Alongside, with the help of next-generation genomics study, the team has studied the antimalarial drug resistance in India. Further, he has extended his research in the development of Humanized mice for the study of liver-stage malaria and identification of molecular marker(s) for the Artemisinin resistance. At present, his research focuses on understanding the role of B cells in the activation of CD8+ T cells in malaria. Received the CSIR-SRF (Senior Research Fellow) award-2018, FIMSA (Federation of Immunological Societies of Asia-Oceania) Travel Bursary award to attend the IUIS-IIS-FIMSA Immunology course-2019',institutionString:"Nirma University",institution:{name:"Nirma University",country:{name:"India"}}},{id:"334383",title:"Ph.D.",name:"Simone",middleName:"Ulrich",surname:"Ulrich Picoli",slug:"simone-ulrich-picoli",fullName:"Simone Ulrich Picoli",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/334383/images/15919_n.jpg",biography:"Graduated in Pharmacy from Universidade Luterana do Brasil (1999), Master in Agricultural and Environmental Microbiology from Federal University of Rio Grande do Sul (2002), Specialization in Clinical Microbiology from Universidade de São Paulo, USP (2007) and PhD in Sciences in Gastroenterology and Hepatology (2012). She is currently an Adjunct Professor at Feevale University in Medicine and Biomedicine courses and a permanent professor of the Academic Master\\'s Degree in Virology. She has experience in the field of Microbiology, with an emphasis on Bacteriology, working mainly on the following topics: bacteriophages, bacterial resistance, clinical microbiology and food microbiology.",institutionString:null,institution:{name:"Universidade Feevale",country:{name:"Brazil"}}},{id:"229220",title:"Dr.",name:"Amjad",middleName:"Islam",surname:"Aqib",slug:"amjad-aqib",fullName:"Amjad Aqib",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/229220/images/system/229220.png",biography:"Dr. Amjad Islam Aqib obtained a DVM and MSc (Hons) from University of Agriculture Faisalabad (UAF), Pakistan, and a PhD from the University of Veterinary and Animal Sciences Lahore, Pakistan. Dr. Aqib joined the Department of Clinical Medicine and Surgery at UAF for one year as an assistant professor where he developed a research laboratory designated for pathogenic bacteria. Since 2018, he has been Assistant Professor/Officer in-charge, Department of Medicine, Manager Research Operations and Development-ORIC, and President One Health Club at Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan. He has nearly 100 publications to his credit. His research interests include epidemiological patterns and molecular analysis of antimicrobial resistance and modulation and vaccine development against animal pathogens of public health concern.",institutionString:"Cholistan University of Veterinary and Animal Sciences",institution:{name:"University of Agriculture Faisalabad",country:{name:"Pakistan"}}},{id:"333753",title:"Dr.",name:"Rais",middleName:null,surname:"Ahmed",slug:"rais-ahmed",fullName:"Rais Ahmed",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/333753/images/20168_n.jpg",biography:null,institutionString:null,institution:{name:"University of Agriculture Faisalabad",country:{name:"Pakistan"}}},{id:"62900",title:"Prof.",name:"Fethi",middleName:null,surname:"Derbel",slug:"fethi-derbel",fullName:"Fethi Derbel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62900/images/system/62900.jpeg",biography:"Professor Fethi Derbel was born in 1960 in Tunisia. He received his medical degree from the Sousse Faculty of Medicine at Sousse, University of Sousse, Tunisia. He completed his surgical residency in General Surgery at the University Hospital Farhat Hached of Sousse and was a member of the Unit of Liver Transplantation in the University of Rennes, France. He then worked in the Department of Surgery at the Sahloul University Hospital in Sousse. Professor Derbel is presently working at the Clinique les Oliviers, Sousse, Tunisia. His hospital activities are mostly concerned with laparoscopic, colorectal, pancreatic, hepatobiliary, and gastric surgery. He is also very interested in hernia surgery and performs ventral hernia repairs and inguinal hernia repairs. He has been a member of the GREPA and Tunisian Hernia Society (THS). During his residency, he managed patients suffering from diabetic foot, and he was very interested in this pathology. For this reason, he decided to coordinate a book project dealing with the diabetic foot. Professor Derbel has published many articles in journals and collaborates intensively with IntechOpen Access Publisher as an editor.",institutionString:"Clinique les Oliviers",institution:null},{id:"300144",title:"Dr.",name:"Meriem",middleName:null,surname:"Braiki",slug:"meriem-braiki",fullName:"Meriem Braiki",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/300144/images/system/300144.jpg",biography:"Dr. Meriem Braiki is a specialist in pediatric surgeon from Tunisia. She was born in 1985. She received her medical degree from the University of Medicine at Sousse, Tunisia. She achieved her surgical residency training periods in Pediatric Surgery departments at University Hospitals in Monastir, Tunis and France.\r\nShe is currently working at the Pediatric surgery department, Sidi Bouzid Hospital, Tunisia. Her hospital activities are mostly concerned with laparoscopic, parietal, urological and digestive surgery. She has published several articles in diffrent journals.",institutionString:"Sidi Bouzid Regional Hospital",institution:null},{id:"229481",title:"Dr.",name:"Erika M.",middleName:"Martins",surname:"de Carvalho",slug:"erika-m.-de-carvalho",fullName:"Erika M. de Carvalho",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/229481/images/6397_n.jpg",biography:null,institutionString:null,institution:{name:"Oswaldo Cruz Foundation",country:{name:"Brazil"}}},{id:"186537",title:"Prof.",name:"Tonay",middleName:null,surname:"Inceboz",slug:"tonay-inceboz",fullName:"Tonay Inceboz",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/186537/images/system/186537.jfif",biography:"I was graduated from Ege University of Medical Faculty (Turkey) in 1988 and completed his Med. PhD degree in Medical Parasitology at the same university. I became an Associate Professor in 2008 and Professor in 2014. I am currently working as a Professor at the Department of Medical Parasitology at Dokuz Eylul University, Izmir, Turkey.\n\nI have given many lectures, presentations in different academic meetings. I have more than 60 articles in peer-reviewed journals, 18 book chapters, 1 book editorship.\n\nMy research interests are Echinococcus granulosus, Echinococcus multilocularis (diagnosis, life cycle, in vitro and in vivo cultivation), and Trichomonas vaginalis (diagnosis, PCR, and in vitro cultivation).",institutionString:"Dokuz Eylül University",institution:{name:"Dokuz Eylül University",country:{name:"Turkey"}}},{id:"71812",title:"Prof.",name:"Hanem Fathy",middleName:"Fathy",surname:"Khater",slug:"hanem-fathy-khater",fullName:"Hanem Fathy Khater",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/71812/images/1167_n.jpg",biography:"Prof. Khater is a Professor of Parasitology at Benha University, Egypt. She studied for her doctoral degree, at the Department of Entomology, College of Agriculture, Food and Natural Resources, University of Missouri, Columbia, USA. She has completed her Ph.D. degrees in Parasitology in Egypt, from where she got the award for “the best scientific Ph.D. dissertation”. She worked at the School of Biological Sciences, Bristol, England, the UK in controlling insects of medical and veterinary importance as a grant from Newton Mosharafa, the British Council. Her research is focused on searching of pesticides against mosquitoes, house flies, lice, green bottle fly, camel nasal botfly, soft and hard ticks, mites, and the diamondback moth as well as control of several parasites using safe and natural materials to avoid drug resistances and environmental contamination.",institutionString:null,institution:{name:"Banha University",country:{name:"Egypt"}}},{id:"99780",title:"Prof.",name:"Omolade",middleName:"Olayinka",surname:"Okwa",slug:"omolade-okwa",fullName:"Omolade Okwa",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/99780/images/system/99780.jpg",biography:"Omolade Olayinka Okwa is presently a Professor of Parasitology at Lagos State University, Nigeria. She has a PhD in Parasitology (1997), an MSc in Cellular Parasitology (1992), and a BSc (Hons) Zoology (1990) all from the University of Ibadan, Nigeria. She teaches parasitology at the undergraduate and postgraduate levels. She was a recipient of a Commonwealth fellowship supported by British Council tenable at the Centre for Entomology and Parasitology (CAEP), Keele University, United Kingdom between 2004 and 2005. She was awarded an Honorary Visiting Research Fellow at the same university from 2005 to 2007. \nShe has been an external examiner to the Department of Veterinary Microbiology and Parasitology, University of Ibadan, MSc programme between 2010 and 2012. She is a member of the Nigerian Society of Experimental Biology (NISEB), Parasitology and Public Health Society of Nigeria (PPSN), Science Association of Nigeria (SAN), Zoological Society of Nigeria (ZSN), and is Vice Chairperson of the Organisation of Women in Science (OWSG), LASU chapter. She served as Head of Department of Zoology and Environmental Biology, Lagos State University from 2007 to 2010 and 2014 to 2016. She is a reviewer for several local and international journals such as Unilag Journal of Science, Libyan Journal of Medicine, Journal of Medicine and Medical Sciences, and Annual Research and Review in Science. \nShe has authored 45 scientific research publications in local and international journals, 8 scientific reviews, 4 books, and 3 book chapters, which includes the books “Malaria Parasites” and “Malaria” which are IntechOpen access publications.",institutionString:"Lagos State University",institution:{name:"Lagos State University",country:{name:"Nigeria"}}},{id:"273100",title:"Dr.",name:"Vijay",middleName:null,surname:"Gayam",slug:"vijay-gayam",fullName:"Vijay Gayam",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/273100/images/system/273100.jpeg",biography:"Dr. Vijay Bhaskar Reddy Gayam is currently practicing as an internist at Interfaith Medical Center in Brooklyn, New York, USA. He is also a Clinical Assistant Professor at the SUNY Downstate University Hospital and Adjunct Professor of Medicine at the American University of Antigua. He is a holder of an M.B.B.S. degree bestowed to him by Osmania Medical College and received his M.D. at Interfaith Medical Center. His career goals thus far have heavily focused on direct patient care, medical education, and clinical research. He currently serves in two leadership capacities; Assistant Program Director of Medicine at Interfaith Medical Center and as a Councilor for the American\r\nFederation for Medical Research. As a true academician and researcher, he has more than 50 papers indexed in international peer-reviewed journals. He has also presented numerous papers in multiple national and international scientific conferences. His areas of research interest include general internal medicine, gastroenterology and hepatology. He serves as an editor, editorial board member and reviewer for multiple international journals. His research on Hepatitis C has been very successful and has led to multiple research awards, including the 'Equity in Prevention and Treatment Award” from the New York Department of Health Viral Hepatitis Symposium (2018) and the 'Presidential Poster Award” awarded to him by the American College of Gastroenterology (2018). He was also awarded 'Outstanding Clinician in General Medicine” by Venus International Foundation for his extensive research expertise and services, perform over and above the standard expected in the advancement of healthcare, patient safety and quality of care.",institutionString:"Interfaith Medical Center",institution:{name:"Interfaith Medical Center",country:{name:"United States of America"}}},{id:"93517",title:"Dr.",name:"Clement",middleName:"Adebajo",surname:"Meseko",slug:"clement-meseko",fullName:"Clement Meseko",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/93517/images/system/93517.jpg",biography:"Dr. Clement Meseko obtained DVM and PhD degree in Veterinary Medicine and Virology respectively. He has worked for over 20 years in both private and public sectors including the academia, contributing to knowledge and control of infectious disease. Through the application of epidemiological skill, classical and molecular virological skills, he investigates viruses of economic and public health importance for the mitigation of the negative impact on people, animal and the environment in the context of Onehealth. \r\nDr. Meseko’s field experience on animal and zoonotic diseases and pathogen dynamics at the human-animal interface over the years shaped his carrier in research and scientific inquiries. He has been part of the investigation of Highly Pathogenic Avian Influenza incursions in sub Saharan Africa and monitors swine Influenza (Pandemic influenza Virus) agro-ecology and potential for interspecies transmission. He has authored and reviewed a number of journal articles and book chapters.",institutionString:"National Veterinary Research Institute",institution:{name:"National Veterinary Research Institute",country:{name:"Nigeria"}}},{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",biography:"Professor Dr. Shailendra K. Saxena is a vice dean and professor at King George's Medical University, Lucknow, India. His research interests involve understanding the molecular mechanisms of host defense during human viral infections and developing new predictive, preventive, and therapeutic strategies for them using Japanese encephalitis virus (JEV), HIV, and emerging viruses as a model via stem cell and cell culture technologies. His research work has been published in various high-impact factor journals (Science, PNAS, Nature Medicine) with a high number of citations. He has received many awards and honors in India and abroad including various Young Scientist Awards, BBSRC India Partnering Award, and Dr. JC Bose National Award of Department of Biotechnology, Min. of Science and Technology, Govt. of India. Dr. Saxena is a fellow of various international societies/academies including the Royal College of Pathologists, United Kingdom; Royal Society of Medicine, London; Royal Society of Biology, United Kingdom; Royal Society of Chemistry, London; and Academy of Translational Medicine Professionals, Austria. He was named a Global Leader in Science by The Scientist. He is also an international opinion leader/expert in vaccination for Japanese encephalitis by IPIC (UK).",institutionString:"King George's Medical University",institution:{name:"King George's Medical University",country:{name:"India"}}},{id:"94928",title:"Dr.",name:"Takuo",middleName:null,surname:"Mizukami",slug:"takuo-mizukami",fullName:"Takuo Mizukami",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/94928/images/6402_n.jpg",biography:null,institutionString:null,institution:{name:"National Institute of Infectious Diseases",country:{name:"Japan"}}},{id:"233433",title:"Dr.",name:"Yulia",middleName:null,surname:"Desheva",slug:"yulia-desheva",fullName:"Yulia Desheva",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/233433/images/system/233433.png",biography:"Dr. Yulia Desheva is a leading researcher at the Institute of Experimental Medicine, St. Petersburg, Russia. She is a professor in the Stomatology Faculty, St. Petersburg State University. She has expertise in the development and evaluation of a wide range of live mucosal vaccines against influenza and bacterial complications. Her research interests include immunity against influenza and COVID-19 and the development of immunization schemes for high-risk individuals.",institutionString:'Federal State Budgetary Scientific Institution "Institute of Experimental Medicine"',institution:null},{id:"238958",title:"Mr.",name:"Atamjit",middleName:null,surname:"Singh",slug:"atamjit-singh",fullName:"Atamjit Singh",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/238958/images/6575_n.jpg",biography:null,institutionString:null,institution:null},{id:"252058",title:"M.Sc.",name:"Juan",middleName:null,surname:"Sulca",slug:"juan-sulca",fullName:"Juan Sulca",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/252058/images/12834_n.jpg",biography:null,institutionString:null,institution:null},{id:"191392",title:"Dr.",name:"Marimuthu",middleName:null,surname:"Govindarajan",slug:"marimuthu-govindarajan",fullName:"Marimuthu Govindarajan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/191392/images/5828_n.jpg",biography:"Dr. M. Govindarajan completed his BSc degree in Zoology at Government Arts College (Autonomous), Kumbakonam, and MSc, MPhil, and PhD degrees at Annamalai University, Annamalai Nagar, Tamil Nadu, India. He is serving as an assistant professor at the Department of Zoology, Annamalai University. His research interests include isolation, identification, and characterization of biologically active molecules from plants and microbes. He has identified more than 20 pure compounds with high mosquitocidal activity and also conducted high-quality research on photochemistry and nanosynthesis. He has published more than 150 studies in journals with impact factor and 2 books in Lambert Academic Publishing, Germany. He serves as an editorial board member in various national and international scientific journals.",institutionString:null,institution:null},{id:"274660",title:"Dr.",name:"Damodar",middleName:null,surname:"Paudel",slug:"damodar-paudel",fullName:"Damodar Paudel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/274660/images/8176_n.jpg",biography:"I am DrDamodar Paudel,currently working as consultant Physician in Nepal police Hospital.",institutionString:null,institution:null},{id:"241562",title:"Dr.",name:"Melvin",middleName:null,surname:"Sanicas",slug:"melvin-sanicas",fullName:"Melvin Sanicas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/241562/images/6699_n.jpg",biography:null,institutionString:null,institution:null},{id:"117248",title:"Dr.",name:"Andrew",middleName:null,surname:"Macnab",slug:"andrew-macnab",fullName:"Andrew Macnab",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of British Columbia",country:{name:"Canada"}}},{id:"322007",title:"Dr.",name:"Maria Elizbeth",middleName:null,surname:"Alvarez-Sánchez",slug:"maria-elizbeth-alvarez-sanchez",fullName:"Maria Elizbeth Alvarez-Sánchez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidad Autónoma de la Ciudad de México",country:{name:"Mexico"}}},{id:"337443",title:"Dr.",name:"Juan",middleName:null,surname:"A. Gonzalez-Sanchez",slug:"juan-a.-gonzalez-sanchez",fullName:"Juan A. Gonzalez-Sanchez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Puerto Rico System",country:{name:"United States of America"}}},{id:"337446",title:"Dr.",name:"Maria",middleName:null,surname:"Zavala-Colon",slug:"maria-zavala-colon",fullName:"Maria Zavala-Colon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Puerto Rico, Medical Sciences Campus",country:{name:"United States of America"}}}]}},subseries:{item:{id:"19",type:"subseries",title:"Animal Science",keywords:"Animal Science, Animal Biology, Wildlife Species, Domesticated Animals",scope:"The Animal Science topic welcomes research on captive and wildlife species, including domesticated animals. The research resented can consist of primary studies on various animal biology fields such as genetics, nutrition, behavior, welfare, and animal production, to name a few. Reviews on specialized areas of animal science are also welcome.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/19.jpg",hasOnlineFirst:!0,hasPublishedBooks:!0,annualVolume:11415,editor:{id:"259298",title:"Dr.",name:"Edward",middleName:null,surname:"Narayan",slug:"edward-narayan",fullName:"Edward Narayan",profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",biography:"Dr. Edward Narayan graduated with Ph.D. degree in Biology from the University of the South Pacific and pioneered non-invasive reproductive and stress endocrinology tools for amphibians - the novel development and validation of non-invasive enzyme immunoassays for the evaluation of reproductive hormonal cycle and stress hormone responses to environmental stressors. \nDr. Narayan leads the Stress Lab (Comparative Physiology and Endocrinology) at the University of Queensland. A dynamic career research platform which is based on the thematic areas of comparative vertebrate physiology, stress endocrinology, reproductive endocrinology, animal health and welfare, and conservation biology. \nEdward has supervised 40 research students and published over 60 peer reviewed research.",institutionString:null,institution:{name:"University of Queensland",institutionURL:null,country:{name:"Australia"}}},editorTwo:null,editorThree:null,series:{id:"13",title:"Veterinary Medicine and Science",doi:"10.5772/intechopen.73681",issn:"2632-0517"},editorialBoard:[{id:"258334",title:"Dr.",name:"Carlos Eduardo",middleName:null,surname:"Fonseca-Alves",slug:"carlos-eduardo-fonseca-alves",fullName:"Carlos Eduardo Fonseca-Alves",profilePictureURL:"https://mts.intechopen.com/storage/users/258334/images/system/258334.jpg",institutionString:null,institution:{name:"Universidade Paulista",institutionURL:null,country:{name:"Brazil"}}},{id:"191123",title:"Dr.",name:"Juan José",middleName:null,surname:"Valdez-Alarcón",slug:"juan-jose-valdez-alarcon",fullName:"Juan José Valdez-Alarcón",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSBfcQAG/Profile_Picture_1631354558068",institutionString:"Universidad Michoacana de San Nicolás de Hidalgo",institution:{name:"Universidad Michoacana de San Nicolás de Hidalgo",institutionURL:null,country:{name:"Mexico"}}},{id:"161556",title:"Dr.",name:"Maria Dos Anjos",middleName:null,surname:"Pires",slug:"maria-dos-anjos-pires",fullName:"Maria Dos Anjos Pires",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bS8q2QAC/Profile_Picture_1633432838418",institutionString:null,institution:{name:"University of Trás-os-Montes and Alto Douro",institutionURL:null,country:{name:"Portugal"}}},{id:"209839",title:"Dr.",name:"Marina",middleName:null,surname:"Spinu",slug:"marina-spinu",fullName:"Marina Spinu",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRLXpQAO/Profile_Picture_1630044895475",institutionString:null,institution:{name:"University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca",institutionURL:null,country:{name:"Romania"}}},{id:"92185",title:"Dr.",name:"Sara",middleName:null,surname:"Savic",slug:"sara-savic",fullName:"Sara Savic",profilePictureURL:"https://mts.intechopen.com/storage/users/92185/images/system/92185.jfif",institutionString:'Scientific Veterinary Institute "Novi Sad"',institution:{name:'Scientific Veterinary Institute "Novi Sad"',institutionURL:null,country:{name:"Serbia"}}}]},onlineFirstChapters:{paginationCount:2,paginationItems:[{id:"82936",title:"Soil Degradation Processes Linked to Long-Term Forest-Type Damage",doi:"10.5772/intechopen.106390",signatures:"Pavel Samec, Aleš Kučera and Gabriela Tomášová",slug:"soil-degradation-processes-linked-to-long-term-forest-type-damage",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Forest Degradation Under Global Change",coverURL:"https://cdn.intechopen.com/books/images_new/11457.jpg",subseries:{id:"94",title:"Climate Change and Environmental Sustainability"}}},{id:"82124",title:"Assessment of Diversity, Growth Characteristics and Aboveground Biomass of Tree Species in Selected Urban Green Areas of Osogbo, Osun State",doi:"10.5772/intechopen.104982",signatures:"Omolara Aremu, Olusola O. Adetoro and Olusegun Awotoye",slug:"assessment-of-diversity-growth-characteristics-and-aboveground-biomass-of-tree-species-in-selected-u",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Forest Degradation Under Global Change",coverURL:"https://cdn.intechopen.com/books/images_new/11457.jpg",subseries:{id:"94",title:"Climate Change and Environmental Sustainability"}}}]},publishedBooks:{paginationCount:5,paginationItems:[{type:"book",id:"8737",title:"Rabies Virus at the Beginning of 21st Century",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8737.jpg",slug:"rabies-virus-at-the-beginning-of-21st-century",publishedDate:"May 11th 2022",editedByType:"Edited by",bookSignature:"Sergey Tkachev",hash:"49cce3f548da548c718c865feb343509",volumeInSeries:9,fullTitle:"Rabies Virus at the Beginning of 21st Century",editors:[{id:"61139",title:"Dr.",name:"Sergey",middleName:null,surname:"Tkachev",slug:"sergey-tkachev",fullName:"Sergey Tkachev",profilePictureURL:"https://mts.intechopen.com/storage/users/61139/images/system/61139.png",institutionString:"Russian Academy of Sciences",institution:{name:"Russian Academy of Sciences",institutionURL:null,country:{name:"Russia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10497",title:"Canine Genetics, Health and Medicine",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10497.jpg",slug:"canine-genetics-health-and-medicine",publishedDate:"June 2nd 2021",editedByType:"Edited by",bookSignature:"Catrin Rutland",hash:"b91512e31ce34032e560362e6cbccc1c",volumeInSeries:7,fullTitle:"Canine Genetics, Health and Medicine",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9081",title:"Equine Science",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9081.jpg",slug:"equine-science",publishedDate:"September 23rd 2020",editedByType:"Edited by",bookSignature:"Catrin Rutland and Albert Rizvanov",hash:"ac415ef2f5450fa80fdb9cf6cf32cd2d",volumeInSeries:5,fullTitle:"Equine Science",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8524",title:"Lactation in Farm Animals",subtitle:"Biology, Physiological Basis, Nutritional Requirements, and Modelization",coverURL:"https://cdn.intechopen.com/books/images_new/8524.jpg",slug:"lactation-in-farm-animals-biology-physiological-basis-nutritional-requirements-and-modelization",publishedDate:"January 22nd 2020",editedByType:"Edited by",bookSignature:"Naceur M'Hamdi",hash:"2aa2a9a0ec13040bbf0455e34625504e",volumeInSeries:3,fullTitle:"Lactation in Farm Animals - Biology, Physiological Basis, Nutritional Requirements, and Modelization",editors:[{id:"73376",title:"Dr.",name:"Naceur",middleName:null,surname:"M'Hamdi",slug:"naceur-m'hamdi",fullName:"Naceur M'Hamdi",profilePictureURL:"https://mts.intechopen.com/storage/users/73376/images/system/73376.jpg",institutionString:null,institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7144",title:"Veterinary Anatomy and Physiology",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7144.jpg",slug:"veterinary-anatomy-and-physiology",publishedDate:"March 13th 2019",editedByType:"Edited by",bookSignature:"Catrin Sian Rutland and Valentina Kubale",hash:"75cdacb570e0e6d15a5f6e69640d87c9",volumeInSeries:2,fullTitle:"Veterinary Anatomy and Physiology",editors:[{id:"202192",title:"Dr.",name:"Catrin",middleName:null,surname:"Rutland",slug:"catrin-rutland",fullName:"Catrin Rutland",profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",institutionString:null,institution:{name:"University of Nottingham",institutionURL:null,country:{name:"United Kingdom"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:11,numberOfPublishedChapters:91,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:108,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:333,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:11,numberOfPublishedChapters:144,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:126,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:23,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:13,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[{id:"3",title:"Bacterial Infectious Diseases",scope:"
\r\n\tThe era of antibiotics led us to the illusion that the problem of bacterial infection is over. However, bacterial flexibility and adaptation mechanisms allow them to survive and grow in extreme conditions. The best example is the formation of a sophisticated society of bacteria defined as a biofilm. Understanding the mechanism of bacterial biofilm formation has changed our perception of the development of bacterial infection but successfully eradicating biofilm remains a challenge. Considering the above, it is not surprising that bacteria remain a major public health threat despite the development of many groups of antibiotics. Additionally, increasing prevalence of acquired antibiotic resistance forces us to realize that we are far from controlling the development of bacterial infections. On the other hand, many infections are endogenous and result from an unbalanced relationship between the host and the microorganism. The increasing use of immunosuppressants, such as chemotherapy or organ transplantation, increases the incidence of patients highly susceptible to bacterial infections in the population.
\r\n
\r\n\tThis topic will focus on the current challenges and advantages in the diagnosis and treatment of bacterial infections. We will discuss the host-microbiota relationship, the treatment of chronic infections due to biofilm formation, and the development of new diagnostic tools to rapidly distinguish between colonization and probable infection.
",coverUrl:"https://cdn.intechopen.com/series_topics/covers/3.jpg",keywords:"Antibiotics, Biofilm, Antibiotic Resistance, Host-microbiota Relationship, Treatment, Diagnostic Tools"},{id:"4",title:"Fungal Infectious Diseases",scope:"Fungi are ubiquitous and there are almost no non-pathogenic fungi. Fungal infectious illness prevalence and prognosis are determined by the exposure between fungi and host, host immunological state, fungal virulence, and early and accurate diagnosis and treatment. \r\nPatients with both congenital and acquired immunodeficiency are more likely to be infected with opportunistic mycosis. Fungal infectious disease outbreaks are common during the post- disaster rebuilding era, which is characterised by high population density, migration, and poor health and medical conditions.\r\nSystemic or local fungal infection is mainly associated with the fungi directly inhaled or inoculated in the environment during the disaster. The most common fungal infection pathways are human to human (anthropophilic), animal to human (zoophilic), and environment to human (soilophile). Diseases are common as a result of widespread exposure to pathogenic fungus dispersed into the environment. \r\nFungi that are both common and emerging are intertwined. In Southeast Asia, for example, Talaromyces marneffei is an important pathogenic thermally dimorphic fungus that causes systemic mycosis. Widespread fungal infections with complicated and variable clinical manifestations, such as Candida auris infection resistant to several antifungal medicines, Covid-19 associated with Trichoderma, and terbinafine resistant dermatophytosis in India, are among the most serious disorders. \r\nInappropriate local or systemic use of glucocorticoids, as well as their immunosuppressive effects, may lead to changes in fungal infection spectrum and clinical characteristics. Hematogenous candidiasis is a worrisome issue that affects people all over the world, particularly ICU patients. CARD9 deficiency and fungal infection have been major issues in recent years. Invasive aspergillosis is associated with a significant death rate. Special attention should be given to endemic fungal infections, identification of important clinical fungal infections advanced in yeasts, filamentous fungal infections, skin mycobiome and fungal genomes, and immunity to fungal infections.\r\nIn addition, endemic fungal diseases or uncommon fungal infections caused by Mucor irregularis, dermatophytosis, Malassezia, cryptococcosis, chromoblastomycosis, coccidiosis, blastomycosis, histoplasmosis, sporotrichosis, and other fungi, should be monitored. \r\nThis topic includes the research progress on the etiology and pathogenesis of fungal infections, new methods of isolation and identification, rapid detection, drug sensitivity testing, new antifungal drugs, schemes and case series reports. It will provide significant opportunities and support for scientists, clinical doctors, mycologists, antifungal drug researchers, public health practitioners, and epidemiologists from all over the world to share new research, ideas and solutions to promote the development and progress of medical mycology.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/4.jpg",keywords:"Emerging Fungal Pathogens, Invasive Infections, Epidemiology, Cell Membrane, Fungal Virulence, Diagnosis, Treatment"},{id:"5",title:"Parasitic Infectious Diseases",scope:"Parasitic diseases have evolved alongside their human hosts. In many cases, these diseases have adapted so well that they have developed efficient resilience methods in the human host and can live in the host for years. Others, particularly some blood parasites, can cause very acute diseases and are responsible for millions of deaths yearly. Many parasitic diseases are classified as neglected tropical diseases because they have received minimal funding over recent years and, in many cases, are under-reported despite the critical role they play in morbidity and mortality among human and animal hosts. The current topic, Parasitic Infectious Diseases, in the Infectious Diseases Series aims to publish studies on the systematics, epidemiology, molecular biology, genomics, pathogenesis, genetics, and clinical significance of parasitic diseases from blood borne to intestinal parasites as well as zoonotic parasites. We hope to cover all aspects of parasitic diseases to provide current and relevant research data on these very important diseases. In the current atmosphere of the Coronavirus pandemic, communities around the world, particularly those in different underdeveloped areas, are faced with the growing challenges of the high burden of parasitic diseases. At the same time, they are faced with the Covid-19 pandemic leading to what some authors have called potential syndemics that might worsen the outcome of such infections. Therefore, it is important to conduct studies that examine parasitic infections in the context of the coronavirus pandemic for the benefit of all communities to help foster more informed decisions for the betterment of human and animal health.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/5.jpg",keywords:"Blood Borne Parasites, Intestinal Parasites, Protozoa, Helminths, Arthropods, Water Born Parasites, Epidemiology, Molecular Biology, Systematics, Genomics, Proteomics, Ecology"},{id:"6",title:"Viral Infectious Diseases",scope:"The Viral Infectious Diseases Book Series aims to provide a comprehensive overview of recent research trends and discoveries in various viral infectious diseases emerging around the globe. The emergence of any viral disease is hard to anticipate, which often contributes to death. A viral disease can be defined as an infectious disease that has recently appeared within a population or exists in nature with the rapid expansion of incident or geographic range. This series will focus on various crucial factors related to emerging viral infectious diseases, including epidemiology, pathogenesis, host immune response, clinical manifestations, diagnosis, treatment, and clinical recommendations for managing viral infectious diseases, highlighting the recent issues with future directions for effective therapeutic strategies.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/6.jpg",keywords:"Novel Viruses, Virus Transmission, Virus Evolution, Molecular Virology, Control and Prevention, Virus-host Interaction"}],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983",scope:"Biochemistry, the study of chemical transformations occurring within living organisms, impacts all areas of life sciences, from molecular crystallography and genetics to ecology, medicine, and population biology. Biochemistry examines macromolecules - proteins, nucleic acids, carbohydrates, and lipids – and their building blocks, structures, functions, and interactions. Much of biochemistry is devoted to enzymes, proteins that catalyze chemical reactions, enzyme structures, mechanisms of action and their roles within cells. Biochemistry also studies small signaling molecules, coenzymes, inhibitors, vitamins, and hormones, which play roles in life processes. Biochemical experimentation, besides coopting classical chemistry methods, e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic tools, e.g., auxotroph mutants and their revertants, fermentation, etc. More recently, biochemistry embraced the ‘big data’ omics systems. Initial biochemical studies have been exclusively analytic: dissecting, purifying, and examining individual components of a biological system; in the apt words of Efraim Racker (1913 –1991), “Don’t waste clean thinking on dirty enzymes.” Today, however, biochemistry is becoming more agglomerative and comprehensive, setting out to integrate and describe entirely particular biological systems. The ‘big data’ metabolomics can define the complement of small molecules, e.g., in a soil or biofilm sample; proteomics can distinguish all the comprising proteins, e.g., serum; metagenomics can identify all the genes in a complex environment, e.g., the bovine rumen. This Biochemistry Series will address the current research on biomolecules and the emerging trends with great promise.",coverUrl:"https://cdn.intechopen.com/series/covers/11.jpg",latestPublicationDate:"August 17th, 2022",hasOnlineFirst:!0,numberOfOpenTopics:4,numberOfPublishedChapters:333,numberOfPublishedBooks:33,editor:{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}},subseries:[{id:"14",title:"Cell and Molecular Biology",keywords:"Omics (Transcriptomics; Proteomics; Metabolomics), Molecular Biology, Cell Biology, Signal Transduction and Regulation, Cell Growth and Differentiation, Apoptosis, Necroptosis, Ferroptosis, Autophagy, Cell Cycle, Macromolecules and Complexes, Gene Expression",scope:"The Cell and Molecular Biology topic within the IntechOpen Biochemistry Series aims to rapidly publish contributions on all aspects of cell and molecular biology, including aspects related to biochemical and genetic research (not only in humans but all living beings). We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics include, but are not limited to: Advanced techniques of cellular and molecular biology (Molecular methodologies, imaging techniques, and bioinformatics); Biological activities at the molecular level; Biological processes of cell functions, cell division, senescence, maintenance, and cell death; Biomolecules interactions; Cancer; Cell biology; Chemical biology; Computational biology; Cytochemistry; Developmental biology; Disease mechanisms and therapeutics; DNA, and RNA metabolism; Gene functions, genetics, and genomics; Genetics; Immunology; Medical microbiology; Molecular biology; Molecular genetics; Molecular processes of cell and organelle dynamics; Neuroscience; Protein biosynthesis, degradation, and functions; Regulation of molecular interactions in a cell; Signalling networks and system biology; Structural biology; Virology and microbiology.",annualVolume:11410,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",institutionString:"University of Alicante",institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"79367",title:"Dr.",name:"Ana Isabel",middleName:null,surname:"Flores",fullName:"Ana Isabel Flores",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRpIOQA0/Profile_Picture_1632418099564",institutionString:null,institution:{name:"Hospital Universitario 12 De Octubre",institutionURL:null,country:{name:"Spain"}}},{id:"328234",title:"Ph.D.",name:"Christian",middleName:null,surname:"Palavecino",fullName:"Christian Palavecino",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000030DhEhQAK/Profile_Picture_1628835318625",institutionString:null,institution:{name:"Central University of Chile",institutionURL:null,country:{name:"Chile"}}},{id:"186585",title:"Dr.",name:"Francisco Javier",middleName:null,surname:"Martin-Romero",fullName:"Francisco Javier Martin-Romero",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSB3HQAW/Profile_Picture_1631258137641",institutionString:null,institution:{name:"University of Extremadura",institutionURL:null,country:{name:"Spain"}}}]},{id:"15",title:"Chemical Biology",keywords:"Phenolic Compounds, Essential Oils, Modification of Biomolecules, Glycobiology, Combinatorial Chemistry, Therapeutic peptides, Enzyme Inhibitors",scope:"Chemical biology spans the fields of chemistry and biology involving the application of biological and chemical molecules and techniques. In recent years, the application of chemistry to biological molecules has gained significant interest in medicinal and pharmacological studies. This topic will be devoted to understanding the interplay between biomolecules and chemical compounds, their structure and function, and their potential applications in related fields. Being a part of the biochemistry discipline, the ideas and concepts that have emerged from Chemical Biology have affected other related areas. This topic will closely deal with all emerging trends in this discipline.",annualVolume:11411,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",editor:{id:"441442",title:"Dr.",name:"Şükrü",middleName:null,surname:"Beydemir",fullName:"Şükrü Beydemir",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003GsUoIQAV/Profile_Picture_1634557147521",institutionString:null,institution:{name:"Anadolu University",institutionURL:null,country:{name:"Turkey"}}},editorTwo:{id:"13652",title:"Prof.",name:"Deniz",middleName:null,surname:"Ekinci",fullName:"Deniz Ekinci",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLT1QAO/Profile_Picture_1634557223079",institutionString:null,institution:{name:"Ondokuz Mayıs University",institutionURL:null,country:{name:"Turkey"}}},editorThree:null,editorialBoard:[{id:"219081",title:"Dr.",name:"Abdulsamed",middleName:null,surname:"Kükürt",fullName:"Abdulsamed Kükürt",profilePictureURL:"https://mts.intechopen.com/storage/users/219081/images/system/219081.png",institutionString:null,institution:{name:"Kafkas University",institutionURL:null,country:{name:"Turkey"}}},{id:"241413",title:"Dr.",name:"Azhar",middleName:null,surname:"Rasul",fullName:"Azhar Rasul",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRT1oQAG/Profile_Picture_1635251978933",institutionString:null,institution:{name:"Government College University, Faisalabad",institutionURL:null,country:{name:"Pakistan"}}},{id:"178316",title:"Ph.D.",name:"Sergey",middleName:null,surname:"Sedykh",fullName:"Sergey Sedykh",profilePictureURL:"https://mts.intechopen.com/storage/users/178316/images/system/178316.jfif",institutionString:null,institution:{name:"Novosibirsk State University",institutionURL:null,country:{name:"Russia"}}}]},{id:"17",title:"Metabolism",keywords:"Biomolecules Metabolism, Energy Metabolism, Metabolic Pathways, Key Metabolic Enzymes, Metabolic Adaptation",scope:"Metabolism is frequently defined in biochemistry textbooks as the overall process that allows living systems to acquire and use the free energy they need for their vital functions or the chemical processes that occur within a living organism to maintain life. Behind these definitions are hidden all the aspects of normal and pathological functioning of all processes that the topic ‘Metabolism’ will cover within the Biochemistry Series. Thus all studies on metabolism will be considered for publication.",annualVolume:11413,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",editor:{id:"138626",title:"Dr.",name:"Yannis",middleName:null,surname:"Karamanos",fullName:"Yannis Karamanos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6Jv2QAE/Profile_Picture_1629356660984",institutionString:null,institution:{name:"Artois University",institutionURL:null,country:{name:"France"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"243049",title:"Dr.",name:"Anca",middleName:null,surname:"Pantea Stoian",fullName:"Anca Pantea Stoian",profilePictureURL:"https://mts.intechopen.com/storage/users/243049/images/system/243049.jpg",institutionString:null,institution:{name:"Carol Davila University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}},{id:"203824",title:"Dr.",name:"Attilio",middleName:null,surname:"Rigotti",fullName:"Attilio Rigotti",profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institutionString:null,institution:{name:"Pontifical Catholic University of Chile",institutionURL:null,country:{name:"Chile"}}},{id:"300470",title:"Dr.",name:"Yanfei (Jacob)",middleName:null,surname:"Qi",fullName:"Yanfei (Jacob) Qi",profilePictureURL:"https://mts.intechopen.com/storage/users/300470/images/system/300470.jpg",institutionString:null,institution:{name:"Centenary Institute of Cancer Medicine and Cell Biology",institutionURL:null,country:{name:"Australia"}}}]},{id:"18",title:"Proteomics",keywords:"Mono- and Two-Dimensional Gel Electrophoresis (1-and 2-DE), Liquid Chromatography (LC), Mass Spectrometry/Tandem Mass Spectrometry (MS; MS/MS), Proteins",scope:"With the recognition that the human genome cannot provide answers to the etiology of a disorder, changes in the proteins expressed by a genome became a focus in research. Thus proteomics, an area of research that detects all protein forms expressed in an organism, including splice isoforms and post-translational modifications, is more suitable than genomics for a comprehensive understanding of the biochemical processes that govern life. The most common proteomics applications are currently in the clinical field for the identification, in a variety of biological matrices, of biomarkers for diagnosis and therapeutic intervention of disorders. From the comparison of proteomic profiles of control and disease or different physiological states, which may emerge, changes in protein expression can provide new insights into the roles played by some proteins in human pathologies. Understanding how proteins function and interact with each other is another goal of proteomics that makes this approach even more intriguing. Specialized technology and expertise are required to assess the proteome of any biological sample. Currently, proteomics relies mainly on mass spectrometry (MS) combined with electrophoretic (1 or 2-DE-MS) and/or chromatographic techniques (LC-MS/MS). MS is an excellent tool that has gained popularity in proteomics because of its ability to gather a complex body of information such as cataloging protein expression, identifying protein modification sites, and defining protein interactions. The Proteomics topic aims to attract contributions on all aspects of MS-based proteomics that, by pushing the boundaries of MS capabilities, may address biological problems that have not been resolved yet.",annualVolume:11414,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null,editorialBoard:[{id:"72288",title:"Dr.",name:"Arli Aditya",middleName:null,surname:"Parikesit",fullName:"Arli Aditya Parikesit",profilePictureURL:"https://mts.intechopen.com/storage/users/72288/images/system/72288.jpg",institutionString:null,institution:{name:"Indonesia International Institute for Life Sciences",institutionURL:null,country:{name:"Indonesia"}}},{id:"40928",title:"Dr.",name:"Cesar",middleName:null,surname:"Lopez-Camarillo",fullName:"Cesar Lopez-Camarillo",profilePictureURL:"https://mts.intechopen.com/storage/users/40928/images/3884_n.png",institutionString:null,institution:{name:"Universidad Autónoma de la Ciudad de México",institutionURL:null,country:{name:"Mexico"}}},{id:"81926",title:"Dr.",name:"Shymaa",middleName:null,surname:"Enany",fullName:"Shymaa Enany",profilePictureURL:"https://mts.intechopen.com/storage/users/81926/images/system/81926.png",institutionString:"Suez Canal University",institution:{name:"Suez Canal University",institutionURL:null,country:{name:"Egypt"}}}]}]}},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"chapter.detail",path:"/chapters/64314",hash:"",query:{},params:{id:"64314"},fullPath:"/chapters/64314",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()